8-K


 
 
 
 
 
UNITED STATES SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
_____________________
FORM 8-K
_____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 9, 2016
_____________________
WILLIS TOWERS WATSON PUBLIC LIMITED COMPANY
(Exact name of registrant as specified in its charter)
_____________________
Ireland
001-16503
98-0352587
(State or other jurisdiction or incorporation)
(Commission File Number)
(IRS Employer Identification No.)
c/o Willis Group Limited,
51 Lime Street, London, EC3M 7DQ, England and Wales
(Address, including Zip Code, of Principal Executive Offices)
(011) 44-20-3124-6000
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
_____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:
¨    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))





 
 
 
 
 





Item 2.02. Results of Operations and Financial Condition
The information contained in Exhibits 99.1, 99.2 and 99.3 attached hereto is incorporated by reference into this Item 2.02. The information contained in this Item 2.02, including the attached exhibits, is being furnished under Item 2.02 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
Item 9.01. Financial Statements and Exhibits.
(a)
Financial Statements of Businesses Acquired. The unaudited condensed consolidated financial statements of Towers Watson & Co. for the six months ended December 31, 2015 and December 31, 2014, and the audited consolidated financial statements of Towers Watson & Co. for the fiscal year ended June 30, 2015, 2014 and 2013 are filed herewith as Exhibits 99.1 and 99.4, respectively and incorporated herein by reference.
(b)
Pro Forma Financial Information. The unaudited pro forma condensed consolidated financial information for Willis Towers Watson Public Limited Company as of and for the year ended December 31, 2015 is filed herewith as Exhibit 99.3 and incorporated herein by reference.
(d)Exhibits.
Exhibit No.

Description
23.1
 
Consent of Deloitte & Touche LLP
99.1

Unaudited Condensed Consolidated Financial Statements of Towers Watson & Co. for the three and six months ended December 31, 2015 and December 31, 2014
99.2
 
Non-GAAP financial measures and reported financial results of Towers Watson & Co. for the three and six months ended December 31, 2015 and December 31, 2014
99.3
 
Unaudited Pro Forma Condensed Consolidated Balance Sheet and the Condensed Consolidated Statement of Income of Willis Towers Watson Public Limited Company as of and for the year ended December 31, 2015
99.4

Audited Consolidated Financial Statements of Towers Watson & Co. for the fiscal year ended June 30, 2015, 2014 and 2013
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Willis Towers Watson Public Limited Company
 
 
By:
 
/s/ ROGER F. MILLAY
 
 
Roger F. Millay
 
 
Chief Financial Officer
 
 
 
By:
 
/s/ SUSAN D. DAVIES
 
 
Susan D. Davies
 
 
Controller and
 
 
Principal Accounting Officer
 
 
 
Dated: March 9, 2016








EXHIBIT INDEX

Exhibit No.
 
Description
23.1
 
Consent of Deloitte & Touche LLP
99.1
 
Unaudited Condensed Consolidated Financial Statements of Towers Watson & Co. for the three and six months ended December 31, 2015 and December 31, 2014
99.2
 
Non-GAAP financial measures and reported financial results of Towers Watson & Co. for the three and six months ended December 31, 2015 and December 31, 2014
99.3
 
Unaudited Pro Forma Condensed Consolidated Balance Sheet and the Condensed Consolidated Statement of Income of Willis Towers Watson Public Limited Company as of and for the year ended December 31, 2015
99.4
 
Audited Consolidated Financial Statements of Towers Watson & Co. for the fiscal year ended June 30, 2015, 2014 and 2013




Exhibit


Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in Registration Statement Nos. 333-208876, 333-197706, 333-62780, 333-63186, 333-130605, 333-153202, 333-153770, 333-169961 and 333-181150 on Form S-8 and 333-208924 on Form S-3 of Willis Towers Watson Public Limited Company of our report dated August 14, 2015, relating to the financial statements of Towers Watson & Co., appearing in the Current Report on Form 8-K of Willis Towers Watson Public Limited Company.

/s/ DELOITTE & TOUCHE LLP

McLean, Virginia

March 9, 2016




Exhibit


Exhibit 99.1
TOWERS WATSON & CO.
Condensed Consolidated Statements of Operations
(In thousands of U.S. dollars)
(Unaudited)
 
Three Months Ended December 31,
 
Six Months Ended December 31,
 
2015
 
2014
 
2015
 
2014
Revenue
$
949,615

 
$
957,922

 
$
1,845,236

 
$
1,836,029

Costs of providing services:
 
 
 
 
 
 
 
Salaries and employee benefits
547,267

 
556,319

 
1,091,739

 
1,089,847

Professional and subcontracted services
77,643

 
71,630

 
142,755

 
133,835

Occupancy
32,452

 
36,756

 
64,197

 
72,829

General and administrative expenses
87,007

 
82,100

 
158,377

 
157,534

Depreciation and amortization
53,752

 
44,107

 
97,944

 
88,976

Transaction and integration expenses
80,801

 

 
90,131

 

 
878,922

 
790,912

 
1,645,143

 
1,543,021

Income from operations
70,693

 
167,010

 
200,093

 
293,008

 
 
 
 
 
 
 
 
Loss from affiliates
(1,589
)
 

 
(1,538
)
 

Interest income
901

 
894

 
2,093

 
1,957

Interest expense
(3,060
)
 
(2,186
)
 
(5,132
)
 
(4,514
)
Other non-operating income
303

 
34

 
55,673

 
865

INCOME BEFORE INCOME TAXES
67,248

 
165,752

 
251,189

 
291,316

Provision for income taxes
55,653

 
55,372

 
116,211

 
99,434

NET INCOME BEFORE NON-CONTROLLING INTERESTS
11,595

 
110,380

 
134,978

 
191,882

Less: Income attributable to non-controlling interests
384

 
204

 
385

 
148

NET INCOME (attributable to common stockholders)
$
11,211

 
$
110,176

 
$
134,593

 
$
191,734

See accompanying notes to the condensed consolidated financial statements


1



TOWERS WATSON & CO.
Condensed Consolidated Statements of Comprehensive Income
(In thousands of U.S. dollars)
(Unaudited) 

 
Three Months Ended December 31,
 
Six Months Ended December 31,
 
2015
 
2014
 
2015
 
2014
Net income before non-controlling interests
$
11,595

 
$
110,380

 
$
134,978

 
$
191,882

Other comprehensive (loss)/income, net of tax:
 
 
 
 
 
 
 
Foreign currency translation
(55,707
)
 
(79,502
)
 
(127,265
)
 
(184,833
)
Defined pension and post-retirement benefit costs
5,676

 
2,844

 
10,444

 
5,719

Hedge effectiveness
68

 
92

 
(734
)
 
898

Available-for-sale securities
(120
)
 
(107
)
 
(202
)
 
(235
)
Other comprehensive loss before non-controlling interests
(50,083
)
 
(76,673
)
 
(117,757
)
 
(178,451
)
Comprehensive (loss)/income before non-controlling interests
(38,488
)
 
33,707

 
17,221

 
13,431

Comprehensive income/(loss) attributable to non-controlling interest
337

 
(288
)
 
332

 
(399
)
Comprehensive (loss)/income (attributable to common stockholders)
$
(38,825
)
 
$
33,995

 
$
16,889

 
$
13,830

See accompanying notes to the condensed consolidated financial statements


2



TOWERS WATSON & CO.
Condensed Consolidated Balance Sheets
(In thousands of U.S. dollars, except share data)
(Unaudited) 
 
December 31,
2015
 
June 30,
2015
Assets
 
 
 
Cash and cash equivalents
$
475,928

 
$
715,151

Fiduciary assets
26,582

 
38,075

Short-term investments
16,801

 
127,156

Receivables from clients:
 
 
 
Billed, net of allowances of $8,259 and $7,665
530,442

 
479,536

Unbilled, at estimated net realizable value
294,322

 
320,827

 
824,764

 
800,363

Other current assets
115,698

 
155,487

Total current assets
1,459,773

 
1,836,232

Fixed assets, net
404,209

 
390,681

Deferred income taxes
60,178

 
62,772

Goodwill
2,195,709

 
2,278,351

Intangible assets, net
614,195

 
654,087

Other assets
230,716

 
172,051

Total Assets
$
4,964,780

 
$
5,394,174

Liabilities
 
 
 
Accounts payable, accrued liabilities and deferred income
$
429,094

 
$
424,403

Employee-related liabilities
354,923

 
581,115

Fiduciary liabilities
26,582

 
38,075

Current portion of long-term debt
485,000

 
25,000

Other current liabilities
75,092

 
62,281

Total current liabilities
1,370,691

 
1,130,874

Revolving credit facility

 
40,000

Term loans
255,000

 
175,000

Accrued retirement benefits and other employee-related liabilities
598,352

 
648,655

Professional liability claims reserve
240,041

 
235,856

Other noncurrent liabilities
234,148

 
216,277

Total Liabilities
2,698,232

 
2,446,662

Commitments and contingencies
 
 
 
Stockholders’ Equity
 
 
 
Class A Common Stock — $0.01 par value: 300,000,000 shares authorized; 69,461,890 and 74,552,661 issued and 69,461,890 and 69,281,754 outstanding
694

 
746

Additional paid-in capital
1,464,974

 
1,870,745

Treasury stock, at cost — 0 and 5,270,907 shares

 
(429,286
)
Retained earnings
1,479,049

 
2,066,104

Accumulated other comprehensive loss
(694,002
)
 
(576,298
)
Total Stockholders’ Equity
2,250,715

 
2,932,011

Non-controlling interest
15,833

 
15,501

Total Equity
2,266,548

 
2,947,512

Total Liabilities and Total Equity
$
4,964,780

 
$
5,394,174

See accompanying notes to the condensed consolidated financial statements


3



TOWERS WATSON & CO.
Condensed Consolidated Statements of Cash Flows
(In thousands of U.S. dollars)
(Unaudited)
 
Six Months Ended December 31,
 
2015
 
2014
Cash flows (used in)/from operating activities:
 
 
 
Net income before non-controlling interests
$
134,978

 
$
191,882

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
Provision for doubtful receivables from clients
10,224

 
11,157

Depreciation
57,800

 
54,160

Amortization of intangible assets
40,144

 
34,816

Gain on sale of business, pretax
(55,390
)
 

Provision for deferred income taxes
16,609

 
24,569

Equity from affiliates
1,538

 

Stock-based compensation
12,760

 
18,414

Other, net
(3,114
)
 
535

Changes in operating assets and liabilities (net of business acquisitions)
 
 
 
Receivables from clients
(58,403
)
 
(76,970
)
Fiduciary assets
11,488

 
(7,783
)
Other current assets
(7,313
)
 
(15,117
)
Other noncurrent assets
(1,796
)
 
717

Accounts payable, accrued liabilities and deferred income
21,679

 
(31,885
)
Employee-related liabilities
(214,976
)
 
(104,651
)
Fiduciary liabilities
(11,488
)
 
7,783

Accrued retirement benefits and other employee-related liabilities
(56,273
)
 
(78,919
)
Professional liability claims reserves
8,787

 
15,427

Other current liabilities
7,313

 
14,682

Other noncurrent liabilities
3,944

 
(18,528
)
Income tax related accounts
73,858

 
(38,389
)
Cash flows (used in)/from operating activities
(7,631
)
 
1,900

Cash flows from investing activities:
 
 
 
Cash paid for business acquisitions
(16,023
)
 
(1,255
)
Net proceeds from sale of business
65,264

 

Fixed assets and software for internal use
(30,666
)
 
(33,113
)
Capitalized software costs
(43,019
)
 
(33,507
)
Purchases of held-to-maturity investments
(12,650
)
 
(155,927
)
Redemptions of held-to-maturity investments
116,923

 
214,510

Purchases of available-for-sale securities
(350
)
 
(1,677
)
Sales and redemptions of available-for-sale securities
526

 
11,734

Investment in affiliates
(4,832
)
 

Cash flows from investing activities
75,173

 
765

Cash flows used in financing activities:
 
 
 
Borrowings under credit facility
1,011,500

 
275,000

Repayments under credit facility
(869,000
)
 
(225,000
)
Borrowings under term loan
340,000

 

Repayment of Term Loan
(12,500
)
 
(12,500
)
Loan origination fees
(1,218
)
 

Cash paid on retention liability
(10,067
)
 
(10,338
)
Dividends paid
(726,109
)
 
(20,204
)
Repurchases of common stock

 
(81,410
)
Payroll tax payments on vested shares
(12,410
)
 
(10,833
)
Issuances of common stock and excess tax benefit
12,576

 
4,618

Cash flows used in financing activities
(267,228
)
 
(80,667
)
Effect of exchange rates on cash
(39,537
)
 
(28,456
)
Decrease in cash and cash equivalents
(239,223
)
 
(106,458
)
Cash and cash equivalents at beginning of period
715,151

 
727,849

Cash and cash equivalents at end of period
$
475,928

 
$
621,391

Supplemental disclosures:
 
 
 
Cash paid for interest
$
2,389

 
$
1,956

Cash paid for income taxes, net of refunds
$
12,424

 
$
104,927

Common stock issued upon the vesting of our restricted stock units
$
21,185

 
$

See accompanying notes to the condensed consolidated financial statements

4



TOWERS WATSON & CO.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
(In thousands of U.S. Dollars and numbers of shares in thousands)
(Unaudited)
 
 
Class A
Common
Stock
Outstanding
 
Class A
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury
Stock, at
Cost
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
(Loss)/Income
 
Non-
Controlling
Interest
 
Total
Balance as of June 30, 2014
74,552

 
$
746

 
$
1,849,119

 
$
(286,182
)
 
$
1,722,927

 
$
(189,702
)
 
$
14,041

 
$
3,110,949

Net income

 

 

 

 
191,734

 

 
148

 
191,882

Other comprehensive loss

 

 

 

 

 
(177,904
)
 
(547
)
 
(178,451
)
Repurchases of common stock

 

 

 
(81,410
)
 

 

 

 
(81,410
)
Shares received for employee taxes upon vesting of restricted stock units

 

 

 
(6,675
)
 

 

 

 
(6,675
)
Exercises of stock options

 

 
(2,298
)
 
2,354

 

 

 

 
56

Vesting of restricted stock units

 

 
(3,965
)
 
8,924

 

 

 

 
4,959

Class A Common Stock:
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Cash dividends declared

 

 

 

 
(21,116
)
 

 

 
(21,116
)
Excess tax benefits

 

 
4,618

 

 

 

 

 
4,618

Stock-based compensation

 

 
18,414

 

 

 

 

 
18,414

Balance as of December 31, 2014
74,552

 
$
746

 
$
1,865,888

 
$
(362,989
)
 
$
1,893,545

 
$
(367,606
)
 
$
13,642

 
$
3,043,226

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance as of June 30, 2015
74,552

 
$
746

 
$
1,870,745

 
$
(429,286
)
 
$
2,066,104

 
$
(576,298
)
 
$
15,501

 
$
2,947,512

Net income

 

 

 

 
134,593

 

 
385

 
134,978

Other comprehensive loss

 

 

 

 

 
(117,704
)
 
(53
)
 
(117,757
)
Shares received for employee taxes upon vesting of restricted stock units

 

 

 
(8,445
)
 

 

 

 
(8,445
)
Exercises of stock options

 

 
(937
)
 
1,887

 

 

 

 
950

Vesting of restricted stock units

 

 
(14,295
)
 
21,185

 

 

 

 
6,890

Treasury stock retirement
(5,090
)
 
(52
)
 
(414,607
)
 
414,659

 
 
 
 
 
 
 

Class A Common Stock:
 
 
 
 
 
 
 
 
 
 
 
 
 
 


Cash dividends declared

 

 

 

 
(721,648
)
 

 

 
(721,648
)
Excess tax benefits

 

 
11,626

 

 

 

 

 
11,626

Stock-based compensation

 

 
12,442

 

 

 

 

 
12,442

Balance as of December 31, 2015
69,462

 
$
694

 
$
1,464,974

 
$

 
$
1,479,049

 
$
(694,002
)
 
$
15,833

 
$
2,266,548

See accompanying notes to the condensed consolidated financial statements


5



TOWERS WATSON & CO.
Notes to the Condensed Consolidated Financial Statements
(Tabular amounts are in thousands)
(Unaudited)
Note 1 — Organization, Basis of Presentation and Merger
The accompanying unaudited quarterly condensed consolidated financial statements of Towers Watson & Co. (“Towers Watson”, the “Company” or “we”) and our subsidiaries are presented in accordance with U.S. GAAP, which requires management to make estimates and assumptions, including estimates of future contract costs and earnings. Such estimates and assumptions affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and earnings during the current reporting period. Management periodically assesses and evaluates the adequacy and/or deficiency of estimated liabilities recorded for various reserves, liabilities, contract risks and uncertainties. Actual results could differ from these estimates. In the opinion of management, these condensed consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are necessary for a fair presentation of the condensed consolidated financial statements and results for the interim periods. All intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements should be read together with the Towers Watson audited consolidated financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K for the fiscal year ended June 30, 2015, which was filed with the SEC on August 14, 2015, and may be accessed via EDGAR on the SEC’s web site at www.sec.gov.
Our fiscal year 2016 began July 1, 2015 and ends June 30, 2016.
The results of operations for the three and six months ended December 31, 2015 are not necessarily indicative of the results that can be expected for the entire fiscal year ending June 30, 2016. The results reflect certain estimates and assumptions made by management including those estimates used in calculating acquisition consideration and fair value of tangible and intangible assets and liabilities, professional liability claims, estimated bonuses, valuation of billed and unbilled receivables, and anticipated tax liabilities that affect the amounts reported in the condensed consolidated financial statements and related notes.
Merger
Towers Watson merged with Willis Group Holdings Public Limited Company (“Willis”) on January 4, 2016, pursuant to the previously announced Agreement and Plan of Merger (the “Merger”). The Merger was accounted for using the acquisition method of accounting with Willis considered the accounting acquirer of Towers Watson and Willis the surviving entity. Immediately following the Merger, Willis effected an amendment to its Constitution and other organizational documents to change its name from Willis Group Holdings Public Limited Company to Willis Towers Watson Public Limited Company (“Willis Towers Watson”).
Please see Note 2 — Merger, Acquisitions and Divestitures for more information related to this Merger.
Recent Accounting Pronouncements
Not yet adopted
On May 28, 2014, the Financial Accounting Standards Board (“FASB”) and International Accounting Standards Board (“IASB”) issued their final standard on revenue from contracts with customers. The standard, issued as Accounting Standards Update (“ASU”) 2014-09 by the FASB, outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, and supersedes most current revenue recognition guidance. The core principle of the revenue model is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU applies to all contracts with customers, except those that are within the scope of other topics in the FASB Accounting Standards Codification. Compared with current U.S. GAAP, the ASU also requires significantly expanded disclosures about revenue recognition. The ASU was originally effective for interim and annual reporting periods that begin after December 15, 2016, and early adoption was prohibited. However, the FASB issued ASU 2015-14 on August 12, 2015, which defers the adoption date for one year and allows for early adoption. ASU 2014-09 is now effective for interim and annual reporting periods that begin after December 15, 2017.
On June 19, 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide a Performance Target Could Be Achieved After the Requisite Service Period. The ASU is intended to resolve the diverse accounting treatment of these types of awards in practice. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in “Compensation - Stock Compensation (Topic 718)” as it relates to awards with

6



performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved, and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The ASU is effective for interim and annual reporting periods that begin after December 15, 2015.
On September 25, 2015, the FASB issued ASU 2015-16, Business Combinations, Simplifying the Accounting for Measurement Period Adjustments. The ASU eliminates the requirement that an acquirer in a business combination account for measurement-period adjustments retrospectively. Instead, an acquirer will recognize a measurement-period adjustment during the period in which it determines the amount of the adjustment, including the effect on earnings of any amounts it would have recorded in previous periods if the accounting had been completed at the acquisition date. The ASU is effective for interim and annual periods that begin after December 15, 2015.
On November 20 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes.  The ASU simplifies the accounting for deferred taxes by allowing issuers to classify all deferred taxes as non-current. The ASU is effective for interim and annual periods that begin after December 15, 2016. Early adoption is permitted for all entities as of the beginning of an interim or annual reporting period.
On January 5, 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities. The ASU requires that equity securities be measured at fair value with changes in fair value recognized in net income and simplifies the impairment assessment of equity securities without readily determinable fair values. The ASU also makes changes to disclosure and presentation requirements of certain financial assets and liabilities. The ASU is effective for interim and annual periods that begin after December 15, 2017. Early adoption is not permitted.
There were no accounting pronouncements adopted in the current period. Due to the Merger closing on January 4, 2016, we are evaluating all accounting policies and pending pronouncements and integrating accounting policies and adoption dates as part of Willis Towers Watson.
Note 2 — Merger, Acquisitions and Divestitures
Merger
Subsequent to the Balance Sheet date, on January 4, 2016, pursuant to the previously announced Agreement and Plan of Merger, dated June 29, 2015, as amended on November 19, 2015 (the “Merger Agreement”), between Willis, Towers Watson, and Citadel Merger Sub, Inc., a wholly-owned subsidiary of Willis formed for the purpose of facilitating this transaction (“Merger Sub”), Merger Sub merged with and into Towers Watson with Towers Watson continuing as the surviving corporation and a wholly-owned subsidiary of Willis.
At the effective time of the Merger (the “Effective Time”), each issued and outstanding share of Towers Watson common stock (the “Towers Watson shares”), was converted into the right to receive 2.6490 validly issued, fully paid and nonassessable ordinary shares of Willis (the “Willis ordinary shares”), $0.000115 nominal value per share, other than any Towers Watson shares owned by Towers Watson, Willis or Merger Sub at the Effective Time and the Towers Watson shares held by stockholders who are entitled to and who properly exercised dissenter’s rights under Delaware law.
Immediately following the Merger, Willis effected (i) a consolidation (i.e., a reverse stock split under Irish law) of Willis ordinary shares whereby every 2.6490 Willis ordinary shares were consolidated into one Willis ordinary share (the “Consolidation”) and (ii) an amendment to its Constitution and other organizational documents to change its name from Willis Group Holdings Public Limited Company to Willis Towers Watson Public Limited Company.
On December 29, 2015, the third business day immediately prior to the closing date, Towers Watson declared and paid a special dividend (the “pre-Merger special dividend”), in an amount of $10.00 per share of Towers Watson common stock, approximately $694 million in the aggregate based on approximately 69 million Towers Watson shares issued and outstanding at December 29, 2015.
On December 30, 2015, all Towers Watson treasury stock was canceled.
The Merger was accounted for using the acquisition method of accounting with Willis considered the accounting acquirer of Towers Watson.

7



The table below presents the calculation of aggregate Merger Consideration.
 
 
January 4, 2016
Number of shares of Towers Watson common stock outstanding as of January 4, 2016
 
69 million

Exchange ratio
 
2.649

Number of Willis Group Holdings shares issued (prior to reverse stock split)
 
184 million

Willis Group Holdings price per share on January 4, 2016
 
$
47.18

Fair value (millions) of 184 million Willis ordinary shares
 
$
8,686

Value of equity awards assumed
 
37

Preliminary estimated aggregate Merger Consideration
 
$
8,723

Acquisitions
Longitude Acquisition
On October 1, 2015, Towers Watson purchased 48,322 common shares of Longitude Holdings Limited (“Longitude”) representing 24.2% of outstanding equity ownership for $4.8 million. The related carrying amount of the equity investment was recorded at cost and will be adjusted using the equity method to recognize our share of the earnings or losses of Longitude. We have entered into a subscription agreement for $40.0 million, of which $35.2 million may be called upon for additional investment.
Acclaris Acquisition
On May 11, 2015, Towers Watson acquired Acclaris Holdings, Inc. (“Acclaris”) for $140.0 million in cash. Headquartered in Tampa, FL, and with locations in Kansas and India, Acclaris offers flexible products that include integrated technology and services to support consumer-directed benefits on a single platform in a scalable way. Its core business focuses on health care and reimbursement accounts which include health reimbursement arrangements (HRAs), health savings accounts (HSAs), flexible spending accounts, commuter accounts and custom reimbursement accounts. Acclaris was integrated into our Exchange Solutions segment and joined the Other line of business as the Consumer-Directed Accounts practice. Together, Towers Watson and Acclaris enable clients of any size to offer benefits in new and cost-effective ways.
During the fourth quarter of fiscal year 2015, we recorded the tangible assets received, liabilities assumed, and the fair value of intangibles. The intangibles included developed technology, valued at $14.5 million, and a customer related intangible, valued at $12.3 million. Our estimate of fair value for the developed technology intangible and the customer related intangible was based on the relief from royalty method and the multi-period excess earnings method, respectively. Significant assumptions used in the valuation were estimated revenues and expenses, contributory asset charges, required rates of return, and discount rates. During the first quarter of fiscal year 2016, working capital and acquisition accounting adjustments were made resulting in a refund of $1.7 million of cash consideration and a $3.1 million decrease to goodwill. It was determined that total consideration was $139.5 million, and we recorded $109.2 million of goodwill related to the acquisition of Acclaris.
Saville Consulting Acquisition
On April 23, 2015, Towers Watson acquired Saville Consulting Group Limited (“Saville”) for £42.0 million ($64.5 million) in cash. Saville is a U.K. and Jersey-based global psychometric assessment business. Its principal activities include helping employers to improve the match between people, work and organizations through the development and sale of objective psychometric assessment tools and related user training and consultancy services. Saville is included within our Data, Surveys and Technology line of business within our Talent and Rewards segment.
During the fourth quarter of fiscal 2015, we recorded the tangible assets received, liabilities assumed, and the fair value of intangibles. The intangibles included a product intangible, valued at £25.8 million, and other intangibles that were collectively immaterial. Our estimate of fair value for the product intangible was based on the relief from royalty method. Significant assumptions used in the valuation were estimated revenues and expenses, contributory asset charges, required rates of return, and discount rates. It was determined that total consideration was £43.4 million, and we recorded £5.8 million of goodwill related to the acquisition of Saville, inclusive of £0.6 million of deferred consideration recorded in the first quarter of fiscal year 2016.

8



Divestitures
Sale of Human Resources Service Delivery Practice
On July 9, 2015, we entered into a definitive agreement with KPMG to sell our Human Resources Service Delivery (“HRSD”) practice. The sale closed on August 14, 2015 for proceeds of $65.8 million, which reflects working capital adjustments and excludes transaction costs. The HRSD practice was a component of our Talent and Rewards segment. We divested this business to enhance our focus on other targeted areas like software offerings, integrating the Saville acquisition, and continuing to drive market leadership of our core businesses.
ASU 2014-08, Presentation of Financial Statements and Property, Plant, and Equipment - Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity, amended the requirements for the presentation of discontinued operations in the financial statements. Discontinued operations that do not represent a strategic shift or will not have a major effect on an entity’s operations and financial results are no longer reported in discontinued operations and are only disclosed in the notes to the financial statements. The divestiture of HRSD does not qualify for discontinued operations presentation in the financial statements. Included in other non-operating income on the condensed consolidated statements of operations for the six months ended December 31, 2015 is $55.4 million related to the gain on the sale of HRSD.
The following amounts are directly attributable to the results of operations of our HRSD practice and are included in the condensed consolidated statements of operations for the three and six months ended December 31, 2015 and 2014, respectively:
 
Three Months Ended December 31,
 
Six Months Ended December 31,
 
2015
 
2014
 
2015
 
2014
Revenue
$
529

 
$
8,688

 
$
6,337

 
$
16,298

Costs of providing services
377

 
6,257

 
5,011

 
12,469

Income from operations
$
152

 
$
2,431

 
$
1,326

 
$
3,829

Note 3 — Investments
Held-to-maturity - Our held-to-maturity investments are comprised of term deposits, certificates of deposit, and certain bonds with original maturities greater than 90 days. As of December 31, 2015 and June 30, 2015, all held-to-maturity investments were included in short-term investments in the accompanying condensed consolidated balance sheet. During the six months ended December 31, 2015 and December 31, 2014, proceeds from maturities of held-to-maturity investments were $116.9 million and $214.5 million, respectively, resulting in immaterial realized gains.
Available-for-sale - Our available-for-sale securities are comprised of equity securities and mutual funds / exchange-traded funds. During the six months ended December 31, 2015 and December 31, 2014, proceeds from the sales and maturities of available-for-sale investments were $0.5 million and $11.7 million, respectively, resulting in immaterial realized gains.

9



Additional information on the Company’s investments is provided in the following table as of December 31, 2015 and June 30, 2015:
 
As of December 31, 2015
 
As of June 30, 2015
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Estimated
Fair Value
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Estimated
Fair Value
Short Term Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Held-to-maturity:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Term deposits & Certificates of deposit
$
17

 
$

 
$

 
$
17

 
$
70,346

 
$

 
$

 
$
70,346

Fixed income securities
11,680

 

 

 
11,680

 
51,685

 

 

 
51,685

Available-for-sale:
 
 
 
 
 
 

 
 
 
 
 
 
 
 
Equity securities
102

 
4

 
(25
)
 
81

 
102

 
11

 
(10
)
 
103

Mutual funds and exchange-traded funds
5,068

 

 
(45
)
 
5,023

 
5,033

 
5

 
(16
)
 
5,022

Total Short-Term Investments:
16,867

 
4

 
(70
)
 
16,801

 
127,166

 
16

 
(26
)
 
127,156

Other Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds and exchange-traded funds
43,337

 

 
(639
)
 
42,698

 
43,711

 
6

 
(147
)
 
43,570

Total Investments in Other Assets
$
43,337

 
$

 
$
(639
)
 
$
42,698

 
$
43,711

 
$
6

 
$
(147
)
 
$
43,570

For all investments other than fixed income securities, amortized cost represents the cost basis of the investment as of the purchase date. For fixed income securities, amortized cost represents the face value of the bond plus the unamortized portion of the bond premium as of the date presented. The aggregate fair value of investments with unrealized losses as of December 31, 2015 was $47.8 million. There were no material investments that have been in a continuous loss position for more than twelve months, and there have been no other-than-temporary impairments recognized.
Note 4 — Goodwill and Intangible Assets
The components of goodwill are outlined below for the six months ended December 31, 2015:
 
Benefits
 
Exchange
Solutions
 
Risk and
Financial
Services
 
Talent and
Rewards
 
All Other
 
Total
Balance as of June 30, 2015
$
1,088,504

 
$
682,033

 
$
370,274

 
$
136,326

 
$
1,214

 
$
2,278,351

Goodwill related to acquisitions

 

 
1,410

 

 

 
1,410

Goodwill related to disposals

 

 

 
(1,412
)
 

 
(1,412
)
Purchase accounting adjustments

 
(2,841
)
 

 
933

 

 
(1,908
)
Translation adjustment
(53,994
)
 

 
(19,916
)
 
(6,822
)
 

 
(80,732
)
Balance as of December 31, 2015
$
1,034,510

 
$
679,192

 
$
351,768

 
$
129,025

 
$
1,214

 
$
2,195,709

The following table reflects changes in the net carrying amount of the components of finite-lived intangible assets for the six months ended December 31, 2015:
 
Customer
related
intangible
 
Core/
developed
technology
 
Product
 
Favorable
agreements
 
Total
Balance as of June 30, 2015
$
168,319

 
$
68,015

 
$
40,184

 
$
6,091

 
$
282,609

Intangible assets acquired

 
13,441

 

 

 
13,441

Impairment loss
(6,300
)
 

 

 

 
(6,300
)
Amortization
(20,711
)
 
(11,696
)
 
(1,041
)
 
(763
)
 
(34,211
)
Translation adjustment
(3,926
)
 
(230
)
 
(2,445
)
 
(278
)
 
(6,879
)
Balance as of December 31, 2015
$
137,382

 
$
69,530

 
$
36,698

 
$
5,050

 
$
248,660

We record amortization related to our finite-lived intangible assets. Exclusive of the amortization of our favorable lease agreements, for the three and six months ended December 31, 2015, we recorded $17.0 million and $33.8 million, respectively,

10



of amortization, and for the three and six months ended December 31, 2014, we recorded $17.3 million and $34.8 million, respectively, of amortization.
During the three months ended December 31, 2015, management recorded an impairment of the customer related intangible asset acquired from the purchase of Acclaris, which is part of the Exchange Solutions segment in the Other line of business. The impairment charge was triggered by the December 10, 2015 notice of the largest client of the Acclaris product to terminate services effective December 31, 2016. The amount of the impairment loss was calculated at $6.3 million and is included within Depreciation and Amortization in the accompanying condensed consolidated statement of operations. Management calculated the fair value of the customer intangible using a multi-period excess earnings method to discount future cash flows of the customer relationship intangible.
Our indefinite-lived non-amortizable intangible assets consist of acquired trade names. The carrying value of these assets was $365.5 million and $371.5 million as of December 31, 2015 and June 30, 2015, respectively. The change during the period was due to foreign currency translation.
Our acquired unfavorable lease liabilities were $6.1 million and $7.3 million as of December 31, 2015 and June 30, 2015, respectively, and are recorded in the other noncurrent liabilities in the condensed consolidated balance sheet. The change for the six months ended December 31, 2015 was comprised of a reduction to rent expense of $1.2 million.
The following table reflects the carrying value of finite-lived intangible assets and liabilities as of December 31, 2015 and June 30, 2015:
 
As of December 31, 2015
 
As of June 30, 2015
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Gross
Carrying
Amount
 
Accumulated
Amortization
Finite-lived intangible assets and liabilities:
 
 
 
 
 
 
 
Trademark and trade name
$
150

 
$
150

 
$
150

 
$
150

Customer related intangibles
376,772

 
239,390

 
388,113

 
219,794

Core/developed technology
186,959

 
117,429

 
174,480

 
106,465

Product
38,031

 
1,333

 
40,537

 
353

Favorable agreements
10,379

 
5,329

 
10,866

 
4,775

Total finite-lived intangible assets
$
612,291

 
$
363,631

 
$
614,146

 
$
331,537

 
 
 
 
 
 
 
 
Unfavorable lease agreements
$
20,593

 
$
14,535

 
$
21,793

 
$
14,512

Total finite-lived intangible liabilities
$
20,593

 
$
14,535

 
$
21,793

 
$
14,512

Our intangible assets were revalued to fair value on the effective date of the Merger and will not be amortized in future periods based on the remaining life and net book values on the balance sheet date in these financial statements. We have therefore not included the future amortization expense expected for the next 5 years in these financial statements.
Note 5 — Fair Value Measurements
We have categorized our financial instruments into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets and liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). In some cases, the inputs used to measure fair value might fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety.
Financial assets and liabilities recorded in the accompanying condensed consolidated balance sheets are categorized based on the inputs in the valuation techniques as follows:
Level 1 — Financial assets and liabilities whose values are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.
Level 2 — Financial assets and liabilities whose values are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3 — Financial assets and liabilities whose values are based on unobservable inputs for the asset or liability.

11



The following presents our assets and liabilities measured at fair value on a recurring basis at December 31, 2015 and June 30, 2015:
 
Fair Value Measurements on a Recurring Basis at December 31, 2015
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
Equity securities
$
81

 
$

 
$

 
$
81

Mutual funds / exchange traded funds
$
47,721

 
$

 
$

 
$
47,721

Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
683

 
$

 
$
683

Liabilities:
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
3,437

 
$

 
$
3,437

 
Fair Value Measurements on a Recurring Basis at June 30, 2015
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
Equity securities
$
102

 
$

 
$

 
$
102

Mutual funds / exchange traded funds
$
48,592

 
$

 
$

 
$
48,592

Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
2,177

 
$

 
$
2,177

Liabilities:
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
272

 
$

 
$
272

Contingent Liabilities:
 
 
 
 
 
 
 
Retention bonus liability (b)
$

 
$

 
$
9,934

 
$
9,934

_________________________
(a)
These derivative investments are included in other current assets or accounts payable, accrued liabilities and deferred income on the accompanying condensed consolidated balance sheet. See Note 6 for further information on our derivative investments.
(b)
These liabilities are included in other current liabilities and other noncurrent liabilities at December 31, 2015 and June 30, 2015 on the accompanying condensed consolidated balance sheet. The fair value was determined using a discounted cash flow model.
We record gains or losses related to the changes in the fair value of our financial instruments for foreign exchange forward contracts accounted for as foreign currency hedges in general and administrative expenses in the condensed consolidated statements of operations. For the three and six months ended December 31, 2015 we recorded losses of $2.9 million for instruments still held at December 31, 2015. We recorded an immaterial amount of gains for the three and six months ended December 31, 2014 for instruments still held at December 31, 2014. There were no material gains or losses recorded in the condensed consolidated statements of operations for available-for-sale securities still held at December 31, 2015 or 2014.
We generally use third-party pricing services in determining the fair value of our investments. The pricing services use observable inputs when available. These values take into account recent market activity as well as other market observable data such as interest rate, spread and prepayment information. We perform various procedures to evaluate the accuracy of the fair values provided by the third-party service provider. These procedures include obtaining a detailed understanding of the models, inputs, and assumptions used in developing prices provided by the pricing services. This understanding includes a review of the vendors’ Service Organization Controls report and, as necessary, discussions with valuation resources at the pricing services. We obtain the information necessary to assess the model, inputs and assumptions used to comply with U.S. GAAP, including disclosure requirements. Additional information related to the Company’s fair valuation process is included in our financial statements and the notes thereto contained in our 2015 Annual Report on Form 10-K filed with the SEC on August 14, 2015.

12



There were no transfers of securities between any levels for the three and six months ended December 31, 2015 or the fiscal year ended June 30, 2015. The Company’s policy is to recognize transfers in and transfers out as of the beginning of the reporting period.
Level 3 Financial Instruments
Fair Value Measurements using significant unobservable inputs (Level 3):
Beginning balance - June 30, 2015
$
9,934

Payments
(9,356
)
Realized gain
(578
)
Ending balance - December 31, 2015
$

Note 6 — Derivative Financial Instruments
We are exposed to market risk from changes in foreign currency exchange rates. Where possible, we identify exposures in our business that can be offset internally. Where no natural offset is identified, we may choose to enter into various derivative transactions. These instruments have the effect of reducing our exposure to unfavorable changes in foreign currency rates. We do not enter into derivative transactions for trading purposes.
A number of our foreign subsidiaries receive revenues (through either internal or external billing) in currencies other than their functional currency. As a result, the foreign subsidiary’s functional currency revenue will fluctuate as the currency exchange rates change. To reduce this variability, we use foreign exchange forward contracts to hedge the foreign exchange risk of the forecast collections. We have designated these derivatives as cash flow hedges of the forecast foreign currency denominated collections. We also use derivative financial contracts, principally foreign exchange forward contracts, to hedge other non-functional currency obligations. These exposures primarily arise from intercompany lending and other liabilities denominated in foreign currencies. At December 31, 2015, the longest outstanding maturity was 9 months. As of December 31, 2015, a net $0.4 million pretax gain was deferred in accumulated other comprehensive income and is expected to be recognized in general and administrative expenses during the next 12 months when the hedged revenue is recognized.
As of December 31, 2015 and June 30, 2015, we had cash flow and economic hedges with a notional value of $445.3 million and $43.2 million, respectively, to hedge cash flow and balance sheet exposures. We determine the fair value of our foreign currency derivatives based on quoted prices received from the counterparty for each contract, which we evaluate using pricing models whose inputs are observable. The net fair value of all derivatives held as of December 31, 2015 and June 30, 2015 was a liability of $2.8 million and an asset of $1.9 million, respectively. See Note 5, Fair Value Measurements, for further information regarding the determination of fair value.
Included in the notional values above are $413.4 million and $20.4 million as of December 31, 2015 and June 30, 2015, respectively, of derivatives held as economic hedges primarily to hedge intercompany loans denominated in currencies other than the functional currency. Losses of $4.1 million and $0.8 million related to derivatives not designated as hedging instruments was recorded in general and administrative expenses for the three months ended December 31, 2015 and December 31, 2014, respectively. Losses of $3.9 million and $2.7 million related to derivatives not designated as hedging instruments was recorded in general and administrative expenses for the six months ended December 31, 2015 and December 31, 2014, respectively. Our notional values increased in the current quarter, primarily due to the hedging of intercompany loans to offset risks related to the repatriation of cash held in foreign denominations.
Note 7 — Retirement Benefits
Defined Benefit Plans
Towers Watson sponsors both qualified and non-qualified defined benefit pension plans and other post-retirement benefit plans in North America and Europe. As of June 30, 2015, these funded and unfunded plans represented 98 percent of Towers Watson’s pension and other post-retirement benefit obligations and are disclosed herein. Towers Watson also sponsors funded and unfunded defined benefit pension plans in certain other countries as well, representing the remaining two percent of the liability.

13



Components of Net Periodic Benefit Cost for Defined Benefit Pension Plans
The following table sets forth the components of net periodic benefit cost for the Company’s defined benefit pension plan for North America and Europe for the three months ended December 31, 2015 and 2014:
 
Three Months Ended December 31,
 
2015
 
2014
 
North
America
 
Europe
 
North
America
 
Europe
Service cost
$
18,014

 
$
1,068

 
$
17,683

 
$
3,190

Interest cost
36,152

 
9,475

 
34,522

 
9,883

Expected return on plan assets
(52,094
)
 
(12,733
)
 
(53,078
)
 
(12,533
)
Amortization of net loss
9,959

 
2,666

 
4,573

 
3,123

Amortization of prior service (credit)/cost
(1,994
)
 
10

 
(2,095
)
 
10

Net periodic benefit cost
$
10,037

 
$
486

 
$
1,605

 
$
3,673

The following table sets forth the components of net periodic benefit cost for the Company’s defined benefit pension plan for North America and Europe for the six months ended December 31, 2015 and 2014:
 
Six Months Ended December 31,
 
2015
 
2014
 
North
America
 
Europe
 
North
America
 
Europe
Service cost
$
36,056

 
$
2,146

 
$
35,894

 
$
6,562

Interest cost
72,337

 
19,047

 
69,153

 
20,318

Expected return on plan assets
(104,231
)
 
(25,599
)
 
(106,368
)
 
(25,758
)
Amortization of net loss
19,928

 
5,357

 
8,951

 
6,425

Amortization of prior service (credit)/cost
(3,988
)
 
20

 
(4,190
)
 
21

Net periodic benefit cost
$
20,102

 
$
971

 
$
3,440

 
$
7,568

The increase in our North American pension expense was primarily driven by lower than expected return on assets and a change in assumptions based on the new mortality tables.
Components of Net Periodic Benefit Cost for Other Postretirement Plans
The following table sets forth the components of net periodic benefit cost for the Company’s post-retirement plans for the three and six months ended December 31, 2015 and 2014:
 
Three Months Ended 
 December 31,
 
Six Months Ended 
 December 31,
 
2015
 
2014
 
2015
 
2014
Service cost
$
168

 
$
320

 
$
336

 
$
641

Interest cost
1,430

 
2,042

 
2,862

 
4,094

Expected return on plan assets
(20
)
 
(24
)
 
(40
)
 
(48
)
Amortization of net gain
(1,508
)
 
(440
)
 
(3,014
)
 
(880
)
Amortization of prior service credit
(1,726
)
 
(1,726
)
 
(3,452
)
 
(3,452
)
Net periodic benefit (credit)/cost
$
(1,656
)
 
$
172

 
$
(3,308
)
 
$
355

Employer Contributions to Defined Benefit Pension Plans
The Company made $32.2 million in contributions to the North American plans during the first half of fiscal year 2016, and anticipates making $1.9 million in contributions over the next six months. The Company made $22.1 million in contributions to European plans during the first half of fiscal year 2016, and anticipates making $14.0 million in contributions over the next six months.

14



Defined Contribution Plans
The cost of the Company’s contributions to the various U.S. defined contribution plans was $7.6 million and $6.5 million for the three months ended December 31, 2015 and 2014, respectively, and $12.8 million and $11.1 million for the six months ended December 31, 2015 and 2014, respectively.
The cost of the Company’s contributions to the various U.K. defined contribution plans was $5.7 million and $4.9 million for the three months ended December 31, 2015 and 2014, respectively, and $11.3 million and $9.9 million for the six months ended December 31, 2015 and 2014, respectively.
Note 8 — Debt, Commitments, Contingent and Other Liabilities
The debt, commitments and contingencies described below are currently in effect and would require Towers Watson, or domestic subsidiaries, to make payments to third parties under certain circumstances. In addition to commitments and contingencies specifically described below, Towers Watson has historically provided guarantees on an infrequent basis to third parties in the ordinary course of business.
Towers Watson Senior Credit Facility
On November 7, 2011, Towers Watson and certain subsidiaries entered into a five-year, $500 million revolving credit facility, which amount may be increased by an aggregate amount of $250 million, subject to the satisfaction of customary terms and conditions, with a syndicate of banks (the “Senior Credit Facility”). Borrowings under the Senior Credit Facility bear interest at a spread to either LIBOR or the Prime Rate. During the six months ended December 31, 2015 and 2014, the weighted-average interest rate on borrowings under the Senior Credit Facility was 1.69% and 1.40%, respectively. We are charged a quarterly commitment fee, currently 0.175% of the Senior Credit Facility, which varies with our financial leverage and is paid on the unused portion of the Senior Credit Facility. Obligations under the Senior Credit Facility are guaranteed by Towers Watson and all of its domestic subsidiaries (other than Professional Consultants Insurance Company (“PCIC”), a majority-owned captive insurance company, and Stone Mountain Insurance Company (“SMIC”), a wholly-owned captive insurance company).
The Senior Credit Facility contains customary representations and warranties and affirmative and negative covenants. The Senior Credit Facility requires Towers Watson to maintain certain financial covenants that include a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Leverage Ratio (which terms in each case are defined in the Senior Credit Facility). In addition, the Senior Credit Facility contains restrictions on the ability of Towers Watson to, among other things, incur additional indebtedness; pay dividends; make distributions; create liens on assets; make acquisitions; dispose of property; engage in sale-leaseback transactions; engage in mergers or consolidations, liquidations and dissolutions; engage in certain transactions with affiliates; and make changes in lines of businesses. As of December 31, 2015, we were in compliance with our covenants.
As of December 31, 2015, we had $212.5 million outstanding borrowings under the Senior Credit Facility.
The Company repaid all outstanding indebtedness under the Senior Credit Facility and terminated it on the closing date of the Merger.
Letters of Credit under the Senior Credit Facility
In connection with the Merger, the letters of credit under this facility were also terminated and were reissued as standalone letters of credit on December 30, 2015. As of December 31, 2015, Towers Watson had standby letters of credit totaling $22.4 million associated with our captive insurance companies in the event that we fail to meet our financial obligations. Additionally, Towers Watson had $0.9 million of standby letters of credit covering various other existing or potential business obligations.
Term Loan Agreement Due June 2017
On June 1, 2012, the Company entered into a five-year $250 million amortizing term loan facility (“the Term Loan”) with a consortium of banks. The interest rate on the term loan is based on the Company’s choice of one, three or six month LIBOR plus a spread of 1.25% to 1.75%, or alternatively the bank base rate plus 0.25% to 0.75%. The spread to each index is dependent on the Company’s consolidated leverage ratio. The weighted-average interest rate on the Term Loan during the three months ended December 31, 2015 and 2014 was 1.45% and 1.40%, respectively. The Term Loan amortizes at a rate of $6.25 million per quarter, beginning in September 2013, with a final maturity date of June 1, 2017. The Company has the right to prepay a portion or all of the outstanding Term Loan balance on any interest payment date without penalty. At December 31, 2015, the balance on the Term Loan was $187.5 million.

15



This agreement contains substantially the same terms and conditions as our Senior Credit Facility, including guarantees from all of the domestic subsidiaries of Towers Watson (other than PCIC and SMIC). The Company entered into the Term Loan as part of the financing of our acquisition of Extend Health on May 29, 2012.
The Company repaid all outstanding indebtedness under the Term Loan and terminated it on the closing date of the Merger.
Term Loan Due December 2019
On November 20, 2015, Towers Watson Delaware Inc. entered into a four-year amortizing term loan agreement for up to $340 million with a consortium of banks to help fund the pre-Merger special dividend. On December 28, 2015, Towers Watson Delaware Inc. borrowed the full $340 million.
The interest rate on the term loan is based on the Company’s choice of one, two, three or six month LIBOR plus a spread of 1.25% to 1.75%, or alternatively the bank base rate plus 0.25% to 0.75%. The spread to each index is dependent on the Company’s consolidated leverage ratio. The weighted-average interest rate on this term loan between the borrowing date of December 28, 2015 and the year ended December 31, 2015 was 3.23%. The term loan amortizes at a rate of $21.25 million per quarter, beginning in March 2016, with a final maturity date of December 2019. The Company has the right to prepay a portion or all of the outstanding term loan balance on any interest payment date without penalty. At December 31, 2015, the balance on the term loan was $340.0 million.
Restrictive covenants associated with this financing contains customary representations and warranties and affirmative and negative covenants. The term loan requires Towers Watson Delaware Inc. as a consolidated entity to maintain certain financial covenants that include a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Leverage Ratio (which terms in each case are defined in the term loan agreement). In addition, the term loan contains restrictions on the ability of Towers Watson Delaware Inc. to, among other things, incur additional indebtedness; pay dividends; make distributions; create liens on assets; make acquisitions; dispose of property; engage in sale-leaseback transactions; engage in mergers or consolidations, liquidations and dissolutions; engage in certain transactions with affiliates; and make changes in lines of businesses. Additionally, Towers Watson Delaware Inc. is prohibited from providing guarantees of debt outside of the Towers Watson Delaware Inc. consolidated entity.
Indemnification Agreements
Towers Watson has various agreements which provide that it may be obligated to indemnify the other party to the agreement with respect to certain matters. Generally, these indemnification provisions are included in contracts arising in the normal course of business and in connection with the purchase and sale of certain businesses. Although it is not possible to predict the maximum potential amount of future payments that may become due under these indemnification agreements because of the conditional nature of Towers Watson’s obligations and the unique facts of each particular agreement, Towers Watson does not believe any potential liability that might arise from such indemnity provisions is probable or material. There are no provisions for recourse to third parties, nor are any assets held by any third parties that any guarantor can liquidate to recover amounts paid under such indemnities.
Legal Proceedings
From time to time, Towers Watson and its subsidiaries are parties to various lawsuits, arbitrations or mediations that arise in the ordinary course of business. Towers Watson was formed on January 1, 2010 upon the merger (the “Towers Perrin | Watson Wyatt Merger”) of Watson Wyatt Worldwide, Inc. (“Watson Wyatt”) and Towers, Perrin, Forster & Crosby, Inc. (“Towers Perrin”), and its subsidiaries include both Watson Wyatt and Towers Perrin. The matters reported on below relate to certain pending claims or demands against Towers Watson and its subsidiaries. We do not expect the impact of claims or demands not described below to be material to Towers Watson’s financial statements. We also receive subpoenas in the ordinary course of business and, from time-to-time, receive requests for information in connection with governmental investigations.
Towers Watson carries substantial professional liability insurance which, effective July 1, 2010, has been provided by SMIC. For the policy period beginning July 1, 2011 certain changes were made to our professional liability insurance program. Our professional liability insurance for each annualized policy period commencing July 1, 2011, up to and including the policy period commencing July 1, 2016, includes a $10 million aggregate self-insured retention above the $1 million self-insured retention per claim, including the cost of defending such claims. SMIC provides us with $40 million of coverage per claim and in the aggregate, above the retentions, including the cost of defending such claims. SMIC secured $25 million of reinsurance from unaffiliated reinsurance companies in excess of the $15 million SMIC retained layer. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies.

16



This structure effectively results in Towers Watson and SMIC bearing the first $25 million of loss per occurrence or in the aggregate above the $1 million per claim self-insured retention. As a wholly-owned captive insurance company, SMIC is consolidated into our financial statements.
Before the Towers Perrin | Watson Wyatt Merger, Watson Wyatt and Towers Perrin each obtained substantial professional liability insurance from PCIC. A limit of $50 million per claim and in the aggregate was provided by PCIC subject to a $1 million per claim self-insured retention. PCIC secured reinsurance of $25 million attaching above the $25 million PCIC retained layer from unaffiliated reinsurance companies. Our ownership interest in PCIC is 72.86%. As a consequence, PCIC’s results are consolidated in Towers Watson’s operating results. PCIC ceased issuing insurance policies effective July 1, 2010 and at that time entered into a run-off mode of operation. Our shareholder agreements with PCIC could require additional payments to PCIC if development of claims significantly exceeds prior expectations.
We provide for the self-insured retention where specific estimated losses and loss expenses for known claims are considered probable and reasonably estimable. Although we maintain professional liability insurance coverage, this insurance does not cover claims made after expiration of our current policies of insurance. Generally accepted accounting principles require that we record a liability for incurred but not reported (“IBNR”) professional liability claims if they are probable and reasonably estimable. We use actuarial assumptions to estimate and record our IBNR liability. As of December 31, 2015, we had a $186.1 million IBNR liability balance, net of estimated IBNR recoverable receivables of our captive insurance companies. This net liability was $181.5 million as of June 30, 2015. To the extent our captive insurance companies, PCIC and SMIC, expect losses to be covered by a third party, they record a receivable for the amount expected to be recovered. This receivable is classified in other current or other noncurrent assets in our condensed consolidated balance sheet.
We reserve for contingent liabilities based on ASC 450, Contingencies, when it is determined that a liability, inclusive of defense costs, is probable and reasonably estimable. The contingent liabilities recorded are primarily developed actuarially. Litigation is subject to many factors which are difficult to predict so there can be no assurance that in the event of a material unfavorable result in one or more claims, we will not incur material costs.
City of Houston
On August 1, 2014, the City of Houston (“plaintiff”) filed suit against the Company in the United States District Court for the Southern District of Texas, Houston Division.
In the complaint, plaintiff alleges various deficiencies in pension actuarial work-product and advice stated to have been provided by the Company’s predecessor firm, Towers Perrin, in its capacity as principal actuary to the Houston Firefighters’ Relief and Retirement Fund (the “Fund”). ‎Towers Perrin is stated to have acted in this capacity between “the early 1980s until 2002”. ‎
In particular, the complaint is critical of three reports allegedly issued by Towers Perrin — one in February 2000, one in April 2000, and one in January 2001 — containing actuarial valuations upon which plaintiff claims to have relied. Plaintiff claims that the reports indicated that the City’s minimum contribution percentages to the Fund would remain in place through at least 2019; and ‎that existing benefits under the Fund could be increased, and new benefits could be added, without increasing plaintiff’s financial burden, and without increasing plaintiff’s rate of annual contributions to the Fund. The complaint alleges that plaintiff relied on these reports when supporting a new benefit package for the Fund.  These reports, and other advice, are alleged, among other things, to have been negligent, to have misrepresented the present and future financial condition of the Fund and the contributions required to be made by plaintiff to support those benefits. Plaintiff asserts that, but for Towers Perrin’s alleged negligence and misrepresentations, plaintiff would not have supported the benefit increase, and that such increased benefits would not and could not have been approved or enacted.  It is further asserted that Towers Perrin’s alleged “negligence and misrepresentations damaged the City to the tune of tens of millions of dollars in annual contributions.”
Plaintiff seeks the award of actual damages, exemplary damages, special damages, attorney’s fees and expenses, costs of suit, pre- and post- judgment interest at the maximum legal rate, and other unspecified legal and equitable relief.  Plaintiff has not yet quantified fully its asserted damages. 
On October 10, 2014, the Company filed a motion to dismiss plaintiff’s entire complaint on the basis that the complaint fails to state a claim upon which relief can be granted. On November 21, 2014, the City filed its response in opposition to the Company’s motion to dismiss. On September 23, 2015, the Company’s motion to dismiss was denied by the United States District Court for the Southern District of Texas, Houston Division.
Given the stage of the proceedings, the Company is currently unable to provide an estimate of the reasonably possible loss or range of loss. The Company disputes the allegations, and intends to defend the lawsuit vigorously.

17



British Coal Staff Superannuation Scheme
On September 4, 2014, Towers Watson Limited (“TWL”), a wholly-owned subsidiary of the Company, received a Letter of Claim (the “Demand Letter”) on behalf of Coal Staff Superannuation Scheme Trustees Limited (the “Trustee”), trustee of the British Coal Staff Superannuation Scheme (the “Scheme”). The Demand Letter was sent under the Professional Negligence Pre-Action Protocol, a pre-action dispute resolution procedure which applies in England and Wales.
In the Demand Letter, it is asserted that the Trustee has a claim against TWL in respect of allegedly negligent investment consulting advice provided to it by Watson Wyatt Limited, in the United Kingdom, in particular with regard to a currency hedge that was implemented in connection with the Scheme’s investment of £250 million in a Bluebay local currency emerging market debt fund in August 2008 (the “Investment”). It is alleged that the currency hedge has caused a substantial loss to the Scheme, compensatory damages for which losses are quantified at £47.5 million, for the period August 2008 to October 2012.
TWL sent a Letter of Response on December 23, 2014.
On November 11, 2015, the Trustee issued a Claim Form in the English High Court of Justice, Queen’s Bench Division, Commercial Court, in which TWL is named defendant. The Trustee asserts that, in breach of retainer, or of a duty of care alleged to have been owed under contract or at common law, TWL acted negligently and/or provided negligent advice in connection with the Investment and/or in relation to the monitoring of the performance of the Investment. The Trustee asserts that, but for the alleged breaches, the Scheme would have achieved a return on the Investment that was approximately £47.5 million greater than the return on Investment which it ultimately achieved, in the period between August 2008 and 28 September 2012. To date, TWL has not been served with the Claim Form.
Based on all of the information to date, and given the stage of the matter, TWL is currently unable to provide an estimate of the reasonably possible loss or range of loss. TWL disputes the allegations, and intends to defend the matter vigorously.
Meriter Health Services 
On January 12, 2015, Towers Watson Delaware Inc. (“TWDE”), a wholly-owned subsidiary of the Company, was served with a Summons and Complaint (the “Complaint”) on behalf of Meriter Health Services, Inc. (“Meriter”), plan sponsor of the Meriter Health Services Employee Retirement Plan (the “Plan”). The Complaint was filed in Wisconsin State Court in Dane County; on February 12, 2015, the Complaint was removed to the United States District Court for the Western District of Wisconsin. On March 10, 2015, Meriter filed a Motion to Remand, seeking to transfer the Complaint back to Wisconsin State Court in Dane County. On November 20, 2015, the district court granted Meriter’s motion and remanded the case back to the Circuit Court of Dane County, Wisconsin.  
On July 24, 2015, Meriter filed an Amended Complaint, to which TWDE and other defendants filed answers on August 10, 2015.  Meriter filed a Second Amended Complaint on December 29, 2015. Meriter filed a Third Amended Complaint on March 1, 2016.   
In the Third Amended Complaint, Meriter alleges that Towers, Perrin, Forster & Crosby, Inc. (“TPFC”) and Davis, Conder, Enderle & Sloan, Inc. (“DCES”), and other entities and individuals, acted negligently concerning the benefits consulting advice provided to Meriter, including TPFC’s involvement in the Plan design and drafting of the Plan document in 1987, and DCES’ Plan review in 2001, Plan redesign, Plan amendment, and drafting of ERISA section 204(h) notices. Additionally, Meriter asserts that TPFC and DCES, and other entities and individuals, breached alleged fiduciary duties to advise Meriter regarding the competency of Meriter’s then ERISA counsel.  Meriter also has asserted causes of action for contribution, indemnity, and equitable subrogation related to amounts paid to settle a class action lawsuit related to the Plan that was filed by Plan participants against Meriter in 2010, alleging a number of ERISA violations and related claims. Meriter settled that lawsuit in 2015 for $82 million. In its initial disclosures, Meriter indicated that it seeks damages in the amount of $135 million, which include amounts it claims to have paid to settle and defend the class action litigation, and amounts it claims to have incurred as a result of “improper plan design.”  Meriter seeks to recover these alleged damages from TWDE. 
On January 12, 2016, TWDE and the other defendants filed a motion for summary judgment seeking dismissal of Meriter’s negligence and breach of fiduciary duty claims. 
Based on all of the information to date, and given the stage of the matter, TWDE is currently unable to provide an estimate of the reasonably possible loss or range of loss. TWDE disputes the allegations, and intends to defend the matter vigorously. 
Merger-related Appraisal demands
Between November 12, 2015, and December 10, 2015, in connection with the then-proposed Merger, Towers Watson received demands for appraisal under Section 262 of the Delaware General Corporation Law on behalf of ten purported beneficial

18



owners of an aggregate of approximately 2.4% of the shares of Towers Watson common stock outstanding at the time of the Merger. As of March 9, 2016, demands for appraisal purportedly relating to 2% of the shares of Towers Watson common stock that were outstanding at the time of the Merger remain outstanding and have not been withdrawn. On March 3, 2016, two appraisal petitions were filed in the Court of Chancery for the State of Delaware on behalf of three purported beneficial owners of an aggregate of 1,242,400 shares of Towers Watson common stock, captioned Rangeley Capital LLC v. Towers Watson & Co., C.A. No. 12063-CB, and Merion Capital L.P. v. Towers Watson & Co., C.A. No. 12064-CB. The appraisal petitions seek, among other things, a determination of the fair value of the appraisal petitioners’ shares at the time of the Merger; an order that Towers Watson pay that value to the appraisal petitioners, together with interest at the statutory rate; and an award of costs, attorneys’ fees, and other expenses. Based on all of the information to date, the Company is currently unable to provide an estimate of the reasonably possible loss or range of loss.  The Company intends to vigorously defend against the appraisal proceedings.
In re Towers Watson & Co. Stockholders Litigation
Five putative class action complaints challenging the Merger were filed in the Court of Chancery for the State of Delaware, captioned New Jersey Building Laborers’ Statewide Annuity Fund v. Towers Watson & Co., et al., C.A. No. 11270-CB (filed on July 9, 2015), Stein v. Towers Watson & Co., et al., C.A. No. 11271-CB (filed on July 9, 2015), City of Atlanta Firefighters’ Pension Fund v. Ganzi, et al., C.A. No. 11275-CB (filed on July 10, 2015), Cordell v. Haley, et al., C.A. No. 11358-CB (filed on July 31, 2015), and Mills v. Towers Watson & Co., et al., C.A. No. 11423-CB (filed on August 24, 2015).  The Stein action was voluntarily dismissed on July 28, 2015.  These complaints were filed by purported stockholders of Towers Watson on behalf of a putative class comprised of all Towers Watson stockholders. The complaints sought, among other things, to enjoin the Merger, and generally alleged that Towers Watson’s directors breached their fiduciary duties to Towers Watson stockholders by agreeing to merge Towers Watson with Willis through an inadequate and unfair process, which led to inadequate and unfair consideration, and by agreeing to unfair deal protection devices.  The complaints also alleged that Willis and the Merger Sub formed for purposes of consummating the Merger aided and abetted the alleged breaches of fiduciary duties by Towers Watson directors.  On August 17, 2015, the court consolidated the New Jersey Building Laborers’ Statewide Annuity Fund, City of Atlanta Firefighters’ Pension Fund, and Cordell actions (the Mills action had not yet been filed) and any other actions then pending or thereafter filed arising out of the same issues of fact under the caption In re Towers Watson & Co. Stockholders Litigation, Consolidated C.A. No. 11270-CB.  On September 9, 2015, the plaintiffs in the consolidated action and in Mills filed a consolidated amended complaint, which, among other things, added claims for alleged misstatements and omissions from a preliminary proxy statement and prospectus for the Merger dated August 27, 2015.  On September 17, 2015, plaintiffs filed a motion for expedited proceedings and a motion for a preliminary injunction, which motions plaintiffs voluntarily withdrew on October 19, 2015.  On December 14, 2015, the defendants filed motions to dismiss the consolidated amended complaint. Based on all of the information to date, the Company is currently unable to provide an estimate of the reasonably possible loss or range of loss.  The Towers Watson defendants intend to vigorously defend the lawsuit.  
Note 9 — Accumulated Other Comprehensive Loss
Changes in accumulated other comprehensive loss, net of non-controlling interests, are provided in the following table. The difference between the amounts presented in this table and the amounts presented in the condensed consolidated statements of comprehensive income are the corresponding components attributable to non-controlling interests, which are not material for further disclosure.
 
Foreign
currency
translation
(1)
 
Hedge effectiveness (1)
 
Available-for-sale
securities (2)
 
Defined pension and
post-retirement benefit costs (3)
 
 
Before
Tax
 
Tax
 
After
Tax
 
Before
Tax
 
Tax
 
After
Tax
 
Before
Tax
 
Tax
 
After
Tax
As of June 30, 2015
$
(226,041
)
 
$
1,616

 
$
(657
)
 
$
959

 
$
141

 
$
(60
)
 
$
81

 
$
(512,767
)
 
$
161,470

 
$
(351,297
)
Other comprehensive loss before reclassifications
(127,211
)
 
(407
)
 
160

 
(247
)
 
(298
)
 
95

 
(203
)
 

 

 

Amounts reclassified from accumulated other comprehensive income

 
(802
)
 
315

 
(487
)
 

 

 

 
15,207

 
(4,763
)
 
10,444

Net current-period other comprehensive loss
(127,211
)
 
(1,209
)
 
475

 
(734
)
 
(298
)
 
95

 
(203
)
 
15,207

 
(4,763
)
 
10,444

As of December 31, 2015
$
(353,252
)
 
$
407

 
$
(182
)
 
$
225

 
$
(157
)
 
$
35

 
$
(122
)
 
$
(497,560
)
 
$
156,707

 
$
(340,853
)
________________________
(1)
Reclassification adjustments from accumulated other comprehensive income are included in general and administrative expenses (see Note 6 Derivative Financial Instruments for additional information)
(2)
Reclassification adjustments from accumulated other comprehensive income are included in general and administrative expenses

19



(3)
Reclassification adjustments from accumulated other comprehensive income are included in the computation of net periodic pension cost (see Note 7 – Retirement Benefits for additional details)
Note 10 — Share-Based Compensation
Restricted Stock Units
Executives and Employees
The Compensation Committee of our Board of Directors approves performance-vested restricted stock unit awards pursuant to the Towers Watson & Co. 2009 Long Term Incentive Plan. RSUs are designed to provide us an opportunity to offer our long-term incentive program (“LTIP”) and to provide key executives with a long-term stake in our success. RSUs are notional, non-voting units of measurement based on our common stock. Under the RSU agreement, participants become vested in a number of RSUs based on the achievement of specified levels of financial performance during the performance period set forth in the agreement, provided that the participant remains in continuous service with us through the end of the performance period. Any RSUs that become vested are payable in shares of our Class A Common Stock. Dividend equivalents will accrue on certain RSUs and vest to the same extent as the underlying shares. The form of performance-vested restricted stock unit award agreement includes a provision whereby the Committee could provide for continuation of vesting of restricted stock units upon an employee’s termination under certain circumstances such as a qualified retirement. This definition of qualified retirement is age 55 and with 15 years of experience at the company and a minimum of one year of service in the performance period.
These awards are typically approved by the Compensation Committee of the Board of Directors in the first quarter of the fiscal year. The LTIP awards are generally based on the value of the executive officer’s annual base salary and a multiplier, which is then converted into a target number of RSUs based on our closing stock price as of the date of grant. Except for the Exchange Solutions (“ES”) LTIP awards, between 0% and 204% of the target number of RSUs will vest based on the extent to which specified performance metrics are achieved over the applicable performance period, subject to the employee or executive officers’ continued employment with us through the end of the performance period, except in the case of a qualified retirement. For participants that meet the requirement for qualified retirement, we record the expense of their awards over the one-year service period as performed. For the 2014 ES LTIP awards, 240% of the target number of RSUs vested, and for the 2016 ES LTIP awards, between 0% and 196% of the target number of RSUs will vest, based on the extent to which specified performance metrics are achieved over the applicable performance period, subject to the employee or executive officers’ continued employment with us through the end of the performance period. Except for the ES LTIP awards, the Compensation Committee approved the grants and established adjusted three-year average EPS and revenue growth during the performance period as the performance metrics for the awards. The performance metrics for the 2014 ES LTIP awards are based on EBITDA margin and revenue growth, and the performance metrics for the 2016 ES LTIP awards are based on ES net operating income margin and revenue. We record stock-based compensation expense over the performance period beginning with the date of grant and will adjust the expense for their awards based upon the level of performance achieved.
The Compensation Committee of the Board of Directors also approves RSUs to certain employees under our Select Equity Plan (“SEP”) during the first quarter of the fiscal year. The RSUs vest annually over a three-year period and include an assumed forfeiture rate.
The following table presents key information with regard to each of the awards that had been granted as of December 31, 2015:
Plan
 
Performance Period
 
RSUs Awarded
 
Grant Date Stock Price
 
Assumed Forfeiture Rate
2015 LTIP
 
July 1, 2014 to June 30, 2017
 
82,350
 
$100.02 and $131.35
 
None
2014 LTIP
 
July 1, 2013 to June 30, 2016
 
65,355
 
$105.90 and $110.70
 
None
2013 LTIP
 
July 1, 2012 to June 30, 2015
 
121,075
 
$54.59
 
None
2016 ES LTIP
 
July 1, 2015 to June 30, 2017
 
38,864
 
$125.50
 
None
2014 ES LTIP
 
July 1, 2013 to June 30, 2015
 
30,192
 
$91.43
 
None
2015 SEP
 
July 1, 2015 to June 30, 2018
 
103,217
 
$119.30
 
5%
2014 SEP
 
July 1, 2014 to June 30, 2017
 
112,464
 
$106.89
 
5%
2013 SEP
 
July 1, 2013 to June 30, 2016
 
131,286
 
$91.43
 
5%
2012 SEP
 
July 1, 2012 to June 30, 2015
 
147,503
 
$53.93
 
5%
Total expense related to our LTIP and SEP awards, and other miscellaneous RSU awards for the three months ended December 31, 2015 and 2014 was $6.2 million and $6.1 million, respectively, and $9.1 million and $16.1 million for the six months ended December 31, 2015 and 2014, respectively.

20



Outside Directors
The Towers Watson & Co. Compensation Plan for Non-Employee Directors provides for cash and stock compensation for outside directors for service on the board of directors. During the three months ended September 30, 2015, 7,234 RSUs were granted for the annual award for outside directors, which vest in equal quarterly installments over fiscal year 2016. During the three months ended September 30, 2014, 8,059 RSUs were granted for the annual award for outside directors, which vest in equal quarterly installments over fiscal year 2015. We recorded stock-based compensation expense related to these grants in the amount of $0.6 million and $0.3 million for the three months ended December 31, 2015 and 2014, respectively, and $1.1 million and $0.7 million for the six months ended December 31, 2015 and 2014, respectively.
Stock Options
Due to the pending Merger, the Compensation Committee of our Board of Directors determined that it would be very difficult to establish performance metrics for our key executives under a performance-vested based restricted stock unit awards type of plan for fiscal year 2016. As a result, the Compensation Committee approved the issuance of stock options under the existing 2009 Long Term Incentive Plan. This is similar to the approach taken by Watson Wyatt Worldwide, Inc., in connection with the merger between Towers, Perrin, Foster & Crosby, Inc. and Watson Wyatt Worldwide, Inc. The number of options granted under the new plan is 542,869 and the options have an exercise price equal to the grant date market price of Towers Watson’s common stock of $120.58 to $134.15. The options vest on July 1, 2018 contingent upon the optionee’s continued service with Towers Watson or the merged entity, except in the case of a qualified retirement. The vesting of 204,618 of these options is also contingent upon the occurrence of the Merger on or before December 31, 2016, and therefore, a performance factor is applied to these options when determining the expense. We will adjust the expense based upon the performance achieved. Compensation expense is recorded on a straight-line basis over the vesting term.  For participants who meet the requirement for qualified retirement, we record the expense of their awards over the one-year service period as performed. We recorded stock-based compensation expense related to these stock options in the amount of $2.2 million and $2.6 million for the three and six months ended December 31, 2015, respectively. There were no stock options granted in 2014.
The fair value of the stock option grants was calculated using the Black-Scholes formula and is included in the valuation assumptions table below:
 
 
Six Months Ended December 31, 2015
Stock option grants:
 
 
Risk-free interest rate
 
1.57% - 1.70%
Expected lives in years
 
5.2
Expected volatility
 
17.75% - 23.89%
Dividend yield
 
0.50% -1.65%
Weighted-average grant date fair value of options granted
 
$17.56 - $37.24
Number of shares granted
 
542,869
Acquired Plans
Liazon RSUs. In November 2013, in connection with the acquisition, we assumed the Liazon Corporation 2011 Equity Incentive Plan and converted the outstanding unvested restricted stock units into 70,533 Towers Watson restricted stock units using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of these restricted stock units was calculated using the fair value share price of Towers Watson’s closing share price on the date of acquisition. We determined the fair value of the portion of the 70,533 outstanding RSUs related to pre-acquisition employee service using Towers Watson graded vesting methodology from the date of grant to the acquisition date to be $5.7 million which was added to the transaction consideration. The fair value of the remaining portion of RSUs related to the post-acquisition employee services was $2.1 million, and will be recorded over the future vesting periods.
Liazon Options. In November 2013, in connection with the Liazon acquisition, we assumed the Liazon Corporation 2011 Equity Incentive Plan and converted the outstanding unvested employee stock options into 37,162 Towers Watson stock options using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of the vested stock options was calculated using the Black-Scholes model with a volatility and risk-free interest rate over the expected term of each group of options using the fair value share price of Towers Watson’s closing share price on the date of acquisition. The fair value of the new awards was less than the acquisition date fair value of the replaced Liazon options; accordingly, no compensation expense was recorded. We determined the fair value of the portion of the 37,162 outstanding options relating to the pre-acquisition employee service using Towers Watson graded vesting methodology from the date of grant to the

21



acquisition date to be $2.2 million, which was added to the transaction consideration. The fair value of the remaining portion of unvested options related to the post-acquisition employee service was $1.7 million, which will be recorded over the future vesting periods.
Extend Health Options. In May 2012, we assumed the Extend Health, Inc. 2007 Equity Incentive Plan and converted the outstanding unvested employee stock options into 377,614 Towers Watson stock options using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of the vested stock options was calculated using the Black-Scholes model with a volatility and risk-free interest rate over the expected term of each group of options using the fair value share price of Towers Watson’s closing share price on the date of acquisition. The fair value of the new awards were less than the acquisition date fair value of the replaced Extend Health options; accordingly, no compensation expense was recorded. We determined the fair value of the portion of the 377,614 outstanding options related to pre-acquisition employee service using Towers Watson graded vesting methodology from the date of grant to the acquisition date was $11.2 million, which was added to the transaction consideration. The fair value of the remaining portion of the unvested options at the time of the acquisition, less 10% estimated forfeitures, was $7.9 million, and will be recorded over the future vesting periods. We are now estimating a 5% forfeiture rate for the remaining unvested options.
Total expense related to our acquired option plans for the three and six months ended December 31, 2015 was not material. Total expense related to our acquired plans for the three and six months ended December 31, 2014 was $0.9 million and $1.6 million, respectively.
Impact of Merger to Certain Provisions
Certain awards contain provisions affected by a change in control. The Non-Employee Director awards vested immediately upon a change in control. The number of RSUs payable under the 2014 and 2015 LTIP awards is determined at the greater of 100% of the target level or the amount calculated based on the Company’s actual financial performance prior to the change in control. These LTIP awards will be paid on the original payment date, provided the participant remains in service, with the exception for involuntary termination within twelve months of the change in control.
As a result of the pre-Merger special dividend, the exercise price for outstanding options with an exercise price greater than $10 was adjusted to reflect the economic impact of the dividend. The total number of options impacted was 573,584.
Note 11 — Income Taxes
Provision for income taxes on continuing operations for the three and six months ended December 31, 2015 was $55.6 million and $116.2 million, respectively, compared to $55.4 million and $99.4 million, respectively, for the three and six months ended December 31, 2014. The effective tax rate was 46.3% for the six months ended December 31, 2015 and 34.1% for the six months ended December 31, 2014. The increase in the effective tax rate was primarily due to a one-time tax charge of 14.7% for repatriating overseas cash used to fund a portion of the TW special dividend, partially offset with an income tax benefit of 1.2% in connection with the enacted statutory tax rate reduction in the U.K.
As discussed in Note 8, on November 20, 2015, the Company entered into a four-year amortizing term loan agreement for up to $340 million to help fund the pre-Merger special dividend. Concurrently, the board approved an increase to the pre-Merger special dividend. The Company reviewed a number of financing options with our bank advisors and determined the most cost effective means to fund the increased cost of the pre-Merger special dividend was to fund the remaining portion through repatriation of foreign earnings. As a result, the Company repatriated $465 million during the three months ended December 31, 2015 to fund the remaining amount of the pre-Merger special dividend. The excess cash will be used to repay the debt on the term loan and cover transaction and integration expenses. The Company has accrued approximately $41.4 million in income tax expense with respect to the repatriation. ASC 740, Income Taxes, requires a company to recognize income tax expense when it becomes apparent that some or all of the undistributed earnings of a foreign subsidiary will be remitted in the foreseeable future.
We continue to assert that the historical cumulative earnings of our foreign subsidiaries are reinvested indefinitely and we do not provide U.S. deferred tax liabilities on these amounts. We believe the Company’s current cash position, and access to capital markets will allow it to meet its U.S. cash obligations without repatriating historical cumulative foreign earnings. Further, non-U.S. cash is used for working capital needs of our non-U.S. operations and may be used for foreign restructuring expenses or acquisitions.
We have liabilities for uncertain tax positions under ASC 740, Income Taxes of $34.7 million, excluding interest and penalties. The Company believes the outcomes which are reasonably possible within the next 12 months may result in a reduction in the liability for uncertain tax positions in the range of approximately $2.3 million to $5.0 million, excluding interest and penalties.

22



Note 12 — Segment Information
Towers Watson has four reportable operating segments or business areas:
Benefits
Exchange Solutions
Risk and Financial Services
Talent and Rewards
Towers Watson’s chief operating decision maker is its chief executive officer. It was determined that Towers Watson operational data used by the chief operating decision maker is that of the segments. Management bases strategic goals and decisions on these segments and the data presented below is used to assess the adequacy of strategic decisions, the method of achieving these strategies and related financial results.
Management evaluates the performance of its segments and allocates resources to them based on net operating income on a pre-bonus, pre-tax basis. Revenue includes amounts that were directly incurred on behalf of our clients and reimbursed by them (reimbursable expenses).
The table below presents revenue (net of reimbursable expenses) of the reported segments for the three and six months ended December 31, 2015 and 2014:
 
Three Months Ended 
 December 31
 
Six Months Ended 
 December 31
 
2015
 
2014
 
2015
 
2014
Benefits
$
467,378

 
$
488,453

 
$
915,402

 
$
954,040

Exchange Solutions
132,497

 
93,924

 
250,988

 
180,206

Risk and Financial Services
144,664

 
154,278

 
282,387

 
302,304

Talent and Rewards
174,826

 
183,973

 
335,117

 
337,267

Total revenue (net of reimbursable expenses)
$
919,365

 
$
920,628

 
$
1,783,894

 
$
1,773,817

The table below presents net operating income of the reported segments for the three and six months ended December 31, 2015 and 2014:
 
Three Months Ended 
 December 31
 
Six Months Ended 
 December 31
 
2015
 
2014
 
2015
 
2014
Benefits
$
167,550

 
$
175,023

 
$
319,010

 
$
330,782

Exchange Solutions
20,045

 
12,462

 
41,561

 
26,474

Risk and Financial Services
36,754

 
41,744

 
70,256

 
77,305

Talent and Rewards
63,903

 
67,568

 
111,368

 
104,411

Total net operating income
$
288,252

 
$
296,797

 
$
542,195

 
$
538,972


23



The table below presents a reconciliation of the information reported by segment to the consolidated amounts reported for the three and six months ended December 31, 2015 and 2014:
 
Three Months Ended 
 December 31
 
Six Months Ended 
 December 31
 
2015
 
2014
 
2015
 
2014
Revenue:
 
 
 
 
 
 
 
Total segment revenue
$
919,365

 
$
920,628

 
$
1,783,894

 
$
1,773,817

Reimbursable expenses and other
30,250

 
37,294

 
61,342

 
62,212

Revenue
$
949,615

 
$
957,922

 
$
1,845,236

 
$
1,836,029

Net Operating Income:
 
 
 
 
 
 
 
Total segment net operating income
$
288,252

 
$
296,797

 
$
542,195

 
$
538,972

Differences in allocation methods (1)
(5,644
)
 
11,672

 
4,147

 
27,384

Amortization of intangibles
(23,276
)
 
(17,279
)
 
(40,145
)
 
(34,816
)
Transaction and integration expenses
(80,801
)
 

 
(90,131
)
 

Stock-based compensation (2)
(5,946
)
 
(5,738
)
 
(8,411
)
 
(11,290
)
Discretionary compensation
(81,493
)
 
(111,015
)
 
(182,862
)
 
(203,379
)
Payroll tax on discretionary compensation
(8,709
)
 
(6,327
)
 
(14,327
)
 
(11,846
)
Other, net
(11,690
)
 
(1,100
)
 
(10,373
)
 
(12,017
)
Income from operations
$
70,693

 
$
167,010

 
$
200,093

 
$
293,008

________________________
(1)
Depreciation, general and administrative, pension, and medical costs are allocated to our segments based on budgeted expenses determined at the beginning of the fiscal year, as management believes that these costs are largely uncontrollable to the segment. To the extent that the actual expense base upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally allocated expenses and the actual expense that we report for GAAP purposes.
(2)
Stock-based compensation excludes RSUs granted in conjunction with our performance bonus, which are included in discretionary compensation, as well as the 2014 ES LTIP awards granted to certain executives of our Exchange Solutions segment, which are included within the calculation of Exchange Solutions’ net operating income. The 2016 ES LTIP awards are included in corporate stock-based compensation.
Note 13 — Subsequent Events
For the six months ended December 31, 2015, subsequent events were evaluated through March 9, 2016, the date the financial statements were issued.

24
Exhibit


Exhibit 99.2
Non-GAAP financial measures and reported financial results for the three and six months ended December 31, 2015 and December 31, 2014 (Amounts in thousands of U.S. Dollars)
In order to assist readers of Towers Watson & Co.'s ("Towers Watson", the "Company" or "we") financial statements in understanding the core operating results that the Company’s management uses to evaluate the business and for financial planning, we present the following non-U.S. GAAP measures: (1) Constant Currency Change, (2) Organic Change, (3) Adjusted EBITDA, and (4) Adjusted Net Income (attributable to common stockholders). The Company believes these measures are relevant and provide useful information widely used by analysts, investors and other interested parties in our industry to provide a baseline for evaluating and comparing our operating results.
These non-U.S. GAAP measures are not defined in the same manner by all companies and may not be comparable to other similarly titled measures of other companies. Non-U.S. GAAP measures should be considered in addition to, and not as a substitute for, the information contained within our financial statements filed as Exhibit 99.1 to this Form 8-K.
Constant Currency Change and Organic Change
We evaluate our revenue on an as reported, constant currency and organic basis. We believe providing constant currency and organic information provides valuable supplemental information regarding our results, consistent with how we evaluate our performance internally.
Constant Currency Change - Represents the year over year change in revenues excluding the impact of foreign currency fluctuations. To calculate this impact, the prior year local currency results are first translated using the current year monthly average exchange rates. The change is calculated by comparing the adjusted prior year revenues to the current year as reported revenues for the same period.
Organic Change - The organic presentation excludes both the impact of fluctuations in foreign currency exchange rates, as described above, as well as the impact of acquisitions and divestitures.
The constant currency and organic change results, and a reconciliation from the as reported results for consolidated revenues and by segment and line of business are reported in the tables below.
Adjusted EBITDA
We consider Adjusted EBITDA to be an important financial measure, which is used to internally evaluate and assess our core operations, to benchmark our operating results against our competitors, and to evaluate and measure our performance based compensation plans.
Adjusted EBITDA is defined as net income (attributable to common stockholders) adjusted for provision for income taxes, interest, net, depreciation and amortization, transaction and integration expenses, and other non-operating income.
Adjusted Net Income (attributable to common stockholders)
Adjusted Net Income (attributable to common stockholders) is defined as net income (attributable to common stockholders) adjusted for certain tax-effected merger and acquisition related items of amortization of intangible assets, transaction and integration expenses, the tax-effected gain on the sale of the HRSD business, and the tax cost related to our repatriation of cash held outside of the U.S. This measure is used solely for the purpose of calculating adjusted diluted earnings per share.

1



Segment Revenue:
Segment revenue excludes amounts that were directly incurred on behalf of our clients and reimbursed by them (reimbursed expenses); however, these amounts are included in consolidated revenue.
 
 
 
 
 
 
 
Components of Revenue Change
 
Three months ended December 31,
 
As Reported
Change
 
Currency
Impact
 
Constant
Currency
Change
 
Acquisitions
and
Divestitures
 
Organic
Change
 
2015
 
2014
 
 
 
 
 
Benefits
$
467,378

 
$
488,453

 
(4)%
 
(4)%
 
—%
 
—%
 
—%
Exchange Solutions
132,497

 
93,924

 
41%
 
—%
 
41%
 
8%
 
33%
Risk & Financial Services
144,664

 
154,278

 
(6)%
 
(5)%
 
(1)%
 
1%
 
(2)%
Talent & Rewards
174,826

 
183,973

 
(5)%
 
(5)%
 
—%
 
(2)%
 
2%
Reportable Segments
$
919,365

 
$
920,628

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Components of Revenue Change
 
Six months ended December 31,
 
As Reported
Change
 
Currency
Impact
 
Constant
Currency
Change
 
Acquisitions
and
Divestitures
 
Organic
Change
 
2015
 
2014
 
 
 
 
 
Benefits
$
915,402

 
$
954,040

 
(4)%
 
(4)%
 
—%
 
—%
 
—%
Exchange Solutions
250,988

 
180,206

 
39%
 
—%
 
39%
 
8%
 
31%
Risk & Financial Services
282,387

 
302,304

 
(7)%
 
(7)%
 
—%
 
1%
 
(1)%
Talent & Rewards
335,117

 
337,267

 
(1)%
 
(5)%
 
4%
 
(2)%
 
6%
Reportable Segments
$
1,783,894

 
$
1,773,817

 
 
 
 
 
 
 
 
 
 
Reconciliation of As Reported Revenue change to Constant Currency change and Organic Change:
 
 
 
 
 
 
 
Components of Revenue Change
 
Revenue
 
As Reported
Change
 
Currency
Impact
 
Constant
Currency
Change
 
Acquisitions
and
Divestitures
 
Organic
Change
 
2015
 
2014
 
 
 
 
 
Three months
ended December 31,
$
949,615

 
$
957,922

 
(1)%
 
(4)%
 
3%
 
—%
 
3%
Six months
ended December 31,
$
1,845,236

 
$
1,836,029

 
1%
 
(4)%
 
5%
 
1%
 
4%
Reconciliation of Net Income (attributable to common stockholders) to Adjusted Net Income (attributable to common stockholders):
 
Three months ended December 31,
 
Six months ended December 31,
 
2015
 
2014
 
2015
 
2014
Net Income (attributable to common stockholders)
$
11,211

 
$
110,176

 
$
134,593

 
$
191,734

Adjusted for certain items:
 
 
 
 
 
 
 
Amortization of intangible assets
16,304

 
11,507

 
27,376

 
22,932

Transaction and integration expenses including severance
55,285

 

 
61,543

 

Gain on sale of HRSD business

 

 
(37,154
)
 

US Tax Cost of Foreign Repatriation
36,817

 

 
36,817

 

Adjusted Net Income (attributable to common stockholders)
$
119,617

 
$
121,683

 
$
223,175

 
$
214,666


2



The adjustments to net income attributable to common stockholders are net of tax. In calculating the net of tax amounts, the effective tax rates applied were as follows:
 
Three months ended December 31,
 
Six months ended December 31,
 
2015
 
2014
 
2015
 
2014
Amortization of intangible assets
29.95%
 
33.41%
 
31.81%
 
34.13%
Transaction and integration expenses including severance
31.58%
 
n/a
 
31.72%
 
n/a
Gain on sale of HRSD business
n/a
 
n/a
 
32.92%
 
n/a
Reconciliation of Net Income (attributable to common stockholders) to Adjusted EBITDA
 
Three months ended December 31,
 
Six months ended December 31,
 
2015
 
2014
 
2015
 
2014
Net Income (attributable to common stockholders)
$
11,211

 
$
110,176

 
$
134,593

 
$
191,734

Provision for Income Taxes
55,653

 
55,372

 
116,211

 
99,434

Interest, net
2,159

 
1,292

 
3,039

 
2,557

Depreciation and Amortization
53,752

 
44,107

 
97,944

 
88,976

Transaction and Integration Expenses
80,801

 

 
90,131

 

Other Non-Operating Income (a)
1,286

 
(34
)
 
(54,135
)
 
(865
)
Adjusted EBITDA
$
204,862

 
$
210,913

 
$
387,783

 
$
381,836

Adjusted EBITDA Margin
21.6
%
 
22.0
%
 
21.0
%
 
20.8
%
(a) Other non-operating income includes income from affiliates and other non-operating income including a gain on the sale of the Human Resources Service Delivery (HRSD) business of $55.4 million for the six months ended December 31, 2015.

3
Exhibit


Exhibit 99.3
Pro Forma Financial Information
As previously disclosed, on Willis Towers Watson Public Limited Company’s (“Willis Towers Watson”) Current Report on Form 8-K filed on January 5, 2016, Willis Group Holdings Public Limited Company (“Willis”) completed its combination with Towers Watson & Co. (“Towers Watson”). Pursuant to the Agreement and Plan of Merger, dated as of June 29, 2015, as amended on November 19, 2015 (the “Amendment”), by and among Willis, Citadel Merger Sub, Inc. (“Merger Sub”), and Towers Watson, effective as of January 4, 2016, Merger Sub merged with and into Towers Watson (the “Merger”) with Towers Watson continuing as the surviving corporation and a wholly-owned subsidiary of Willis. As a result of the Merger, each issued and outstanding share of Towers Watson Class A common stock (“Towers Watson common stock”) was canceled in exchange for 2.6490 validly issued, fully paid and nonassessable Willis ordinary shares (the “Exchange Ratio”), other than (i) any shares of Towers Watson common stock owned by Towers Watson, Willis, or Merger Sub at the effective time of the Merger, and (ii) shares of Towers Watson common stock held by Towers Watson stockholders who are entitled to and who properly exercise and perfect dissenter’s rights under Delaware law. The cancellation and conversion of each share of Towers Watson common stock into the right to receive 2.6490 Willis ordinary shares is referred to as the “Merger Consideration”.
Immediately following the Merger, Willis effected (i) a consolidation (i.e., a reverse stock split under Irish law) of Willis ordinary shares whereby every 2.6490 Willis ordinary shares were consolidated into one Willis ordinary share (the “Consolidation”) and (ii) an amendment to its Constitution and other organizational documents to change its name from Willis Group Holdings Public Limited Company to Willis Towers Watson Public Limited Company.
COMPARATIVE HISTORICAL AND UNAUDITED PRO FORMA PER SHARE FINANCIAL DATA
The following tables set forth certain historical, pro forma and pro forma equivalent per share financial information for Willis ordinary shares and Towers Watson common stock. The unaudited pro forma and pro forma equivalent per share financial information gives effect to the pending Merger as if the transaction had occurred on December 31, 2015 for book value per share data and as of January 1, 2015 for net income per share data.
The pro forma per share income statement information for the year ended December 31, 2015 combines: (i) the historical consolidated statement of income of Willis for the fiscal year ended December 31, 2015, and (ii) the historical consolidated statement of income of Towers Watson for the twelve months ended December 31, 2015, which was derived by adding the consolidated statement of operations for the fiscal year ended June 30, 2015 to the unaudited condensed consolidated statement of operations for the six months ended December 31, 2015 and deducting the unaudited condensed consolidated statement of operations for the six months ended December 31, 2014.
The following information should be read in conjunction with the audited financial statements of Willis in Willis Towers Watson’s Annual Report on Form 10-K for the year ended December 31, 2015, and Towers Watson’s Annual Report on Form 10-K for the fiscal year ended June 30, 2015 and Towers Watson’s unaudited financial statements for the three and six months ended December 31, 2015 and 2014, included as Exhibit 99.1 on this Form 8-K. The unaudited pro forma information below is presented for illustrative purposes only and is not necessarily indicative of the operating results or financial position that would have occurred if the Merger had been completed as of the date indicated, nor is it necessarily indicative of the future operating results or financial position of the combined company. In addition, the unaudited pro forma information does not purport to project balance sheet data or results of operations data as of any future date or for any future period.
 
Year Ended December 31, 2015
Willis Historical Per Share Data(i)
 
Earnings per share — basic
$
5.49

Earnings per share — diluted
$
5.41

Cash dividends declared per common share
$
3.28

Book value per share (as of period end)
$
32.48


1



 
Fiscal
Year Ended June 30, 2015
Towers Watson Historical Per Share Data
 
Earnings per share — basic
$
5.52

Earnings per share — diluted
$
5.50

Cash dividends declared per common share
$
0.60

Book value per share (as of period end)
$
42.32

 
Year Ended December 31, 2015
Unaudited Pro Forma Consolidated Per Share Data
 
Earnings per share — basic
$
4.62

Earnings per share — diluted
$
4.59

Cash dividends declared per common share(ii)
$
1.92

Book value per share (as of period end)
$
79.16

 
Year Ended December 31, 2015
Unaudited Pro Forma Equivalent Per Share Data for Towers Watson(iii)
 
Earnings per share — basic
$
3.19

Earnings per share — diluted
$
3.19

Cash dividends declared per common share(ii)
$
1.92

Book value per share (as of period end)
$
125.28

____________________
(i)
Willis historical results reflect the reverse stock split of Willis ordinary shares whereby every 2.6490 Willis ordinary shares were consolidated into one Willis ordinary share which occurred immediately following the Merger.
(ii)
The pro forma cash dividends declared per share are based upon the preliminarily expected payment of $0.48 per share each quarter for fiscal year 2016. The first such payment was announced on February 5, 2016.
(iii)
The unaudited pro forma equivalent per share data for Towers Watson are calculated by multiplying the preliminary unaudited pro forma consolidated per share data by the Exchange Ratio and then dividing by the reverse stock split ratio.

2



UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION
The following unaudited pro forma condensed consolidated financial information, which are referred to as the “unaudited pro forma financial information,” is presented to illustrate the estimated effects of the Merger based on the historical financial statements and accounting records of Willis and Towers Watson after giving effect to the Merger, and the Merger-related pro forma adjustments as described in these notes.
The fiscal year of Willis ends on December 31, and prior to the Merger, the fiscal year of Towers Watson ended on June 30. The following unaudited pro forma condensed consolidated statement of income for the fiscal year ended December 31, 2015 was prepared based on the following historical periods: (i) the historical consolidated statement of income of Willis for the year ended December 31, 2015 and (ii) the historical consolidated statement of income of Towers Watson for the twelve months ended December 31, 2015, which was derived by adding the consolidated statement of operations for the fiscal year ended June 30, 2015 to the unaudited condensed consolidated statement of operations for the six months ended December 31, 2015, and deducting the unaudited condensed consolidated statement of operations for the six months ended December 31, 2014.
The following unaudited pro forma condensed consolidated balance sheet was prepared based on the following historical dates: (i) the historical consolidated balance sheet of Willis as of December 31, 2015 and (ii) the historical unaudited condensed consolidated balance sheet of Towers Watson as of December 31, 2015. For further information on historical Towers Watson financial information, refer to the accompanying notes to the unaudited pro forma condensed consolidated financial information.
The following unaudited pro forma condensed consolidated financial information has been prepared to reflect the Merger and is provided for illustrative purposes only. The unaudited pro forma condensed consolidated statement of income assumes that the Merger occurred on January 1, 2015, and does not necessarily reflect what Willis’ results of operations would have been had the Merger occurred on such date or for any future or historical period. The unaudited pro forma condensed consolidated balance sheet assumes that the Merger occurred on December 31, 2015. The unaudited pro forma condensed balance sheet does not necessarily reflect what Willis’ financial position would have been had the Merger been completed on December 31, 2015, or for any future or historical period.
The unaudited pro forma financial information was prepared using the acquisition method of accounting with Willis treated as the accounting acquirer and, therefore, the historical basis of Willis’ assets and liabilities was not affected by the Merger. The unaudited pro forma financial information has been developed from and should be read in conjunction with the audited financial statements of Willis in Willis’ Annual Report on Form 10-K for the year ended December 31, 2015, and audited Towers Watson’s Annual Report on Form 10-K for the fiscal year ended June 30, 2015 and Towers Watson’s unaudited financial statements for the three and six months ended December 31, 2015 and 2014, included as Exhibit 99.1 on this Form 8-K. For purposes of developing the Unaudited Pro Forma Condensed Combined Balance Sheet as of December 31 2015, Towers Watson’s assets, including identifiable intangible assets, and liabilities have been recorded at their estimated fair values and the excess aggregate Merger Consideration has been assigned to goodwill. The fair values assigned in this unaudited pro forma financial information are preliminary and represent Willis Towers Watson’s management’s best estimate of fair value and are subject to revision.
Certain historical balances of Towers Watson have been reclassified to conform to the financial presentation of Willis. Willis Towers Watson management expects that there could be additional reclassifications that have not yet been identified. Additionally, Willis Towers Watson management will continue to assess Willis’ and Towers Watson’s respective accounting policies for any additional adjustments that may be required to conform Towers Watson’s accounting policies to those of Willis.
The unaudited pro forma financial information is provided for illustrative purposes only and is based on adjustments that are preliminary and are based upon available information and certain assumptions that Willis Towers Watson management believes are reasonable under the circumstances, as described in the accompanying notes to the unaudited pro forma consolidated financial information. The unaudited pro forma financial information has not been adjusted to give effect to certain expected financial benefits of the Merger, such as revenue synergies, tax savings and cost synergies, or the anticipated costs to achieve these benefits, including the cost of integration activities. The unaudited pro forma condensed consolidated financial information does not purport to represent what the actual consolidated results of operations or the consolidated financial position of Willis would have been had the Merger occurred on the dates indicated, nor is it necessarily indicative of future consolidated results of operations or consolidated financial position. The actual financial position and results of operations will differ, potentially significantly, from the pro forma amounts reflected herein due to a variety of factors, including access to additional information, changes in value not currently identified and changes in operating results following the date of the unaudited pro forma financial information.
Prior to the closing date, on December 29, 2015 Towers Watson declared and paid a one-time special cash dividend (the “Towers Watson pre-merger special dividend”), in an amount of $10.00 per share of Towers Watson common stock,

3



approximately $694 million in the aggregate based on approximately 69 million Towers Watson shares issued and outstanding at December 29, 2015. Upon closing of the Merger and prior to the Consolidation, Towers Watson stockholders received 2.6490 Willis ordinary shares in exchange for each issued and outstanding share of Towers Watson common stock. For purposes of this unaudited pro forma financial information, the estimated aggregate consideration to complete the Merger was approximately $8.7 billion based upon a per share price of $47.18, the closing price of Willis ordinary shares on January 4, 2016, and approximately 69 million shares of Towers Watson common stock outstanding as of January 4, 2016.

4



UNAUDITED PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF INCOME
For the year ended December 31, 2015
 
 
 
Historical
 
Pro Forma
 
 
 
 
 
Historical
 
Towers
 
Adjustments
 
 
 
Pro Forma
 
Willis
 
Watson
 
(Note 2)
 
 
 
Combined
 
(Millions, except per share data)
 
(Unaudited)
REVENUES
 
 
 
 
 
 
 
 
 
Commissions and fees
$
3,809

 
$
3,654

 
$
(1
)
 
a,m
 
$
7,462

Investment income
12

 
4

 

 
a
 
16

Other income
8

 

 

 
 
 
8

Total revenues
3,829

 
3,658

 
(1
)
 
 

7,486

EXPENSES
 
 
 
 
 
 
 
 
 
Salaries and benefits
(2,306
)
 
(2,161
)
 
32

 
a,k,o
 
(4,435
)
Other operating expenses
(799
)
 
(816
)
 
147

 
a,c,e,m,p
 
(1,468
)
Depreciation expense
(95
)
 
(110
)
 
44

 
b
 
(161
)
Amortization of intangible assets
(76
)
 
(71
)
 
(386
)
 
a,c
 
(533
)
Restructuring costs
(126
)
 

 

 
 
 
(126
)
Total expenses
(3,402
)
 
(3,158
)
 
(163
)
 
 
 
(6,723
)
OPERATING INCOME
427

 
500

 
(164
)
 
 
 
763

Other income (expense), net
55

 
57

 

 
 
 
112

Interest expense
(142
)
 
(9
)
 
(15
)
 
a,g
 
(166
)
INCOME FROM CONTINUING OPERATIONS BEFORE INCOME TAXES, AND INTEREST IN EARNINGS OF ASSOCIATES
340

 
548

 
(179
)
 
 

709

Income taxes
33

 
(217
)
 
111

 
h
 
(73
)
INCOME FROM CONTINUING OPERATIONS BEFORE INTEREST IN EARNINGS OF ASSOCIATES
373

 
331

 
(68
)
 
 
 
636

Interest in earnings of associates, net of tax
11

 
(2
)
 

 
a
 
9

NET INCOME
384

 
329

 
(68
)
 
 
 
645

Less: net income attributable to noncontrolling interests
(11
)
 
(1
)
 

 
 
 
(12
)
NET INCOME ATTRIBUTABLE TO WILLIS TOWERS WATSON
$
373

 
$
328

 
$
(68
)
 
 
 
$
633

EARNINGS PER SHARE - BASIC AND DILUTED
 
 
 
 
 
 
 
 
 
 - Basic earnings per share
$
5.49

 
$
4.75

 
 
 
l
 
$
4.62

 - Diluted earnings per share
$
5.41

 
$
4.75

 
 
 
l
 
$
4.59

CASH DIVIDENDS DECLARED PER COMMON SHARE
$
3.28

 
$
10.45

 
 
 
 
 
$
3.28

 The accompanying notes are an integral part of the unaudited pro forma condensed consolidated financial information.




5



UNAUDITED PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET
As at December 31, 2015
 
 
 
Historical
 
Pro Forma
 
 
 
 
 
Historical
 
Towers
 
Adjustments
 
 
 
Pro Forma
 
Willis
 
Watson
 
(Note 2)
 
 
 
Combined
 
(Millions)
 
(Unaudited)
ASSETS
 
 
 
 
 
 
 
 
 
CURRENT ASSETS
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
532

 
$
476

 
$

 
 
 
$
1,008

Short-term investments

 
17

 

 
 
 
17

Accounts receivable, net
1,258

 
825

 

 
 
 
2,083

Fiduciary assets
10,458

 
27

 

 
 
 
10,485

Deferred tax assets

 
35

 
(35
)
 
h
 

Other current assets
255

 
80

 

 
 
 
335

Total current assets
12,503

 
1,460

 
(35
)
 
 
 
13,928

NON-CURRENT ASSETS
 
 
 
 
 
 
 
 
 
Fixed assets, net
563

 
404

 
(162
)
 
b
 
805

Goodwill
3,737

 
2,196

 
4,350

 
d,o
 
10,283

Other intangible assets, net
1,115

 
614

 
3,496

 
c
 
5,225

Investments in associates
13

 
4

 

 
 
 
17

Deferred tax assets
76

 
60

 
(27
)
 
h
 
109

Pension benefits asset
623

 
125

 
(54
)
 
a,k
 
694

Other non-current assets
209

 
102

 

 
 
 
311

Total non-current assets
6,336

 
3,505

 
7,603

 
 
 
17,444

TOTAL ASSETS
$
18,839

 
$
4,965

 
$
7,568

 
 
 
$
31,372

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
CURRENT LIABILITIES
 
 
 
 
 
 
 
 
 
Fiduciary liabilities
$
10,458

 
$
27

 
$

 
 
 
$
10,485

Deferred revenue and accrued expenses
752

 
583

 
(67
)
 
a,f,n
 
1,268

Income taxes payable
45

 
67

 

 
a
 
112

Current portion of long-term debt
988

 
485

 

 
g
 
1,473

Deferred tax liabilities

 
5

 
(5
)
 
h
 

Other current liabilities
558

 
205

 
(9
)
 
a,p
 
754

Total current liabilities
12,801

 
1,372

 
(81
)
 
 
 
14,092

NON-CURRENT LIABILITIES
 
 
 
 
 
 
 
 
 
Long-term debt
2,278

 
255

 

 
g
 
2,533

Liability for pension benefits
279

 
563

 
330

 
a,k
 
1,172

Deferred tax liabilities
240

 
118

 
898

 
a,h
 
1,256

Provision for liabilities
295

 
240

 

 
 
 
535

Other non-current liabilities
533

 
151

 
(31
)
 
a,c,p
 
653

Total non-current liabilities
3,625

 
1,327

 
1,197

 
 
 
6,149

TOTAL LIABILITIES
16,426

 
2,699

 
1,116

 
 
 
20,241

REDEEMABLE NONCONTROLLING INTEREST
53

 

 

 
 
 
53

EQUITY
 
 
 
 
 
 
 
 
 
Total Willis stockholders’ equity
2,229

 
2,250

 
6,452

 
i,j,k,o
 
10,931

Noncontrolling interests
131

 
16

 

 
 
 
147

Total equity
2,360

 
2,266

 
6,452

 
 
 
11,078

TOTAL LIABILITIES AND EQUITY
$
18,839

 
$
4,965

 
$
7,568

 
 
 
$
31,372

 The accompanying notes are an integral part of the unaudited pro forma condensed consolidated financial information.


6



NOTES TO UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION
(Tabular amounts are in millions, except share and per share data)
Note 1. Basis of pro forma presentation
As previously disclosed, pursuant to the Merger Agreement, as amended by the Amendment, upon close of business on January 4, 2016, Willis combined with Towers Watson, a leading provider of advisory services and solutions across four business segments: (i) benefits; (ii) risk and financial services, (iii) exchange solutions, and (iv) talent and rewards. As part of the Merger, Towers Watson stockholders received 2.6490 Willis ordinary shares for each share of Towers Watson common stock owned as of immediately prior to the effective time of the Merger. Upon completion of the Merger, Towers Watson stock options and other equity awards converted into stock options and equity awards with respect to Willis ordinary shares, after giving effect to the Exchange Ratio. On the third business day immediately prior to the closing date, December 29, 2015, Towers Watson declared and paid the Towers Watson pre-merger special dividend in the amount of $10.00 per share of Towers Watson common stock, approximately $694 million in the aggregate based on approximately 69 million Towers Watson shares issued and outstanding at December 29, 2015.
The Merger is being accounted for using the acquisition method of accounting with Willis considered the accounting acquirer of Towers Watson.
The accompanying unaudited pro forma financial information is intended to reflect the impact of the Merger on Willis’ consolidated financial statements and presents pro forma consolidated financial position and results of operations of Willis based on the historical financial statements of Willis and Towers Watson after giving effect to the Merger and pro forma adjustments as described in these notes. Pro forma adjustments are included only to the extent they are (i) directly attributable to the Merger, (ii) factually supportable and (iii) with respect to the statement of income, expected to have a continuing impact on the consolidated results. The accompanying unaudited pro forma financial information is presented for illustrative purposes only and has not been adjusted to give effect to certain expected financial benefits of the Merger, such as revenue synergies, tax savings and cost synergies, or the anticipated costs to achieve these benefits, including the cost of integration activities.
The Unaudited Pro Forma Condensed Consolidated Combined Balance Sheet gives effect to the Merger as if it had occurred on December 31, 2015, and the Unaudited Pro Forma Condensed Consolidated Statement of Income give effect to the Merger as if it had occurred on January 1, 2015.
Fair Value Adjustments
The unaudited pro forma financial information reflects the preliminary assessment of fair values and lives assigned to the assets acquired and liabilities assumed. Fair value estimates were determined based on preliminary valuations prepared by a third-party specialist. The allocation of the aggregate Merger Consideration used in the preliminary unaudited pro forma condensed consolidated financial information is based on preliminary estimates. The estimates and assumptions are subject to change as of the effective time of the Merger. The final determination of the allocation of the aggregate Merger Consideration will be based on the actual tangible assets and liabilities, and the intangible assets of Towers Watson at the effective time of the Merger. In particular, the final valuation of intangible assets and the assessment of their useful lives may change significantly from the preliminary estimates, which could result in a material change to the amortization of intangible assets.
Purchase price
The Unaudited Pro Forma Condensed Consolidated Balance Sheet has been adjusted to reflect the estimated fair values of the identifiable assets acquired and liabilities assumed and the excess of the aggregate Merger Consideration over these fair values is recorded in goodwill. The fair value of the aggregate Merger Consideration in the unaudited pro forma financial information is approximately $8.7 billion. This amount was derived based on the outstanding shares of Towers Watson common stock at January 4, 2016, the Exchange Ratio and a price per share of Willis ordinary shares of $47.18, which represents the closing price on January 4, 2016. Towers Watson equity awards outstanding at the time of the closing of the Merger were converted into equity awards of Willis ordinary shares, after giving effect to the Exchange Ratio. The terms of these awards, including vesting provisions, are identical to those of the historical Towers Watson equity awards, except that a grantee’s Towers Watson stock equity awards will vest if the grantee’s employment is terminated without “cause” within 12 months following the effective time of the Merger. As a result of replacing these awards, an additional $37 million was added to Merger Consideration relating to pre-acquisition service.
The table below presents the preliminary aggregate Merger Consideration on January 4, 2016, along with a preliminary allocation of the aggregate Merger Consideration to the assets acquired and liabilities assumed.

7



Preliminary Aggregate Merger Consideration
 
 
January 4, 2016
Number of shares of Towers Watson common stock outstanding as of January 4, 2016
 
69 million

Exchange ratio
 
2.649

Number of Willis Group Holdings shares issued (prior to reverse stock split)
 
184 million

Willis Group Holdings price per share on January 4, 2016
 
$
47.18

Fair value (millions) of 184 million Willis ordinary shares
 
$
8,686

Value of equity awards assumed
 
37

Preliminary estimated aggregate Merger Consideration
 
$
8,723

Preliminary Allocation of Aggregate Merger Consideration
 
 
January 4, 2016
Cash and cash equivalents
 
$
476

Accounts receivable, net
 
825

Other current assets
 
124

Fixed assets, net
 
242

Goodwill
 
6,546

Other intangible assets (i)
 
4,110

Other non-current assets
 
208

Deferred tax liabilities
 
(1,016
)
Pension and other post-retirement liabilities
 
(941
)
Other current liabilities
 
(751
)
Other non-current liabilities
 
(360
)
Long term debt, including current portion (ii)
 
(740
)
Allocated Aggregate Merger Consideration
 
$
8,723

______________________________
(i)
Represents identified finite-lived intangible assets; primarily relates to customer relationships and core/developed technology and other marketing related intangibles.
(ii)
Represents both debt due upon change of control of $400 million borrowed under Towers Watson’s term loan ($188 million) and revolving credit facility ($212 million) and an additional draw down under a new term loan of $340 million. The $400 million debt was repaid by Willis borrowings under the 1-year term loan facility on January 4, 2016. The $340 million new term loan partially funded the $694 million Towers Watson pre-merger special dividend.
Upon completion of the fair value assessment following the Merger, Willis and Towers Watson anticipate the ultimate fair values of the net assets acquired will differ from the preliminary assessment outlined above. Generally, changes to the initial estimates of the fair value of assets and liabilities will be recorded as adjustments to those assets and liabilities and residual amounts will be allocated to goodwill.
Other Transaction-related Adjustments
The unaudited pro forma financial information reflects certain reclassifications of Towers Watson balance sheet and statement of income categories to conform to Willis’ presentation.
The unaudited pro forma financial information reflects certain adjustments to eliminate transactions between Willis and Towers Watson.
The unaudited pro forma financial information does not reflect any adjustments to conform Towers Watson’s accounting policies to those adopted by Willis as no such adjustments were identified that would have a material effect on the unaudited pro forma financial information.
Further review may identify additional reclassifications, intercompany transactions or differences between accounting policies of the two companies that, when conformed, could have a material impact on the unaudited pro forma financial information of

8



the combined company. At this time, Willis Towers Watson is not aware of any reclassifications, intercompany transactions or accounting policy differences that would have a material impact on the unaudited pro forma financial information that are not reflected in these pro forma adjustments.
Items Not Adjusted in the Unaudited Pro Forma Financial Information
The unaudited pro forma financial information does not include any adjustments for liabilities or related costs that may result from integration activities. Significant liabilities and related costs may ultimately be recorded for employee severance or relocation, costs of vacating some facilities and costs associated with other exit and integration activities. These items have not been considered with regard to potential tax planning strategies that may result from the Merger.
Note 2. Transaction-related Adjustments
The unaudited pro forma financial information reflects the following adjustments:
a)
Conforming reclassifications and adjustments. Certain reclassifications have been made to amounts in the Towers Watson historical balance sheet and statement of income to conform to Willis’ presentation, including reclassifying Towers Watson’s accounts payable, accrued liabilities and deferred income and employee-related liabilities caption headings into their component parts and presenting components of Towers Watson’s professional and subcontracted services, occupancy and general and administrative expenses within the relevant Willis captions.
b)
Property and equipment. Adjustments to eliminate Towers Watson’s historical internally developed software of $237 million and related amortization of $57 million for the year ended December 31, 2015, since the fair value of these assets has been reflected within the core/developed technology intangibles assets. This adjustment is offset by a preliminary increase of $75 million from book value to fair value and related increase to depreciation of $13 million for the year ended December 31, 2015 for leasehold improvements, furniture and fixtures and computer hardware and software.
c)
Intangible assets. Adjustments to eliminate Towers Watson’s historical identifiable intangible assets of $614 million and related amortization of $71 million for the year ended December 31, 2015 and to reflect the preliminary estimated fair values of Towers Watson’s identifiable intangible assets and related amortization that management has determined based on estimates and assumptions that it considers to be reasonable. The primary assets include customer relationships, core/developed technology and products, other marketing related intangibles and favorable lease agreements. The amortization adjustment for the customer relationship asset is based on a preliminary assumption of amortization on an accelerated basis (i.e. reducing balance). Other acquired finite-lived intangible assets such as core/developed technology and products, marketing related intangibles and favorable lease agreements are amortized on a straight line basis. These assumptions are subject to further analysis and may change, which would result in a change to the incremental amortization adjustment included in the unaudited pro forma financial information. The following table presents information about the identifiable intangible assets:
 
 
 
Estimated
 
Year ended December 31,
 
Preliminary
 
Useful
 
2015
 
Fair Value
 
Life in Years
 
Amortization
Customer relationships
$
2,231

 
7 - 18
 
$
285

Core/developed technology and products
865

 
1-19
 
132

Marketing related
1,003

 
25
 
40

Favorable lease agreements
11

 
4-11
 
2

Total pro forma adjustments
$
4,110

 
 
 
$
459

Additionally, adjustments to record the preliminary fair value of unfavorable lease agreements for $10 million and the related amortization to operating expenses of $1 million for the year ended December 31, 2015 for the net impact of both the favorable and unfavorable lease agreements.
d)
Goodwill. Adjustments to eliminate Towers Watson’s historical goodwill and record the preliminary fair value of goodwill resulting from the Merger. Goodwill is not amortized but rather is assessed for impairment at least annually or more frequently whenever events or circumstances indicate that goodwill might be impaired.

9



e)
Transaction-related costs. Transaction-related costs of $150 million and related tax benefits, incurred in the twelve months ended December 31, 2015, have been excluded for pro forma financial information purposes.
f)
Change of control clauses. Adjustments to record liabilities for estimated payments of $5 million, net of related tax benefits, due under change of control clauses in certain executive officer management contracts.
g)
Long-term debt. Total pro forma borrowings remained unchanged from the total balances borrowed by both Willis and Towers Watson at December 31, 2015. Towers Watson had $400 million in debt outstanding at December 31, 2015 that was due upon change of control. At time of closing on January 4, 2016, Willis Towers Watson borrowed $400 million under a one-year term loan which is payable on December 19, 2016, and repaid the legacy Towers Watson debt. Additionally, Towers Watson borrowed under a $340 million term loan as part of the funding for the pre-Merger special dividend on December 29, 2015. Adjustments to record related interest expense and amortization of related deferred debt issuance costs of $9 million and $6 million, respectively, for the year ended December 31, 2015.
h)
Income taxes. Adjustments to record the deferred tax impact of acquisition accounting adjustments, primarily related to intangible assets, including customer relationships, core/developed technology, marketing-related intangibles, the current and deferred tax consequence of the repatriation of foreign earnings to partially fund the pre-Merger special dividend and the income and deferred tax impact of the pro forma adjustments. Adjustments also include the deferred tax classification to conform to Willis’ early adoption of ASU No. 2015-17. The incremental deferred tax assets and liabilities and the income tax expense were calculated based on the U.S. and foreign statutory rates where fair value adjustments were estimated. Where applicable, a U.S. statutory rate of 40% was used. Pro forma adjustments for income tax purposes have been determined without regard to potential tax planning strategies that may result from the Merger of Towers Watson with Willis.
i)
Willis ordinary shares issuance. Approximately 184 million Willis ordinary shares (prior to the reverse stock split) were issued to Towers Watson stockholders as the Merger Consideration in connection with the Merger, based on Towers Watson shares of common stock outstanding as of January 4, 2016, at a per share price of $47.18, which was the closing price on that date, for a total value of approximately $8.7 billion.
j)
Towers Watson stockholders’ equity. The elimination of all Towers Watson stockholders’ equity, including common stock, additional paid-in capital, treasury stock, retained earnings and accumulated other comprehensive loss.
k)
Pension amortization and fair value adjustments. Adjustments to remove the net periodic benefit costs of $33 million for the year ended December 31, 2015 associated with the amortization of net actuarial losses and prior service credits/costs for Towers Watson’s pension plans. Net actuarial gains and losses and prior service credits are included in the accumulated other comprehensive income component of equity. Because Towers Watson’s equity, including accumulated other comprehensive income/(loss), net, is eliminated in the opening balance sheet, the results for the period following the Merger will not include any impact from amortization of these deferred net actuarial gains and losses and prior service credits.
Adjustments to record the preliminary fair value of the net funded status of the Towers Watson pension and other postretirement benefit plans which reduced pension assets by $54 million and increased the liability for pension benefits by $330 million.

10



l)Earnings per share. The pro forma consolidated basic and diluted earnings per share for the year ended December 31, 2015 is calculated as follows:
 
Year ended
December 31,
2015
 
(Millions, except per share data)
Willis historic average basic shares in issue
68

Shares issued for Towers Watson (i)
69

Willis historic average basic shares in issue
137

Dilutive effect of securities
1

Diluted weighted average shares outstanding
138

Pro forma net income attributable to Willis Towers Watson
$
633

Earnings per share - basic
$
4.62

Earnings per share - diluted
$
4.59

 ____________________
(i)
Shares issued for Towers Watson based on approximately 69 million Towers Watson shares outstanding at January 4, 2016 and the Exchange Ratio.
m)
Intercompany trading. Adjustments to eliminate trading between Willis and Towers Watson of $1 million for the year ended December 31, 2015.
n)
Deferred income. Adjustment to derecognize Towers Watson deferred income in excess of the remaining performance obligation assumed as part of the business combination of $74 million as of December 31, 2015, from deferred revenue and accrued expenses.
o)
Share based compensation. Adjustments to recognize Towers Watson share-based payments in accordance with Willis accounting policies of $1 million for the year ended December 31, 2015. An adjustment to recognize $37 million for the value of the equity awards assumed increased consideration and the resulting goodwill as of December 31, 2015.
p)
Deferred rent. Adjustment to remove deferred rent credit related to lease incentives of $50 million as of December 31, 2015 and the elimination of the related income statement benefit of $3 million, net of tax, for the year ended December 31, 2015.

11
Exhibit


Exhibit 99.4
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors and Stockholders of
Towers Watson & Co
Arlington, Virginia


We have audited the accompanying consolidated balance sheets of Towers Watson & Co. and subsidiaries (the "Company") as of June 30, 2015 and 2014, and the related consolidated statements of operations, comprehensive income, changes in stockholders' equity, and cash flows for each of the three years in the period ended June 30, 2015. These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these financial statements based on our audits.
We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of Towers Watson & Co. and subsidiaries at June 30, 2015 and 2014, and the results of their operations and their cash flows for each of the three years in the period ended June 30, 2015, in conformity with accounting principles generally accepted in the United States of America.
/s/ DELOITTE & TOUCHE LLP
McLean, Virginia
August 14, 2015

1



TOWERS WATSON & CO.
Consolidated Statements of Operations
(Thousands of U.S. dollars, except share and per share data)
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Revenue
$
3,644,953

 
$
3,481,912

 
$
3,432,515

Costs of providing services:
 
 
 
 
 
Salaries and employee benefits
2,159,057

 
2,106,431

 
2,085,188

Professional and subcontracted services
268,277

 
249,775

 
267,715

Occupancy
137,841

 
137,883

 
139,942

General and administrative expenses
311,906

 
317,448

 
303,472

Depreciation and amortization
172,287

 
174,818

 
173,040

Transaction and integration expenses
6,984

 
1,049

 
30,753

 
3,056,352

 
2,987,404

 
3,000,110

Income from operations
588,601

 
494,508

 
432,405

Income / (loss) from affiliates
33

 

 
(56
)
Interest income
3,943

 
2,803

 
2,400

Interest expense
(9,075
)
 
(9,031
)
 
(12,676
)
Other non-operating income
2,191

 
10,226

 
6,928

Income before income taxes
585,693

 
498,506

 
429,001

Provision for income taxes
200,062

 
138,249

 
136,991

INCOME FROM CONTINUING OPERATIONS
385,631

 
360,257

 
292,010

Income from discontinued operations, net of income tax of $0, $39,202, $15,561, respectively

 
6,057

 
23,642

NET INCOME BEFORE NON-CONTROLLING INTERESTS
385,631

 
366,314

 
315,652

Income / (loss) attributable to non-controlling interests
653

 
7,014

 
(3,160
)
NET INCOME (attributable to common stockholders)
$
384,978

 
$
359,300

 
$
318,812

Basic earnings per share (attributable to common stockholders):
 
 
 
 
 
Net income from continuing operations
$
5.52

 
$
5.00

 
$
4.15

Net income from discontinued operations

 
0.09

 
0.33

Net income - basic
$
5.52

 
$
5.09

 
$
4.48

Diluted earnings per share (attributable to common stockholders):
 
 
 
 
 
Net income from continuing operations
$
5.50

 
$
4.98

 
$
4.13

Net income from discontinued operations

 
0.08

 
0.33

Net income - diluted
$
5.50

 
$
5.06

 
$
4.46

Weighted average shares of common stock, basic (000)
69,766

 
70,587

 
71,150

Weighted average shares of common stock, diluted (000)
70,007

 
70,955

 
71,555

See accompanying notes to the consolidated financial statements


2



TOWERS WATSON & CO.
Consolidated Statements of Comprehensive Income
(In thousands of U.S. dollars)
 
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Net income before non-controlling interests
$
385,631

 
$
366,314

 
$
315,652

Other comprehensive income / (loss), net of tax:
 
 
 
 
 
Foreign currency translation
(227,803
)
 
132,648

 
(57,036
)
Defined pension and post-retirement benefit costs
(159,029
)
 
(23,355
)
 
107,223

Hedge effectiveness
894

 
(67
)
 
(122
)
Available-for-sale securities
149

 
(183
)
 
(81
)
Other comprehensive (loss) / income before non-controlling interests
(385,789
)
 
109,043

 
49,984

Comprehensive (loss) / income before non-controlling interests
(158
)
 
475,357

 
365,636

Comprehensive income / (loss) attributable to non-controlling interest
1,460

 
6,295

 
(4,457
)
Comprehensive (loss) / income attributable to controlling interests
$
(1,618
)
 
$
469,062

 
$
370,093

See accompanying notes to the consolidated financial statements


3



TOWERS WATSON & CO.
Consolidated Balance Sheets
(Thousands of U.S. dollars, except share data)
 
June 30,
 
2015
 
2014
Assets
Cash and cash equivalents
$
715,151

 
$
727,849

Fiduciary assets
38,075

 
12,010

Short-term investments
127,156

 
122,761

Receivables from clients:
 
 
 
Billed, net of allowances of $7,665 and $8,075
479,536

 
507,213

Unbilled, at estimated net realizable value
320,827

 
314,020

 
800,363

 
821,233

Other current assets
155,487

 
124,645

Total current assets
1,836,232

 
1,808,498

Fixed assets, net
390,681

 
374,444

Deferred income taxes
62,772

 
79,103

Goodwill
2,278,351

 
2,313,058

Intangible assets, net
654,087

 
657,293

Other assets
172,051

 
395,390

Total Assets
$
5,394,174

 
$
5,627,786

Liabilities
 
 
 
Accounts payable, accrued liabilities and deferred income
$
424,403

 
$
404,760

Employee-related liabilities
581,115

 
518,532

Fiduciary liabilities
38,075

 
12,010

Term loan - current
25,000

 
25,000

Other current liabilities
62,281

 
74,297

Total current liabilities
1,130,874

 
1,034,599

Revolving credit facility
40,000

 

Term loan
175,000

 
200,000

Accrued retirement benefits and other employee-related liabilities
648,655

 
768,024

Professional liability claims reserve
235,856

 
225,959

Other noncurrent liabilities
216,277

 
288,255

Total Liabilities
2,446,662

 
2,516,837

Commitments and contingencies
 
 
 
Stockholders’ Equity
 
 
 
Class A Common Stock — $0.01 par value: 300,000,000 shares authorized; 74,552,661 issued and 69,281,754 and 70,338,891 outstanding
746

 
746

Additional paid-in capital
1,870,745

 
1,849,119

Treasury stock, at cost — 5,270,907 and 4,213,770 shares
(429,286
)
 
(286,182
)
Retained earnings
2,066,104

 
1,722,927

Accumulated other comprehensive loss
(576,298
)
 
(189,702
)
Total Stockholders’ Equity
2,932,011

 
3,096,908

Non-controlling interest
15,501

 
14,041

Total Equity
2,947,512

 
3,110,949

Total Liabilities and Total Equity
$
5,394,174

 
$
5,627,786

See accompanying notes to the consolidated financial statements


4



TOWERS WATSON & CO.
Consolidated Statements of Cash Flows
(Thousands of U.S. dollars)
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Cash flows from operating activities:
 
 
 
 
 
Net income before non-controlling interests
$
385,631

 
$
366,314

 
$
315,652

Adjustments to reconcile net income to net cash from operating activities:
 
 
 
 
 
Provision for doubtful receivables from clients
20,584

 
4,429

 
8,351

Depreciation
106,546

 
99,606

 
96,811

Amortization of intangible assets
65,741

 
75,932

 
78,910

Gain on sale of discontinued operations, pretax

 
(23,950
)
 

Provision for deferred income taxes
70,452

 
58,220

 
62,510

Stock-based compensation
36,129

 
22,517

 
28,906

Other, net
3,876

 
(3,704
)
 
(3,249
)
Changes in operating assets and liabilities (net of business acquisitions)
 
 
 
 
 
Receivables from clients
(42,534
)
 
17,528

 
40,079

Fiduciary assets
(25,323
)
 
113,317

 
23,177

Other current assets
(3,483
)
 
14,722

 
(16,710
)
Other noncurrent assets
10,617

 
(9,175
)
 
10,507

Accounts payable, accrued liabilities and deferred income
14,655

 
16,000

 
31,144

Employee-related liabilities
111,611

 
(46,766
)
 
33,642

Fiduciary liabilities
25,323

 
(113,317
)
 
(23,177
)
Accrued retirement benefits and other employee-related liabilities
(114,387
)
 
(139,922
)
 
(141,895
)
Professional liability claims reserves
16,393

 
(27,967
)
 
(13,575
)
Other current liabilities
14,560

 
4,838

 
(1,800
)
Other noncurrent liabilities
(36,764
)
 
(26,095
)
 
(2,649
)
Income tax related accounts
(86,108
)
 
53,564

 
4,680

Cash flows from operating activities
573,519

 
456,091

 
531,314

Cash flows used in investing activities:
 
 
 
 
 
Cash paid for business acquisitions
(210,774
)
 
(211,894
)
 
(5,678
)
Cash transferred with discontinued operations

 
(25,066
)
 

Proceeds from discontinued operations

 
259,677

 
7,371

Cash acquired from business acquisitions
3,759

 
17,763

 
636

Fixed assets and software for internal use
(71,435
)
 
(64,825
)
 
(77,891
)
Capitalized software costs
(63,791
)
 
(55,996
)
 
(50,081
)
Purchases of investments of consolidated variable interest entity

 
(109,510
)
 

Purchases of held-to-maturity investments
(288,957
)
 
(142,971
)
 

Redemptions of held-to-maturity investments
261,122

 
37,161

 

Purchases of available-for-sale securities
(14,978
)
 
(30,143
)
 
(61,251
)
Sales and redemptions of available-for-sale securities
23,079

 
57,742

 
49,128

Cash flows used in investing activities
(361,975
)
 
(268,062
)
 
(137,766
)
Cash flows used in financing activities:
 
 
 
 
 
Borrowings under credit facility
493,000

 
220,600

 
422,600

Repayments under credit facility
(423,000
)
 
(220,600
)
 
(630,600
)
Repayments of notes payable
(25,000
)
 
(25,000
)
 

Earn-out payments
(3,526
)
 
(3,652
)
 
(3,556
)
Cash received from consolidated variable interest entity

 
109,510

 

Contingent retention liability

 
21,746

 

Cash paid on retention liability
(10,338
)
 
(1,939
)
 

Dividends paid
(41,801
)
 
(21,058
)
 
(48,153
)
Repurchases of common stock
(168,242
)
 
(92,823
)
 
(46,618
)
Payroll tax payments on vested shares
(16,161
)
 
(11,822
)
 
(25,010
)
Excess tax benefits
4,540

 
9,794

 
4,657

Cash flows used in financing activities
(190,528
)
 
(15,244
)
 
(326,680
)
Effect of exchange rates on cash
(33,714
)
 
22,259

 
(12,242
)
(Decrease) / increase in cash and cash equivalents
(12,698
)
 
195,044

 
54,626

Cash and cash equivalents at beginning of period
727,849

 
532,805

 
478,179

Cash and cash equivalents at end of period
$
715,151

 
$
727,849

 
$
532,805

Supplemental disclosures:
 
 
 
 
 
Cash paid for interest
$
3,577

 
$
3,677

 
$
7,461

Cash paid for income taxes, net of refunds
$
194,383

 
$
62,898

 
$
81,958

Common stock issued upon the vesting of our restricted stock units
$
21,108

 
$
29,194

 
$
9,513

Transfers into consolidated investment funds
$

 
$
223,212

 
$

Deconsolidation of investment funds (see Note 12)
$

 
$
339,019

 
$

See accompanying notes to the consolidated financial statements

5



TOWERS WATSON & CO.
Consolidated Statements of Changes in Stockholders’ Equity
(In Thousands of U.S. dollars and Number of Shares in Thousands)
 
Class A
Common
Stock
Outstanding
 
Class A
Common
Stock
 
Class B
Common
Stock
Outstanding
 
Class B
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury
Stock, at
Cost
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Non-
Controlling
Interest
 
Total
Balance as of June 30, 2012
63,522

 
$
635

 
11,036

 
$
110

 
$
1,833,799

 
$
(168,901
)
 
$
1,117,622

 
$
(350,745
)
 
$
24,797

 
$
2,457,317

Net income/(loss)

 

 

 

 

 

 
318,812

 

 
(3,160
)
 
315,652

Other comprehensive income/(loss)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
51,281

 
(1,297
)
 
49,984

Repurchases of common stock

 

 

 

 

 
(46,618
)
 

 

 

 
(46,618
)
Shares received for employee taxes upon conversion of Restricted A shares
(2
)
 

 

 

 

 
(25,010
)
 

 

 

 
(25,010
)
Exercises of stock options

 

 

 

 
(8,240
)
 
9,373

 

 

 

 
1,133

Vesting of restricted stock units
(3
)
 

 

 

 
(8,674
)
 
9,513

 

 

 

 
839

Class A Common Stock:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash dividends declared ($0.46 per share)

 

 

 

 

 

 
(42,027
)
 

 

 
(42,027
)
Excess tax benefits

 

 

 

 
4,657

 

 

 

 

 
4,657

Stock-based compensation

 

 

 

 
28,906

 

 

 

 

 
28,906

Conversion of Class B-3 shares to Class A shares
5,661

 
57

 
(5,662
)
 
(56
)
 

 

 

 

 

 
1

Balance as of June 30, 2013
69,178

 
$
692

 
5,374

 
$
54

 
$
1,850,448

 
$
(221,643
)
 
$
1,394,407

 
$
(299,464
)
 
$
20,340

 
$
2,744,834

Net Income

 

 

 

 

 

 
359,300

 

 
7,014

 
366,314

Other comprehensive income/(loss)

 

 

 

 

 

 

 
109,762

 
(719
)
 
109,043

Repurchases of common stock

 

 

 

 

 
(92,823
)
 

 

 

 
(92,823
)
Shares received for employee taxes upon conversion of restricted stock units

 

 

 

 

 
(7,612
)
 

 

 

 
(7,612
)
Exercises of stock options

 

 

 

 
(6,018
)
 
6,702

 

 

 

 
684

Vesting of restricted stock units

 

 

 

 
(35,377
)
 
29,194

 

 

 

 
(6,183
)
Acquisitions

 

 

 

 
6,718

 

 

 

 
(6,297
)
 
421

Redeemable non-controlling interest from consolidated variable interest entity

 

 

 

 

 

 

 

 
332,722

 
332,722

Deconsolidation of redeemable non-controlling interest from variable interest entity

 

 

 

 

 

 

 

 
(339,019
)
 
(339,019
)
Class A Common Stock:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash dividends declared ($0.42 per share)

 

 

 

 

 

 
(30,780
)
 

 

 
(30,780
)
Excess tax benefits

 

 

 

 
9,794

 

 

 

 

 
9,794

Stock-based compensation

 

 

 

 
23,554

 

 

 

 

 
23,554

Conversion of Class B-4 shares to Class A shares
5,374

 
54

 
(5,374
)
 
(54
)
 

 

 

 

 

 

Balance as of June 30, 2014
74,552

 
$
746

 

 
$

 
$
1,849,119

 
$
(286,182
)
 
$
1,722,927

 
$
(189,702
)
 
$
14,041

 
$
3,110,949

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Continued)
 
 
 
 
 
 
 
 
 
 
 

6



 
Class A
Common
Stock
Outstanding
 
Class A
Common
Stock
 
Class B
Common
Stock
Outstanding
 
Class B
Common
Stock
 
Additional
Paid-in
Capital
 
Treasury
Stock, at
Cost
 
Retained
Earnings
 
Accumulated
Other
Comprehensive
Loss
 
Non-
Controlling
Interest
 
Total
Net income

 

 

 

 

 

 
384,978

 

 
653

 
385,631

Other comprehensive income/(loss)

 

 

 

 

 

 

 
(386,596
)
 
807

 
(385,789
)
Repurchases of common stock

 

 

 

 

 
(168,242
)
 

 

 

 
(168,242
)
Shares received for employee taxes upon conversion of restricted stock units

 

 

 

 

 
(11,493
)
 

 

 

 
(11,493
)
Exercises of stock options

 

 

 

 
(9,475
)
 
15,523

 

 

 

 
6,048

Vesting of restricted stock units

 

 

 

 
(8,753
)
 
21,108

 

 

 

 
12,355

Class A Common Stock:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash dividends declared ($0.60 per share)

 

 

 

 

 

 
(41,801
)
 

 

 
(41,801
)
Excess tax benefits

 

 

 

 
4,540

 

 

 

 

 
4,540

Stock-based compensation

 

 

 

 
35,314

 

 

 

 

 
35,314

Balance as of June 30, 2015
74,552

 
$
746

 

 
$

 
$
1,870,745

 
$
(429,286
)
 
$
2,066,104

 
$
(576,298
)
 
$
15,501

 
$
2,947,512

See accompanying notes to the consolidated financial statements

7



TOWERS WATSON & CO.
Notes to the Consolidated Financial Statements
(Tabular amounts in thousands except per share data)
Note 1 — Nature of the Business and Mergers
Nature of the Business
Towers Watson & Co. (referred herein as “Towers Watson”, the “Company” or “we”) is a leading global professional services company that helps organizations improve performance through effective people, risk and financial management. We offer solutions in the areas of employee benefits, talent management, rewards, risk and capital management and healthcare exchanges for both retirees and active employees. Our fiscal year ends on June 30th.
Mergers
Towers Watson was formed on January 1, 2010, from the merger (the “Towers Perrin | Watson Wyatt Merger”) of Towers, Perrin, Forster & Crosby, Inc. (“Towers Perrin”) and Watson Wyatt Worldwide, Inc. (“Watson Wyatt”), two leading professional services firms that traced their roots back more than 100 years.
On June 30, 2015, Willis Group Holdings (“Willis”) and Towers Watson announced the signing of a definitive merger agreement under which the companies will combine in an all-stock merger of equals transaction. Based on the closing price of Willis and Towers Watson common stock on June 29, 2015, the implied equity value of the transaction is approximately $18 billion. At the effective time of the merger (“Towers Watson | Willis Merger”), each share of Class A common stock, par value $0.01 per share, of Towers Watson (the “TW Common Stock”) issued and outstanding immediately prior to the Towers Watson | Willis Merger (other than shares held by Towers Watson, Willis, or Merger Sub and dissenting shares) will be converted into the right to receive 2.6490 validly issued, fully paid and nonassessable ordinary shares of Willis. In addition, Towers Watson intends to declare and pay a pre-Towers Watson | Willis Merger special dividend in an amount equal to $4.87 per share of TW Common Stock, payable to holders of record of TW Common Stock prior to the closing date. We are in the process of evaluating our options to fund the special dividend through a bank loan. The transaction is expected to close by December 31, 2015, subject to customary closing conditions, including regulatory approvals, and approval by both Willis shareholders and Towers Watson stockholders.
Note 2 — Summary of Significant Accounting Policies
Principles of Consolidation — Our consolidated financial statements include our accounts and those of our majority-owned and controlled subsidiaries after elimination of intercompany accounts and transactions. Investments in affiliated companies over which we have the ability to exercise significant influence are accounted for using the equity method.
We determine whether we have a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (“VIE”).
Variable interest entities are entities that lack one or more of the characteristics of a voting interest entity and therefore require a different approach in determining which party involved with the VIE should consolidate the entity. With a VIE, either the entity does not have sufficient equity at risk to finance its activities without additional subordinated financial support from other parties or the equity holders, as a group, do not have the power to direct the activities that most significantly impact its financial performance, the obligation to absorb expected losses of the entity, or the right to receive the expected residual returns of the entity. The entity that has a controlling financial interest in a VIE is referred to as the primary beneficiary and is required to consolidate the VIE.
Voting interest entities are entities that have sufficient equity and provide equity investors voting rights that give them the power to make significant decisions relating to the entity’s operations. The usual condition for a controlling financial interest in a voting interest entity is ownership of a majority voting interest. Accordingly, we consolidate our voting interest entity investments in which we hold, directly or indirectly, more than 50% of the voting rights.
Use of Estimates — The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Our estimates, judgments and assumptions are continually evaluated based on available information and experience. Because of the use of estimates inherent in the financial reporting process, actual results could differ from those estimates. Estimates are used when accounting for revenue recognition, allowances for billed and unbilled receivables from clients, discretionary compensation, income taxes, pension and post-retirement assumptions, incurred but not reported claims, legal reserves and goodwill and intangible assets.

8



Cash and Cash Equivalents — We consider all instruments that are readily convertible to known amounts of cash and with original maturities of 90 days or less (calculated from the trade date to maturity date) to be cash equivalents. We consider Term deposits and certificates of deposits with original maturities 90 days or less to be cash equivalents. Term deposits and certificates of deposits with original maturities greater than 90 days are considered to be short-term investments.
Fiduciary assets and liabilities — Certain of our health and welfare benefits administration outsourcing agreements require us to hold funds on behalf of clients to pay obligations on their behalf. These amounts are included in fiduciary assets and fiduciary liabilities on the consolidated balance sheets.
Investments — Our investments are classified at the time of purchase as either available-for-sale or held-to-maturity, and reassessed as of each balance sheet date. Held-to-maturity securities are recorded at amortized cost. The carrying value of our held-to-maturity securities approximates fair value, due to the short-term nature of our investments of less than 12 months. Held-to-maturity securities are classified as short-term investments. Available-for-sale securities are marked-to-market based on prices provided by our investment advisors. Available-for-sale securities are classified as either short-term or long-term based on management’s intention of when to sell the securities or maturity date, if applicable.
Receivables from Clients — Billed receivables from clients are presented at their billed amount less an allowance for doubtful accounts. Billed receivables also include amounts due to us for commissions on premiums currently due from our clients to the reinsurers but uncollected by us as of the balance sheet date. Unbilled receivables are stated at net realizable value less an allowance for unbillable amounts. Allowance for doubtful accounts related to billed receivables was $7.7 million and $8.1 million as of June 30, 2015 and 2014, respectively. Allowance for unbilled receivables was $8.5 million and $9.1 million as of June 30, 2015 and 2014, respectively.
Revenue Recognition — We recognize revenue when it is earned and realized or realizable as demonstrated by persuasive evidence of an arrangement with a client, a fixed or determinable price, services have been rendered or products delivered or available for use, and collectability is reasonably assured.
The majority of our revenue consists of fees earned from providing consulting services. We recognize revenue from these consulting engagements when hours are worked, either on a time-and-expense basis or on a fixed-fee basis, depending on the terms and conditions defined at the inception of an engagement with a client. We have engagement letters with our clients that specify the terms and conditions upon which the engagements are based. These terms and conditions can only be changed upon agreement by both parties. Individual associates’ billing rates are principally based on a multiple of salary and compensation costs.
Revenue for fixed-fee arrangements is based upon the proportional performance method. We typically have three types of fixed-fee arrangements: annual recurring projects, projects of a short duration, and non-recurring system projects. Annual recurring projects and the projects of short duration are typically straightforward and highly predictable in nature. As a result, the project manager and financial staff are able to identify, as the project status is reviewed and bills are prepared monthly, the occasions when cost overruns could lead to the recording of a loss accrual.
We have non-recurring system projects that are longer in duration and subject to more changes in scope as the project progresses. We evaluate at least quarterly, and more often as needed, project managers’ estimates-to-complete to assure that the projects’ current statuses are accounted for properly. Certain software contracts generally provide that if the client terminates a contract, we are entitled to payment for services performed through termination.
Revenue recognition for fixed-fee engagements is affected by a number of factors that change the estimated amount of work required to complete the project such as changes in scope, the staffing on the engagement and/or the level of client participation. The periodic engagement evaluations require us to make judgments and estimates regarding the overall profitability and stage of project completion that, in turn, affect how we recognize revenue. We recognize a loss on an engagement when estimated revenue to be received for that engagement is less than the total estimated costs associated with the engagement. Losses are recognized in the period in which the loss becomes probable and the amount of the loss is reasonably estimable. We have experienced certain costs in excess of estimates from time to time. Management believes it is rare, however, for these excess costs to result in overall project losses.
We have developed various software programs and technologies that we provide to clients in connection with consulting services. In most instances, such software is hosted and maintained by us and ownership of the technology and rights to the related code remain with us. We defer costs for software developed to be utilized in providing services to a client, but for which the client does not have the contractual right to take possession, during the implementation stage. We recognize these deferred costs from the go live date, signaling the end of the implementation stage, until the end of the initial term of the contract with the client. We determined that the system implementation and customized ongoing administrative services are one combined

9



service. Revenue is recognized over the service period, after the go live date, in proportion to the services performed. As a result, we do not recognize revenue during the implementation phase of an engagement.
We deliver software under arrangements with clients that take possession of our software. The maintenance associated with the initial software fees is a fixed percentage which enables us to determine the stand-alone value of the delivered software separate from the maintenance. We recognize the initial software fees as software is delivered to the client and we recognize the maintenance ratably over the contract period based on each element’s relative fair value. For software arrangements in which initial fees are received in connection with mandatory maintenance for the initial software license to remain active, we determined that the initial maintenance period is substantive. Therefore, we recognize the fees for the initial license and maintenance bundle ratably over the initial contract term, which is generally one year. Each subsequent renewal fee is recognized ratably over the contractually stated renewal period.
We collect, analyze and compile data in the form of surveys for our clients who have the option of participating in the survey. The surveys are published online via a web tool which provides simplistic functionality. We have determined that the web tool is inconsequential to the overall arrangement. We record the survey revenue when the results are delivered online and made available to our clients that have a contractual right to the data, including the ability to download and manipulate the data. If the data is updated more frequently than annually, we recognize the survey revenue ratably over the contractually stated period.
Prior to the sale of our reinsurance brokerage business in November, 2013 (see Note 3 for further discussion), in our capacity as a reinsurance broker, we collected premiums from our reinsurance clients and, after deducting our brokerage commissions, we remitted the premiums to the respective reinsurance underwriters on behalf of our reinsurance clients. In general, compensation for reinsurance brokerage services was earned on a commission basis. Commissions were calculated as a percentage of a reinsurance premium as stipulated in the reinsurance contracts with our clients and reinsurers. We recognized brokerage services revenue on the later of the contract’s inception or billing date as fees became known or as our services were provided for premium processing. In addition, we held cash needed to settle amounts due reinsurers or our reinsurance clients, net of any commissions due to us, pending remittance to the ultimate recipient. We were permitted to invest these funds in high quality liquid instruments.
As an insurance exchange, we generate revenue from commission paid to us by insurance carriers for health insurance policies issued through our enrollment services. Under our contracts with insurance carriers, once an application has been accepted by an insurance carrier and a policy has been issued, we will receive commission payments from the policy effective date until the end of the annual policy period as long as the policy is not cancelled by the insured or the carrier. We defer upfront fees and recognize revenue ratably from the policy effective date over the policy period, generally one year. The commission fee per policy placed with a carrier could vary by whether the insured was previously a Medicare participant and whether the policy is in its first or subsequent year. Due to the uncertainty of the commission fee per policy, we do not recognize revenue until the policy is accepted by the carrier, the policy is effective and a communication is received from the carrier of the fee per insured. As the commission fee is cancellable on a pro rata basis related to the underlying insurance policy which we are not party to, we recognize the commission fee ratably over the policy period. Our carrier contracts entitle us to receive commission fees per policy for the life of the policy unless limited by legislation or cancelled by the carrier or insured. As a result, the majority of the revenue is recurring in nature and grows in direct proportion to the number of new policies added each year.
Revenue recognized in excess of billings is recorded as unbilled accounts receivable. Cash collections in excess of revenue recognized are recorded as deferred revenue until the revenue recognition criteria are met. Client reimbursable expenses, including those relating to travel, other out-of-pocket expenses and any third-party costs, are included in revenue, and an equivalent amount of reimbursable expenses are included in professional and subcontracted services as a cost of revenue.
Income Taxes — We account for income taxes in accordance with Accounting Standards Codification (“ASC”) 740, Income Taxes, which prescribes the use of the asset and liability approach to the recognition of deferred tax assets and liabilities related to the expected future tax consequences of events that have been recognized in our financial statements or income tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are established, when necessary, to reduce deferred tax assets when it is more likely than not that a portion or all of a given deferred tax asset will not be realized. In accordance with ASC 740, income tax expense includes (i) deferred tax expense, which generally represents the net change in the deferred tax asset or liability balance during the year plus any change in valuation allowances and (ii) current tax expense, which represents the amount of tax currently payable to or receivable from a taxing authority plus amounts accrued for expected tax contingencies (including both tax penalties and interest). ASC 740-10 prescribes a recognition threshold of more-likely-than-not, and a measurement attribute for all tax positions taken or expected to be taken on a tax return, in order for those positions to be recognized in the financial statements. We continually review tax laws, regulations and

10



related guidance in order to properly record any uncertain tax liability positions. We adjust these reserves in light of changing facts and circumstances, such as the outcome of tax audits.
Foreign Currency — Gains and losses on foreign currency transactions, including settlement of intercompany receivables and payables, are recognized currently in the general and administrative expenses line of our consolidated statements of operations. Foreign currency transactions resulted in losses of $0.4 million, $7.0 million and $0.8 million in fiscal years 2015, 2014 and 2013, respectively. Assets and liabilities of our subsidiaries outside the United States are translated into the reporting currency, the U.S. dollar, based on exchange rates at the balance sheet date. Revenue and expenses of our subsidiaries outside the United States are translated into U.S. dollars at weighted average exchange rates. Gains and losses on translation of our equity interests in our subsidiaries outside the United States and on intercompany notes are reported separately as accumulated other comprehensive income within stockholders’ equity in the consolidated balance sheets, since we do not plan or anticipate settlement of such balances in the foreseeable future.
Fair Value of Financial Instruments — The carrying amount of our cash and cash equivalents, receivables from clients, notes and accounts payable approximates fair value because of the short maturity and liquidity of those instruments. The investments are available-for-sale securities held at estimated fair value with maturities of less than two years. The term loan and revolving credit facility include variable interest rates that approximate market rates and as such, we consider its carrying amount to approximate fair value. The fair value of our term loan and revolving credit facility are considered level 2 financial instruments as they are corroborated by observable market data. Refer to Note 12 for the significant terms of these agreements.
Fair Value Measurement — Financial assets and liabilities recorded in the accompanying consolidated balance sheets are categorized based on the inputs in the valuation techniques as follows:
Level 1 — Financial assets and liabilities whose values are based on quoted prices (unadjusted) in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.
Level 2 — Financial assets and liabilities whose values are based on inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3 — Financial assets and liabilities whose values are based on unobservable inputs for the asset or liability.
In accordance with Subtopic 820-10, Fair Value Measurement and Disclosures, certain investments that are measured at fair value using the net asset value per share practical expedient are not required to be categorized in the fair value hierarchy based on the levels above.
Derivatives — All derivative instruments are recognized in the accompanying consolidated balance sheets at fair value. Derivative instruments with a positive fair value are reported in other current assets and derivative instruments with a negative fair value are reported in other current liabilities in the accompanying consolidated balance sheet. Changes in the fair value of derivative instruments are recognized immediately in general and administrative expenses, unless the derivative is designated as a hedge and qualifies for hedge accounting.
There are three hedging relationships where a derivative (hedging instrument) may qualify for hedge accounting: (1) a hedge of the change in fair value of a recognized asset or liability or firm commitment (fair value hedge), (2) a hedge of the variability in cash flows from forecast transactions (cash flow hedge), and (3) a hedge of the variability caused by changes in foreign currency exchange rates (foreign currency hedge). Under hedge accounting, recognition of derivative gains and losses can be matched in the same period with that of the hedged exposure and thereby minimize earnings volatility. If the underlying risk is recognized in the balance sheet and offsetting the gain / losses in the derivative, we consider the derivative transaction to be an “economic hedge” and changes in the fair value of the derivative are recognized immediately in general and administrative expenses. At June 30, 2015, we had entered into foreign currency cash flow hedges and economic hedges.
In order for a derivative to qualify for hedge accounting, the derivative must be formally designated as a fair value, cash flow, or a foreign currency hedge by documenting the relationship between the derivative and the hedged item. Additionally, the hedge relationship must be expected to be highly effective at offsetting changes in either the fair value or cash flows of the hedged item at both inception of the hedge and on an ongoing basis. We assess the ongoing effectiveness of our hedges and measure and record hedge ineffectiveness, if any, at the end of each quarter.
For a cash flow hedge, the effective portion of the change in fair value of a hedging instrument is recognized in other comprehensive income, as a component of shareholders’ equity, and subsequently reclassified to general and administrative expenses. The ineffective portion of a cash flow hedge is recognized immediately in general and administrative expenses.
We discontinue hedge accounting prospectively when (1) the derivative expires or is sold, terminated, or exercised, (2) we determine that the hedging transaction is no longer highly effective, (3) a hedged forecast transaction is no longer probable of

11



occurring in the time period described in the hedge documentation, (4) the hedged item matures or is sold, or (5) management elects to discontinue hedge accounting voluntarily.
When hedge accounting is discontinued because the derivative no longer qualifies as a cash flow hedge we continue to carry the derivative in the accompanying consolidated balance sheet at its fair value, recognize subsequent changes in the fair value of the derivative in current-period general and administrative expenses, and continue to defer the derivative gain or loss in other comprehensive income or loss until the hedged forecast transaction affects expenses. If the hedged forecast transaction is not likely to occur in the time period described in the hedge documentation or within a two month period of time thereafter, the deferred derivative gain or loss is reclassified immediately to general and administrative expenses.
Concentration of Credit Risk — Financial instruments that potentially subject us to concentrations of credit risk consist principally of certain cash and cash equivalents, fixed income securities, and receivables from clients. We invest our excess cash in financial instruments that are primarily rated in the highest short-term rating category by major rating agencies. Concentrations of credit risk with respect to receivables from clients are limited due to our large number of clients and their dispersion across many industries and geographic regions.
Incurred But Not Reported (IBNR) Claims — We accrue for IBNR professional liability claims that are probable and estimable. We use actuarial assumptions to estimate and record a liability for IBNR professional liability claims. Our estimated IBNR liability is based on long-term trends and averages, and considers a number of factors, including changes in claim reporting patterns, claim settlement patterns, judicial decisions, and legislation and economic decisions, but excludes the effect of claims data for large cases due to the insufficiency of actual experience with such cases. Our estimated IBNR liability will fluctuate if claims experience changes over time. As of June 30, 2015 we had a $181.5 million IBNR liability, net of estimated IBNR recoverable receivables of our captive insurance companies. This net liability increased from $173.8 million as of June 30, 2014. To the extent our captive insurance companies, PCIC and SMIC, expect losses to be covered by a third party, they record a receivable for the amount expected to be recovered. This receivable is classified in other current or other noncurrent assets in our consolidated balance sheet.
Stock-based Compensation — We compensate our directors, executive officers and other select associates with incentive stock-based compensation plans. When granted, awards are governed by the Towers Watson & Co. 2009 Long Term Incentive Plan, which provides for the awards to be valued at their grant date fair value. We record non-cash stock-based compensation on a graded vesting methodology over the expected term of the awards, generally three years. Graded vesting expense methodology assumes that the equity awards are issued to participants in equal amounts of shares that vest over one year, two years and three years giving the effect of more expense in the first year than the second and third. Our equity awards are settled in Towers Watson Class A common stock. During fiscal years 2015, 2014 and 2013, we recognized compensation expense of $36.1 million, $23.6 million and $28.9 million, and associated income tax benefit of $11.5 million, $6.2 million and $10.0 million, respectively, in connection with our stock-based compensation plans.
Earnings per Share (“EPS”) — To the extent that we have participating securities outstanding, we present EPS using the two-class method which discloses the portion of net income attributable to controlling interests and basic and diluted shares that are available for common stockholders separate from participating security holders. Our Restricted Class A shares issued in the Towers Perrin | Watson Wyatt Merger were classified as participating securities because of their voting and dividend rights. These non-vested restricted shares were fully vested as of January 1, 2013 and converted to Towers Watson Class A common stock.
Goodwill and Intangible Assets — In applying the acquisition method of accounting for business combinations, amounts assigned to identifiable assets and liabilities acquired were based on estimated fair values as of the date of acquisition, with the remainder recorded as goodwill. Intangible assets are initially valued at fair value using generally accepted valuation methods appropriate for the type of intangible asset. Intangible assets with definite lives are amortized over their estimated useful lives and are reviewed for impairment if indicators of impairment arise. Intangible assets with indefinite lives are tested for impairment annually as of April 1, and whenever indicators of impairment exist. The fair value of the intangible assets is compared with their carrying value and an impairment loss would be recognized for the amount by which the carrying amount exceeds the fair value. Goodwill is tested for impairment annually as of April 1, and whenever indicators of impairment exist. Goodwill is tested at the reporting unit level which is one level below our operating segments. The Company had ten reporting units on April 1, 2015.
During fiscal year 2015, the Company performed a qualitative assessment for seven of our ten reporting units and our indefinite-lived intangible assets (consisting of trade names). During this assessment, we first assessed qualitative factors to determine whether it is more likely than not that the fair value of the reporting unit or the trade names was less than its carrying amount. Qualitative factors we considered included, but are not limited to, macroeconomic conditions, industry and market conditions, company specific events, changes in circumstances, after tax cash flows and market capitalization. If the qualitative

12



factors indicated that it is more likely than not that the fair value of a reporting unit or the trade names are less than their respective carrying amounts, we performed the two-step process to assess our goodwill for impairment. During fiscal year 2015, we assessed the qualitative factors and determined that the two-step impairment test was not required for the seven reporting units or indefinite-lived intangible assets reviewed.
During fiscal year 2015, the Company also performed Step 1 of the two-step impairment test for three reporting units. The Company performed the Step 1 test for two of these reporting units in order to update the estimated fair value following the segment reorganization. The segment reorganization was effective on July 1, 2014. See Note 18 for additional information regarding the segment reorganization.
Each of the reporting units' estimated fair values were substantially in excess of the carrying values. To perform the test, we used valuation techniques to estimate the fair value of a reporting unit that fall under income or market approaches. Under the discounted cash flow method, an income approach, the business enterprise value is determined by discounting to present value the terminal value which is calculated using debt-free after-tax cash flows for a finite period of years. Key estimates in this approach were internal financial projection estimates prepared by management, business risk, and expected rate of return on capital. The guideline company method, a market approach, develops valuation multiples by comparing our reporting units to similar publicly traded companies. Key estimates and selection of valuation multiples rely on the selection of similar companies, obtaining estimates of forecast revenue and EBITDA estimates for the similar companies and selection of valuation multiples as they apply to the reporting unit characteristics. Under the similar transactions method, a market approach, actual transaction prices and operating data from companies deemed reasonably similar to the reporting units is used to develop valuation multiples as an indication of how much a knowledgeable investor in the marketplace would be willing to pay for the business units.
If the Company was required to perform Step 2, we would determine the implied fair value of the reporting unit used in Step 1 to all the assets and liabilities of that reporting unit (including any recognized or unrecognized intangible assets) as if the reporting unit had been acquired in a business combination. Then the implied fair value of goodwill would be compared to the carrying amount of goodwill to determine if goodwill is impaired. For the fiscal year ended June 30, 2015, we did not record any impairment losses of goodwill or intangibles.
Recent Accounting Pronouncements
Not yet adopted
On May 28, 2014, the Financial Accounting Standards Board ("FASB") and the International Accounting Standards Board ("IASB") issued their final standard on revenue from contracts with customers. The standard, issued as Accounting Standards Update ("ASU") 2014-09 by the FASB, outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers, and supersedes most current revenue recognition guidance. The core principle of the revenue model is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU applies to all contracts with customers, except those that are within the scope of other topics in the FASB Accounting Standards Codification. Compared with current U.S. GAAP, the ASU also requires significantly expanded disclosures about revenue recognition. The ASU is effective for interim and annual reporting periods that begin after December 15, 2016, and early adoption is prohibited. However, the FASB has deferred the adoption date by one year but has allowed for early adoption. An ASU has not yet been released with this position. The Company is currently evaluating the impact of adopting this provision.
On June 19, 2014, the FASB issued ASU 2014-12, Accounting for Share-Based Payments When the Terms of an Award Provide a Performance Target Could Be Achieved After the Requisite Service Period. The update is intended to resolve the diverse accounting treatment of these types of awards in practice. The amendments require that a performance target that affects vesting and that could be achieved after the requisite service period be treated as a performance condition. A reporting entity should apply existing guidance in "Compensation - Stock Compensation (Topic 718)" as it relates to awards with performance conditions that affect vesting to account for such awards. As such, the performance target should not be reflected in estimating the grant-date fair value of the award. Compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved, and should represent the compensation cost attributable to the period(s) for which the requisite service has already been rendered. If the performance target becomes probable of being achieved before the end of the requisite service period, the remaining unrecognized compensation cost should be recognized prospectively over the remaining requisite service period. The ASU is effective for interim and annual reporting periods that begin after December 15, 2015. The Company does not expect the adoption of this pronouncement to have an impact on our financial statements as this guidance mirrors our existing policy for such share-based awards.

13



On June 12, 2015, the FASB issued ASU 2015-10, Technical Corrections and Improvements, which amends a number of topics in the FASB Accounting Standards Codification. The update is a part of an ongoing project on the FASB's agenda to facilitate Codification updates for non-substantive technical corrections, clarifications, and improvements that are not expected to have a significant effect on accounting practice or create a significant administrative cost to most entities. The ASU will apply to all reporting entities within the scope of the affected accounting guidance. Certain amendments in the update require transition guidance and are effective for all entities for fiscal years, and interim periods within those years, beginning after December 15, 2015. Early adoption is permitted, including adoption in an interim period. The Company is currently evaluating the impact of adopting this provision.
Adopted
On February 18, 2015, the FASB issued ASU 2015-02, Consolidation (Topic 810): Amendments to the Consolidation Analysis, which amends the consolidation requirements in Accounting Standards Codification ("ASC") 810 and significantly changes the consolidation analysis required under U.S. GAAP. Generally, the changes were made to introduce the concepts of principal versus agency relationships and to integrate them into the existing rules. The amendments rescind the indefinite deferral of ASU 2009-17 for investment funds and will impact the determination of whether an entity is a variable interest entity; the evaluation of a service provider's fees when identifying variable interests; and the extent to which related party interests are considered in the consolidation conclusion. For public business entities, the ASU is effective for annual periods, and interim periods within those annual periods, beginning after December 15, 2015. Early adoption is allowed for all entities (including during an interim period), but the guidance must be applied as of the beginning of the annual period containing the adoption date. The Company adopted the ASU under the modified retrospective approach in our fourth quarter of fiscal year 2015 and concluded that it no longer held a variable interest in most of the variable interest entities to which it provides certain service offerings. As a result, those entities will be excluded from the disclosure in Note 13. There is no further impact to the Company’s financial statements or disclosures.
On May 1, 2015, the Financial Accounting Standards Board ("FASB") issued ASU 2015-07, Fair Value Measurement (Topic 820) - Disclosures for Investments in Certain Entities That Calculate Net Asset Value per Share (or Its Equivalent). The update is intended to simplify reporting requirements and modify those investments required to be classified within the fair value hierarchy. Certain investments measured at fair value using the Net Asset Value ("NAV") practical expedient are no longer required to be categorized within a level within the fair value hierarchy table. Entities will be required to include in the disclosure the fair value of the investments using NAV practical expedient so that financial statement users can reconcile amounts reporting in the fair value hierarchy table to amounts reported on the balance sheet. The ASU is effective for interim and annual reporting periods beginning after December 15, 2015 and early adoption is permitted. The ASU is to be applied retrospectively in all periods presented in an entity's financial statements. The Company is early adopting the standard as of June 30, 2015. The adoption has been reflected in Note 11 to the financial statements.
Note 3 — Acquisitions and Divestitures
Our acquisitions and divestitures in fiscal years 2015, 2014 and 2013 were not material for the purposes of financial statement disclosures as required by Accounting Standards Codification (“ASC”) 805. Our acquisition and divestiture information is included to provide our investors with a better understanding of our strategic acquisitions.
Acquisitions
Acclaris Acquisition
On May 11, 2015, Towers Watson acquired Acclaris Holdings, Inc. ("Acclaris") for $140.0 million in cash. Headquartered in Tampa, FL, and with locations in Kansas and India, Acclaris offers flexible products that include integrated technology and services to support consumer-directed benefits on a single platform in a scalable way. Its core business focuses on health care and reimbursement accounts which include health reimbursement arrangements (HRAs), health savings accounts (HSAs), flexible spending accounts, commuter accounts and custom reimbursement accounts. Acclaris will be integrated into our Exchange Solutions Segment and join the Other line of business as the Consumer-Directed Accounts practice. Together, Towers Watson and Acclaris will enable clients of any size to offer benefits in new and cost-effective ways.
During the fourth quarter of fiscal year 2015, we recorded the tangible assets received, liabilities assumed, and the preliminary fair value of intangibles. The intangibles included developed technology, valued at $14.5 million, and a customer related intangible, valued at $12.3 million. Our estimate of fair value for the developed technology intangible and the customer related intangible was based on the relief from royalty method and the multi-period excess earnings method, respectively. Significant assumptions used in the valuation were estimated revenues and expenses, contributory asset charges, required rates of return, and discount rates. We also recorded a net deferred tax liability of $2.8 million. It was determined that total consideration was $141 million, and we recorded $112.3 million of goodwill related to the acquisition of Acclaris.

14



Saville Consulting Acquisition
On April 23, 2015, Towers Watson acquired Saville Consulting Group Limited. ("Saville") for £42.0 million ($64.5 million) in cash. Saville is a U.K. and Jersey-based global psychometric assessment business. Its principal activities include helping employers to improve the match between people, work and organizations through the development and sale of objective psychometric assessment tools and related user training and consultancy services. Saville will be aligned with our Data, Surveys and Technology line of business within our Talent and Rewards segment.
During the fourth quarter of fiscal 2015, we recorded the tangible assets received, liabilities assumed, and the preliminary fair value of intangibles. The intangibles included a product intangible, valued at £25.8 million, and other intangibles that were collectively immaterial. Our estimate of fair value for the product intangible was based on the relief from royalty method. Significant assumptions used in the valuation were estimated revenues and expenses, contributory asset charges, required rates of return, and discount rates. It was determined that total consideration was £42.7 million, and we recorded £5.1 million of goodwill related to the acquisition of Saville.
Liazon Corporation Acquisition
On November 22, 2013, Towers Watson purchased Liazon Corporation (“Liazon”), a business focused on developing and delivering private benefit exchanges for active employees, for $204.3 million in cash and assumed equity awards valued at $8.0 million. See Note 16 for further information on the assumed equity awards. The Liazon business initially became a new line of business, which complements our other offerings under the Exchange Solutions segment, and is currently part of the Active Exchanges practice after the segment reorganization which became effective July 1, 2014. Together these solutions help organizations, both large and small, deliver self- and fully-insured benefits to both employees as well as pre- and post-65 retirees. We included the results of Liazon's operations since the acquisition date in both the Exchange Solutions segment and in our consolidated financial statements.
We have recorded the tangible assets received, liabilities assumed, and the fair value of intangibles for Liazon. The intangibles included developed technology, valued at $34.3 million, and other intangibles that were collectively immaterial. Our estimate of fair value for the technology intangible was developed using the multi-period excess earnings method valuation model. Significant assumptions used in the valuation were estimated revenues and expenses, contributory asset charges, required rates of return, and discount rates. It was determined that total consideration was $212.3 million. We recorded $173.2 million of goodwill and a net deferred tax asset of $9.1 million related to the acquisition of Liazon, inclusive of a $1.0 million purchase price adjustment.
Divestitures
Sale of our Brokerage business.
On September 19, 2013, we entered into a definitive agreement to sell our Reinsurance and Property and Casualty Insurance Brokerage (“Brokerage”) business to Jardine Lloyd Thompson Group plc (“JLT”) for cash consideration of $250 million. The Brokerage business was a component of our Risk and Financial Services segment. The sale closed during our second quarter of fiscal year 2014. We divested this business as part of our strategy to focus on other areas of the business. We continue to focus on risk consulting, software and other services for the insurance industry. The business was branded for a transitional period of 10 months from the closing date as JLT Towers Re, but currently operates as JLT Re.
As part of the transaction, we entered into an Alliance Agreement with JLT that will ensure clients have continued access to our risk consulting and software services. This agreement will also provide JLT Re with continued use of Towers Watson’s proprietary actuarial models and software.
The Company assessed the guidance under ASC 205 to determine if the Alliance Agreement or any other terms of the sale agreement constituted significant continuing direct cash flows or significant continuing involvement with the Brokerage business after the sale. The Company compared the cash flows expected to be recognized from the Brokerage business as a result of the continuation or migration of activities after the disposal transaction to the projected generation of cash flows by the Brokerage business that we could have expected absent the disposal transaction. Based on this analysis, the expected annual cash inflows or outflows related to the portion of revenues shared or commissions received or paid and software sales under the Alliance Agreement were each expected to represent approximately 1% or less of the annual revenues generated by our Brokerage business operations prior to the disposal. This was deemed not significant. Actual results have been within the original expectations and continue to be not significant.
The Company also calculated the expected cash flows associated with the placement of its insurance and reinsurance arrangements. The Company agreed to use JLT as its broker-of-record for all insurance and reinsurance transactions to which the Company’s wholly-owned captive insurance company, SMIC, is a party through November 2018. These amounts were

15



previously eliminated as intercompany transactions, and were $2.8 million for fiscal year 2014. Additionally, the Company agreed to a Transitional Services Agreement with JLT for a two-year period ending November 5, 2015. The Company expects to incur approximately $6.3 million each year in occupancy or other infrastructure costs, which were prepaid as part of deal consideration or will be repaid by JLT over the two year period. The cash flows associated with these arrangements represented approximately 7.4% of the annual expenses generated by our Brokerage operations prior to the disposal, which was deemed not significant.
The Company noted that none of the aforementioned agreements or arrangements constituted significant continuing involvement because they do not afford the Company the ability to influence the financial or operating decisions of JLT. Accordingly, we concluded that the continuing cash flows expected after the sale of our Brokerage business did not preclude discontinued operations presentation, and the Company therefore classified the results of our Brokerage business’s operations as discontinued operations for all periods presented in our consolidated statements of operations. There was no revenue or income from discontinued operations in the current fiscal year. The following selected financial information relates to the Brokerage business’s operations for the fiscal years ended June 30, 2014 and 2013, respectively:
 
Fiscal Year Ended June 30,
 
2014
 
2013
Revenue from discontinued operations
$
63,762

 
$
164,270

 
 
 
 
Income from discontinued operations before taxes
21,308

 
$
39,203

Tax expense on discontinued operations
7,522

 
$
15,561

Net income from discontinued operations
13,786

 
23,642

 
 
 
 
Gain from sale of discontinued operations
23,951

 

Tax expense on gain from sale of discontinued operations
31,680

 

Net loss from sale of discontinued operations
(7,729
)
 

Total net income from discontinued operations
$
6,057

 
$
23,642

Only the fiduciary assets and liabilities associated with the European businesses were sold. North American fiduciary assets and liabilities were not disposed of during the sale due to certain legal restrictions which do not permit the transfer of these assets and liabilities. The subsequent settlement of the North American fiduciary assets and liabilities is presented within the operating section of our accompanying statement of cash flows for the year ended June 30, 2014.
In addition to the stated $250 million cash consideration stipulated in the sale agreement, a purchase price adjustment of $31.4 million was paid to the Company by JLT representing the value of net assets transferred in the sale.
As part of the sale, the Company agreed to repay JLT for retention payments made to certain employees of Brokerage if they remain with the business on the 30-day anniversary of the sale and the first and second anniversary of the sale. The value ascribed to this portion of the obligation is $21.7 million at the time of the sale. The remaining liability at June 30, 2015 and 2014 was carried at fair value on the accompanying consolidated balance sheets (see Note 7 – Fair Value Measurements). The total amount has been classified as current or non-current liabilities based on the expected payment dates.
The obligation for retention payments and certain other negotiated terms reduced total consideration received at the transaction closing to $215.1 million. Total transaction costs were approximately $6.4 million. We finalized the completion accounts and the purchase price adjustments during the third quarter of fiscal year 2014. Our final pre-tax gain on the sale was $24.0 million. The sale of our Brokerage business resulted in a significant taxable gain, since the disposal of the goodwill and intangible assets associated with the business was not tax-deductible.
Note 4 — Investments
Held-to-maturity - Our held-to-maturity investments are comprised of term deposits, certificates of deposit, and certain bonds with original maturities greater than 90 days. As of June 30, 2015 and 2014, all held-to-maturity securities were included in short-term investments in the accompanying consolidated balance sheet. Proceeds from maturities of held-to-maturity securities during the fiscal years ended June 30, 2015 and June 30, 2014 were $261.1 million and $37.2 million, respectively resulting in immaterial gains.
Available-for-sale - Our available-for-sale securities are comprised of equity securities and mutual funds / exchange-traded funds. Proceeds from sales and maturities of investments of available-for-sale securities during the fiscal year ended June 30, 2015 were $23.1 million, resulting in a loss of $0.3 million. Proceeds from sales and maturities of investments of available-for-

16



sale securities during the fiscal year ended June 30, 2014 were $57.7 million, resulting in a gain of $1.0 million. Of these proceeds, $1.6 million related to the sale of investments as part of the divestiture of the Brokerage business. Proceeds from sales and maturities of investments of available-for-sale securities during the fiscal years ended June 30, 2013 were $47.6 million, resulting in a gain $0.1 million.
Additional information on the Company's investments is provided in the following table as of June 30, 2015 and 2014:
 
As of 6/30/2015
 
As of 6/30/2014
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Estimated
Fair Value
 
Amortized
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Estimated
Fair Value
Short Term Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Held-to-maturity:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Term deposits & Certificates of deposit
$
70,346

 
$

 
$

 
$
70,346

 
$
107,556

 
$

 
$

 
$
107,556

Fixed income securities
51,685

 

 

 
51,685

 

 

 

 

Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Equity securities
102

 
11

 
(10
)
 
103

 
126

 
7

 
(3
)
 
130

Mutual funds and exchange-traded funds
5,033

 
5

 
(16
)
 
5,022

 
15,033

 
42

 

 
15,075

Total Short-term Investments:
127,166

 
16

 
(26
)
 
127,156

 
122,715

 
49

 
(3
)
 
122,761

Other Investments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Available-for-sale:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mutual funds and exchange-traded funds
43,711

 
6

 
(147
)
 
43,570

 
42,147

 
451

 

 
42,598

Total other Investments in Other Assets
$
43,711

 
$
6

 
$
(147
)
 
$
43,570

 
$
42,147

 
$
451

 
$

 
$
42,598

For all investments other than fixed income securities, amortized cost represents the cost basis of the investment as of the purchase date. For fixed income securities, amortized cost represents the face value of the bond plus the unamortized portion of the bond premium as of the date presented. There were no material investments that have been in a continuous loss position for more than twelve months, and there have been no other-than-temporary impairments recognized. The aggregate fair value of investments with unrealized losses for the fiscal year ended June 30, 2015 was $24.4 million. The aggregate fair value of investments with unrealized losses for the fiscal year ended June 30, 2014 was immaterial.
Note 5 — Fixed Assets
Furniture, fixtures, equipment and leasehold improvements are recorded at cost and presented net of depreciation or amortization. Furniture, fixtures, and equipment are depreciated straight-line over lives ranging from three to seven years. Internally developed software is amortized over the estimated useful life of the asset ranging from three to ten years. Leasehold improvements are amortized on a straight-line basis over the shorter of the lease terms or the asset lives.
The components of fixed assets are as follows:
 
June 30,
 
2015
 
2014
Furniture, fixtures and equipment
$
203,906

 
$
205,598

Computer software, excluding internally developed software
226,457

 
192,206

Internally developed software
212,529

 
165,695

Leasehold improvements
197,435

 
207,126

 
840,327

 
770,625

Less: accumulated depreciation and amortization
(449,646
)
 
(396,181
)
Fixed assets, net
$
390,681

 
$
374,444

Total computer software, net, including internally developed software, was $237.2 million and $210.7 million as of June 30, 2015 and 2014, respectively. Total amortization expense for computer software was $53.9 million, $44.7 million and $40.5 million for fiscal years 2015, 2014 and 2013, respectively. Total depreciation expense was $52.7 million, $54.9 million and $56.3 million for fiscal years 2015, 2014 and 2013, respectively.

17



Note 6 — Goodwill and Intangible Assets
The components of goodwill and intangible assets are outlined below for the fiscal years ended June 30, 2015 and 2014:
 
Benefits
 
Exchange
Solutions
 
Risk and
Financial
Services
 
Talent and
Rewards
 
All Other
 
Total
Balance as of June 30, 2013
$
1,233,272

 
$
341,449

 
$
534,150

 
$
108,850

 
$
1,214

 
$
2,218,935

Goodwill acquired

 
174,195

 

 

 

 
174,195

Goodwill related to disposals

 

 
(167,822
)
 

 

 
(167,822
)
Translation adjustment
57,517

 

 
25,221

 
5,012

 

 
87,750

Balance as of June 30, 2014
$
1,290,789

 
$
515,644

 
$
391,549

 
$
113,862

 
$
1,214

 
$
2,313,058

Goodwill acquired

 
112,337

 

 
8,077

 

 
120,414

Goodwill related to disposals

 

 
(593
)
 

 

 
(593
)
Goodwill reallocated in segment restructuring
(92,327
)
 
54,052

 
12,311

 
25,964

 
 
 

Translation adjustment
(109,958
)
 

 
(32,993
)
 
(11,577
)
 

 
(154,528
)
Balance as of June 30, 2015
$
1,088,504

 
$
682,033

 
$
370,274

 
$
136,326

 
$
1,214

 
$
2,278,351

Goodwill acquired during the fiscal year ended June 30, 2015 in the Talent and Rewards and Exchange Solutions segments totaled $8.1 million and $112.3 million, respectively. The goodwill relates to the acquisitions of Saville and Acclaris. See Note 3 for additional information regarding these transactions.
Included in the goodwill reallocated in segment restructuring is a $54.1 million reclassification of goodwill related to the segment reorganization between Benefits and Exchange Solutions, which was effective on July 1, 2014 and $38.3 million of residual allocation to the remaining segments. See Note 18 for additional information regarding the segment reorganization.
Included in the Exchange Solutions goodwill acquired is $173.2 million of goodwill, inclusive of a $1.0 million purchase price adjustment, related to the acquisition of Liazon, which closed on November 22, 2013. We recorded the consideration less the tangible assets and liabilities as goodwill during the fiscal year ended June 30, 2014. See Note 3 for additional information regarding this acquisition.
Included in the Risk and Financial Services activity is a $167.8 million reduction in goodwill related to the disposal of our Brokerage business, which was completed on November 6, 2013. See Note 3 for additional information regarding the sale of the business.
The following table reflects changes in the net carrying amount of the components of finite-lived intangible assets for the fiscal years ended June 30, 2015 and 2014:
 
Trademark &
trade name
 
Customer
related
intangible
 
Core/
developed
technology
 
Product
 
Favorable
agreements
 
Total
Balance as of June 30, 2013
$

 
$
246,247

 
$
69,515

 
$

 
$
3,565

 
$
319,327

Intangible assets acquired
150

 
600

 
34,300

 

 

 
35,050

Intangible assets related to disposal

 
(8,254
)
 

 

 

 
(8,254
)
Amortization
(150
)
 
(46,907
)
 
(28,875
)
 

 
(947
)
 
(76,879
)
Translation adjustment

 
7,169

 
887

 

 
(1
)
 
8,055

Balance as of June 30, 2014

 
198,855

 
75,827

 

 
2,617

 
277,299

Intangible assets acquired

 
21,884

 
15,286

 
40,537

 
4,556

 
82,263

Intangible assets related to disposal

 

 

 

 

 

Amortization

 
(42,649
)
 
(22,628
)
 
(353
)
 
(1,027
)
 
(66,657
)
Translation adjustment

 
(9,771
)
 
(470
)
 

 
(55
)
 
(10,296
)
Balance as of June 30, 2015
$

 
$
168,319

 
$
68,015

 
$
40,184

 
$
6,091

 
$
282,609


18



For the fiscal years ended June 30, 2015, 2014 and 2013, we recorded $65.7 million, $75.9 million and $78.9 million, respectively, of amortization related to our intangible assets, exclusive of the amortization of our favorable lease agreements. These amounts include amortization that has been classified within income from discontinued operations on the accompanying consolidated statements of operations.
Included in the change in customer related intangible assets is the reduction of $8.3 million associated with the sale of our Brokerage business, which closed on November 6, 2013.
Due to integration of our Retirement business, management decided to discontinue the use of an application that was acquired in the Towers Perrin | Watson Wyatt Merger with an expected useful life of ten years. We calculated no impairment, and we shortened the life of the intangible asset and accelerated the amortization in the same pattern in which our clients were transitioned to the surviving application. To develop our estimated useful remaining life of the application, we used client engagement revenue and the planned transition developed by our business management. We recorded an additional $2.1 million and $5.6 million of amortization for the fiscal years ended June 30, 2014 and June 30, 2013, respectively.
Our indefinite-lived non-amortizable intangible assets consist of acquired trademarks and trade names. The carrying value of these assets was $371.5 million and $380.0 million as of June 30, 2015 and June 30, 2014, respectively. The change during the period was due to foreign currency translation adjustment.
We estimated the fair value of acquired leases and recorded an unfavorable lease liability in accordance with ASC 805. As of June 30, 2015 and June 30, 2014, this liability was $7.3 million and $10.2 million, respectively. The change for the fiscal year ended June 30, 2015 was comprised of a reduction to rent expense of $2.9 million and an immaterial foreign currency translation adjustment.
Components of the change in the gross carrying amount of customer related intangibles, core/developed technology and favorable and unfavorable lease agreements reflect foreign currency translation adjustments for fiscal years 2015 and 2014. Certain of the intangible assets and liabilities are denominated in the currencies of our subsidiaries outside the United States, and are translated into our reporting currency, the U.S. dollar, based on exchange rates at the balance sheet date.
The following table reflects the weighted average remaining life and carrying value of finite-lived intangible assets and liabilities as of June 30, 2015 and 2014:
 
Fiscal Year 2015
 
Fiscal Year 2014
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Weighted
Average
Remaining
Life
 
Gross
Carrying
Amount
 
Accumulated
Amortization
 
Weighted
Average
Remaining
Life
Finite-lived intangible assets and liabilities:
 
 
 
 
 
 
 
 
 
 
 
Trademark and trade name
$
150

 
$
150

 

 
$
520

 
$
520

 

Customer related intangibles
388,113

 
219,794

 
5.8

 
391,201

 
192,346

 
5.6

Core/developed technology
174,480

 
106,465

 
4.0

 
175,948

 
100,121

 
4.1

Product
40,537

 
353

 
18.8

 

 

 
0.0

Favorable agreements
10,866

 
4,775

 
7.8

 
6,488

 
3,871

 
3.6

Total finite-lived intangible assets
$
614,146

 
$
331,537

 
 
 
$
574,157

 
$
296,858

 
 
Unfavorable lease agreements
21,793

 
14,512

 
3.2

 
24,818

 
14,588

 
3.9

Total finite-lived intangible liabilities
$
21,793

 
$
14,512

 
 
 
$
24,818

 
$
14,588

 
 
Certain trademark and trade-name intangibles have indefinite useful lives and are not amortized. The weighted average remaining life of the net amortizable intangible assets and liabilities was 7.2 years and 5.1 years, respectively at June 30, 2015 and June 30, 2014.
The following table reflects:
1)
future estimated amortization expense for amortizable intangible assets consisting of customer related intangibles and core/developed technology, and product.
2)
The rent offset resulting from the amortization of the net lease intangible assets and liabilities:

19



Fiscal year ending June 30,
Amortization
 
Rent
Offset
2016
$
63,585

 
$
(1,603
)
2017
55,126

 
(1,871
)
2018
46,998

 
(1,981
)
2019
39,943

 
(315
)
2020
23,655

 
101

Thereafter
51,657

 
32

Total
$
280,964

 
$
(5,637
)
Note 7 — Fair Value Measurements
We have categorized our financial instruments into a three-level fair value hierarchy. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets and liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). In some cases, the inputs used to measure fair value might fall into different levels of the fair value hierarchy. In such cases, for disclosure purposes, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Refer to Note 2 for a description of each fair value measurement category.
The following presents our assets and liabilities measured at fair value on a recurring basis as of June 30, 2015 and 2014:
 
Fair Value Measurements on a Recurring Basis at
June 30, 2015
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
Equity securities
$
102

 
$

 
$

 
$
102

Mutual funds / exchange-traded funds
$
48,592

 
$

 
$

 
$
48,592

Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
2,177

 
$

 
$
2,177

Liabilities:
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
272

 
$

 
$
272

Contingent Liabilities
 
 
 
 
 
 
 
Retention bonus liability (b)
$

 
$

 
$
9,934

 
$
9,934

 
Fair Value Measurements on a Recurring Basis at
June 30, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
Available-for-sale securities:
 
 
 
 
 
 
 
Equity securities
$
130

 
$

 
$

 
$
130

Mutual funds / exchange-traded funds
$
57,673

 
$

 
$

 
$
57,673

Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
639

 
$

 
$
639

Liabilities:
 
 
 
 
 
 
 
Derivatives:
 
 
 
 
 
 
 
Foreign exchange forwards (a)
$

 
$
550

 
$

 
$
550

Contingent Liabilities
 
 
 
 
 
 
 
Retention bonus liability (b)
$

 
$

 
$
19,998

 
$
19,998

(a)
These derivative investments are included in other current assets or accounts payable, accrued liabilities and deferred income on the consolidated balance sheet. See Note 8 for further information on our derivative investments.

20



(b)
These liabilities are included in other current liabilities and other noncurrent liabilities on the consolidated balance sheet. The fair value was determined using a discounted cash flow model.
We record gains or losses related to the changes in the fair value of our financial instruments for foreign exchange forward contracts accounted for as foreign currency hedges in general and administrative expenses in the consolidated statements of operations. We recorded immaterial losses for the fiscal years ended June 30, 2015 and 2014, respectively, related to the changes in the fair value of these foreign exchange forward contracts which were still held as of June 30, 2015 and 2014. No material gain or loss was recorded in the consolidated statements of operations for available-for-sale securities still held as of June 30, 2015 and 2014.
We generally use third-party pricing services in determining the fair value of our investments. The pricing services use observable inputs when available. These values take into account recent market activity as well as other market observable data such as interest rate, spread and prepayment information. We perform various procedures to evaluate the accuracy of the fair values provided by the third-party service provider. These procedures include obtaining a detailed understanding of the models, inputs, and assumptions used in developing prices provided by the pricing services. This understanding includes a review of the vendors’ Service Organization Controls report and, as necessary, discussions with valuation resources at the pricing services. We obtain the information necessary to assert the model, inputs and assumptions used to comply with U.S. GAAP, including disclosure requirements. In addition, our investment committee periodically reviews the investment portfolios and the performance of our investments against expectations.
We independently review the listing of Level 1 financial assets in the portfolio, including U.S. Treasury securities, equity securities and mutual funds securities, and agree the price received from the third-party pricing service to the closing stock price from a national securities exchange, and on a sample basis.
We also independently review our Level 2 and Level 3 financial assets and liabilities, which include derivative investments, corporate bonds and certain obligations of government agencies or states, municipalities and political subdivisions, pooled funds and mutual funds, limited partnerships and insurance contracts. Corporate bonds and certain obligations of government agencies or states, municipalities and political subdivisions are valued based on yields currently available on comparable securities of issuers with similar credit ratings. Derivative investments are valued using a quoted value from the counterparty for each contract. The quoted price we receive is a Level 2 valuation based on observable quotes in the marketplace for the underlying currency. We use these underlying values to estimate amounts that would be paid or received to terminate the contracts at the reporting date based on current market prices for the underlying currency. See Note 11 for a description of the valuation methodologies used for Level 2 and Level 3 plan assets and liabilities by category.
We perform additional procedures to validate and confirm the accuracy of the Level 2 prices provided by the pricing service. Stale prices and significant price movements are monitored and investigated. If the price changes significantly, the fluctuation is reviewed for reasonableness based on our expectations or other market factors and adjusted if deemed necessary by management.
If we determine that a price provided to us is outside our expectation, we will further examine the price, including having follow-up discussions with the pricing service. If we conclude that a price is not valid, we will adjust the price with the appropriate documentation and approvals by management. These adjustments do not occur frequently and have not historically been material.
The availability of observable market data is monitored to assess the appropriate classification of financial instruments within the fair value hierarchy. Changes in economic conditions or model-based valuation techniques may require the transfer of financial instruments from one fair value level to another. In such instances, the transfer is reported at the beginning of the reporting period. No other-than-temporary impairments occurred during the fiscal year ended June 30, 2015.
Transfers in and out of Level 1 and 2
There were no securities transferred between Level 1 and Level 2 for the fiscal years ended June 30, 2015, 2014 and 2013. The Company’s policy is to recognize transfers in and transfers out as of the beginning of the reporting period.
Level 3 Financial Instruments
The fair value of the retention bonus liability is determined using a discounted cash flows model. The significant unobservable inputs used in the discounted cash flows model are a credit adjusted interest rate of 1.6% and an assumed forfeiture rate of 7.0%. Changes in each of these unobservable inputs would have adjusted the fair value as follows:
Interest rate - The lowest and highest interest rates that we could have used to value the bonus retention liability are 0.5% to 10.0%, which would have resulted in values of $10.0 million and $9.2 million, respectively.

21



Forfeiture rates - Changing the assumed forfeiture rate to either 5.0% or 10.0% would have resulted in values of $10.1 million and $9.6 million, respectively.
The following table summarizes the change in fair value of the Level 3 liabilities for fiscal years ended June 30, 2014 and 2015:
Fair Value Measurements using significant unobservable inputs (Level 3)
Balance as of - June 30, 2013
$

Obligation assumed
(21,746
)
Payments
1,939

Unrealized gains / (losses)
(191
)
Balance as of - June 30, 2014
$
(19,998
)
Payments
10,338

Unrealized gains / (losses)
(274
)
Balance as of - June 30, 2015
$
(9,934
)
Note 8 — Derivative Financial Instruments
We are exposed to market risk from changes in foreign currency exchange rates. Where possible, we identify exposures in our business that can be offset internally. Where no natural offset is identified, we may choose to enter into various derivative transactions. These instruments have the effect of reducing our exposure to unfavorable changes in foreign currency rates. We do not enter into derivative transactions for trading purposes.
Derivative transactions are governed by our established set of policies and procedures covering areas such as authorization, counterparty exposure and hedging practices. We also evaluate new and existing transactions and agreements to determine if they require derivative accounting treatment. Positions are monitored using fair market value and sensitivity analyses. See Note 2 for further information on the accounting policy for derivatives. The Company reviewed the Dodd–Frank Wall Street Reform and Consumer Protection Act: Title VII, Derivatives and has elected and is in compliance with the end-user exemption.
Certain derivatives also give rise to credit risks from the possible non-performance by counterparties. The credit risk is generally limited to the fair value of those contracts that are favorable to us. We have established strict counterparty credit guidelines and enter into transactions only with financial institutions with securities of investment grade or better. We monitor counterparty exposures and review any downgrade in credit rating. To mitigate pre-settlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.
A number of our foreign subsidiaries receive revenues (through either internal or external billing) in currencies other than their functional currency. As a result, the foreign subsidiary’s functional currency revenue will fluctuate as the currency exchange rates change. To reduce this variability, we use foreign exchange forward contracts to hedge the foreign exchange risk of the forecast collections. We have designated these derivatives as cash flow hedges of our forecast foreign currency denominated collections. We also use derivative financial contracts, principally foreign exchange forward contracts, to hedge other non-functional currency obligations. These exposures primarily arise from intercompany lending and other liabilities denominated in foreign currencies. At June 30, 2015, the longest outstanding maturity was 15 months. As of June 30, 2015, a net $1.6 million pretax gain has been deferred in accumulated other comprehensive income and is expected to be recognized in general and administrative expenses during the next twelve months. During the fiscal years ended June 30, 2015 and 2014, we recognized no material gains or losses due to hedge ineffectiveness.
As of June 30, 2015, 2014 and 2013 we had cash flow and economic hedges with a notional value of $43.2 million, $49.5 million and $107.2 million, respectively, to hedge internal and external revenue cash flows. We determine the fair value of our foreign currency derivatives based on quoted prices received from the counterparty for each contract, which we evaluate using pricing models whose inputs are observable. The net fair value of all derivatives held as of June 30, 2015 and 2014 was an asset of $1.9 million and $0.1 million, respectively. See Note 7, Fair Value Measurements, for further information regarding the determination of fair value.

22



The fair value of our derivative instruments held as of June 30, 2015 and 2014 and their location in the consolidated balance sheet are as follows:
 
Asset derivatives
 
Liability derivatives
 
Balance sheet location
 
Fair value
 
Balance sheet location
 
Fair value
 
 
 
June 30,
 
 
 
June 30,
 
 
 
2015
 
2014
 
 
 
2015
 
2014
Derivatives designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
Other current assets
 
$
1,792

 
$
618

 
Accounts payable, accrued liabilities and deferred income
 
$
(157
)
 
$
(513
)
Derivatives not designated as hedging instruments:
 
 
 
 
 
 
 
 
 
 
 
Foreign exchange forwards
Other current assets
 
385

 
21

 
Accounts payable, accrued liabilities and deferred income
 
(115
)
 
(37
)
Total derivative assets (liabilities)
 
 
$
2,177

 
$
639

 
 
 
$
(272
)
 
$
(550
)
The effect of derivative instruments that are designated as hedging instruments on the consolidated statement of operations and the consolidated statement of comprehensive income for the fiscal years ended June 30, 2015, 2014 and 2013 are as follows:
Derivatives designated as
hedging instruments:
 
Gain (loss) recognized in OCI
(effective portion)
 
Location of
gain (loss)
reclassified
from OCI
into income
(effective
portion)
 
Gain (loss) reclassified from OCI into income (effective portion)
 
Location of
gain (loss)
recognized in
income
(ineffective
portion and
amount
excluded from
effectiveness
testing)
 
Gain (loss) recognized in
income (ineffective portion
and amount  excluded from
effectiveness testing)
 
 
2015
 
2014
 
2013
 
 
 
2015
 
2014
 
2013
 
 
 
2015
 
2014
 
2013
Foreign exchange forwards
 
$
3,650

 
$
(1,540
)
 
$
(294
)
 
General and
administrative
expenses
 
$
2,178

 
$
(1,447
)
 
$
(125
)
 
General and
administrative
expenses
 
$
36

 
$
2

 
$
(1
)
Total
 
$
3,650

 
$
(1,540
)
 
$
(294
)
 
 
 
$
2,178

 
$
(1,447
)
 
$
(125
)
 
 
 
$
36

 
$
2

 
$
(1
)
Included in the notional values above are $20.4 million, $24.2 million and $33.6 million as of June 30, 2015, 2014 and 2013, respectively, of derivatives held as economic hedges primarily to hedge intercompany loans denominated in currencies other than the functional currency. The effect of derivatives that have not been designated as hedging instruments on the consolidated statement of operations for the fiscal years ended June 30, 2015, 2014 and 2013 is as follows:
 
 
 
(Loss) gain recognized in income
  
Location of (loss) gain
recognized in income
 
Fiscal year ended June 30,
Derivatives not designated as hedging instruments:
2015
 
2014
 
2013
Foreign exchange forwards
General and administrative expenses
 
$
(4,441
)
 
$
561

 
$
3,325

Total
 
 
$
(4,441
)
 
$
561

 
$
3,325

Note 9 — Supplementary information for select balance sheet accounts
Accounts payable, accrued liabilities and deferred income consists of:
 
June 30,
 
2015
 
2014
Accounts payable
$
19,945

 
$
20,228

Accrued liabilities
99,275

 
116,709

Deferred income
305,183

 
267,823

Accounts payable, accrued liabilities and deferred income
$
424,403

 
$
404,760


23



Current employee-related liabilities consist of:
 
June 30,
 
2015
 
2014
Accrued payroll and bonuses
$
519,185

 
$
447,145

Current pension liability
46,058

 
53,146

Other employee-related liabilities
15,872

 
18,241

Total employee-related liabilities
$
581,115

 
$
518,532

Note 10 — Leases
We lease office space under operating lease agreements with terms generally averaging ten years. Our real estate lease agreements contain rent increases, rent holidays, leasehold incentives or rent concessions. All costs incurred for rent expense are recorded on a straight-line basis (inclusive of any lease incentives and rent holidays) over the life of the lease.
Rental expenses and sub-lease rental income for operating leases are recorded as part of occupancy costs in the consolidated statements of operations along with other occupancy related expenses such as utilities and the amortization of intangible lease assets and liabilities. Rental expense, exclusive of sublease income, was $144.5 million, $144.1 million, and $146.4 million for the fiscal years ended June 30, 2015, 2014 and 2013, respectively. We have entered into sublease agreements for some of our excess leased space. Sublease income was $0.4 million, $0.9 million, and $3.1 million, respectively, for the fiscal years ended June 30, 2015, 2014 and 2013
Future minimum lease payments for the operating lease commitments, which have not been reduced by cumulative anticipated cash inflows for sublease income of $1.4 million, are as follows:
 
 
 
Fiscal year ending June 30,
 
Amortization
2016
 
$
97,551

2017
 
86,132

2018
 
72,566

2019
 
56,823

2020
 
48,685

Thereafter
 
120,490

Total
 
$
482,247

We evaluate office capacity on an ongoing basis to meet changing needs in our markets with a goal of minimizing our occupancy expense.
Note 11 — Retirement Benefits
Defined Benefit Plans
Towers Watson sponsors both qualified and non-qualified defined benefit pension plans and other post-retirement benefit plan (“OPEB”) plans in North America and Europe. As of June 30, 2015, these funded and unfunded plans represented 98 percent of Towers Watson’s pension and OPEB obligations and are disclosed herein. Towers Watson also sponsors funded and unfunded defined benefit pension plans in certain other countries, representing an additional $85.5 million in projected benefit obligations, $64.8 million in assets and a net liability of $20.7 million.
North America
United States – Beginning January 1, 2012, all associates, including named executive officers, accrue qualified and non-qualified benefits under a new stable value pension design. Prior to this date, associates hired prior to December 31, 2010 earned benefits under their legacy plan formulas, which were frozen on December 31, 2011. The non-qualified plan is unfunded. Retiree medical benefits provided under our U.S. postretirement benefit plans were closed to new hires effective January 1, 2011. Life insurance benefits under the same plans were frozen with respect to service, eligibility and amounts as of January 1, 2012 for active associates.
Canada – Effective on January 1, 2011, associates hired on or after January 1, 2011 and effective on January 1, 2012 associates hired prior to January 1, 2011, accrue qualified and non-qualified benefits based on a career average benefit formula. Additionally, participants can choose to make voluntary contributions to purchase enhancements to their pension. Prior to the January 1, 2011, associates earned benefits under their legacy plan formulas. Retiree life, medical

24



and dental benefits provided under our Canadian postretirement benefit plans were closed to new hires effective January 1, 2011. Associates that meet the eligibility requirements as of January 1, 2016 are eligible to participate in the postretirement benefits plan of Towers Perrin or Watson Wyatt, as applicable.
The non-qualified plans in North America provide for the additional pension benefits that would be covered under the qualified plan in the respective country were it not for statutory maximums. The non-qualified plans are unfunded.
Europe
United Kingdom – Benefit accruals earned under the legacy Watson Wyatt defined benefit plan (predominantly pension benefits) ceased on February 28, 2015, although benefits earned prior to January 1, 2008 retain a link to salary until the employee leaves Towers Watson.  Benefit accruals earned under the legacy Towers Perrin defined benefit plan (predominantly lump sum benefits) were frozen on March 31, 2008.  All associates now accrue defined contribution benefits.
Germany – Effective January 1, 2011, all new associates participate in a defined contribution plan. Associates hired prior to this date continue to participate in various defined contribution and defined benefit arrangements according to legacy plan formulas. The legacy defined benefit plans are primarily account-based, with some long-service associates continuing to accrue benefits according to grandfathered final-average-pay formulas.
Netherlands – Benefits under the Netherlands plan used to accrue on a final pay basis on earnings up to a maximum amount each year. The benefit accrual under the final pay plan stopped at December 31, 2010. The accrued benefits will receive conditional indexation each year.
The determination of Towers Watson’s obligations and annual expense under the plans is based on a number of assumptions that, given the longevity of the plans, are long-term in focus. A change in one or a combination of these assumptions could have a material impact on Towers Watson’s pension benefit obligation and related cost. Any difference between actual and assumed results is amortized into Towers Watson’s pension cost over the average remaining service period of participating associates. Towers Watson considers several factors prior to the start of each fiscal year when determining the appropriate annual assumptions, including economic forecasts, relevant benchmarks, historical trends, portfolio composition and peer company comparisons.
Funding is based on actuarially determined contributions and is limited to amounts that are currently deductible for tax purposes. Since funding calculations are based on different measurements than those used for accounting purposes, pension contributions are not equal to net periodic pension cost.
Assumptions Used in the Valuations of the Defined Benefit Pension Plans
The following assumptions were used in the valuations of Towers Watson’s defined benefit pension plans. The assumptions presented for the North American plans represent the weighted-average of rates for all U.S. and Canadian plans. The assumptions presented for Towers Watson’s European plans represent the weighted-average of rates for the U.K., Germany and Netherlands plans.
The assumptions used to determine net periodic benefit cost for the fiscal years ended June 30, 2015, 2014 and 2013 were as follows:
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
 
North
America
 
Europe
 
North
America
 
Europe
 
North
America
 
Europe
Discount rate
4.86
%
 
3.99
%
 
5.32
%
 
4.41
%
 
4.86
%
 
4.80
%
Expected long-term rate of return on assets
7.67
%
 
5.79
%
 
7.67
%
 
5.77
%
 
8.11
%
 
6.07
%
Rate of increase in compensation levels
3.98
%
 
3.00
%
 
4.36
%
 
3.93
%
 
4.35
%
 
3.93
%
The following table presents the assumptions used in the valuation to determine the projected benefit obligation for the fiscal years ended June 30, 2015 and 2014:
 
June 30, 2015
 
June 30, 2014
 
North
America
 
Europe
 
North
America
 
Europe
Discount rate
4.87
%
 
3.45
%
 
4.86
%
 
3.99
%
Rate of increase in compensation levels
4.01
%
 
3.00
%
 
3.98
%
 
3.00
%

25



Components of Net Periodic Benefit Cost for Defined Benefit Pension Plans
The following tables set forth the components of net periodic benefit cost for our defined benefit pension plans for North America and Europe for the fiscal years ended June 30, 2015, 2014 and 2013:
 
Fiscal Year ended June 30,
 
2015
 
2014
 
2013
 
North
America
 
Europe
 
North
America
 
Europe
 
North
America
 
Europe
Service cost
$
71,189

 
$
9,856

 
$
70,346

 
$
12,321

 
$
70,795

 
$
10,262

Interest cost
137,519

 
39,471

 
140,736

 
41,148

 
135,726

 
37,937

Expected return on plan assets
(211,730
)
 
(51,894
)
 
(188,391
)
 
(46,352
)
 
(185,435
)
 
(42,244
)
Amortization of net loss/(gain)
17,667

 
11,686

 
22,088

 
9,019

 
45,372

 
5,905

Amortization of prior service (credit)/cost
(8,380
)
 
41

 
(8,379
)
 
42

 
(8,377
)
 
41

Settlement/curtailment loss

 
3,859

 

 

 

 

Other adjustments

 
196

 

 
254

 

 
85

Net periodic benefit cost
$
6,265

 
$
13,215

 
$
36,400

 
$
16,432

 
$
58,081

 
$
11,986

Changes to other comprehensive income for the Company’s defined benefit pension plans as follows:
 
Fiscal Year ended June 30,
 
2015
 
2014
 
2013
 
North
America
 
Europe
 
North
America
 
Europe
 
North
America
 
Europe
Current year actuarial (gain)/loss
$
254,396

 
$
62,075

 
$
(26,558
)
 
$
60,022

 
$
(188,011
)
 
$
51,384

Amortization of actuarial (loss)/gain
(17,667
)
 
(11,686
)
 
(22,088
)
 
(9,019
)
 
(45,372
)
 
(5,905
)
Amortization of prior service credit/(cost)
8,380

 
(41
)
 
8,379

 
(42
)
 
8,377

 
(41
)
Recognition of actuarial loss due to settlement/curtailment

 
(3,859
)
 

 

 

 

Other
(5,466
)
 
(22,149
)
 
(909
)
 
12,992

 
(1,699
)
 
(1,418
)
Total recognized in other comprehensive (income)/loss
$
239,643

 
$
24,340

 
$
(41,176
)
 
$
63,953

 
$
(226,705
)
 
$
44,020

The change in Other in the 2015 fiscal year is primarily due to the currency impact, specifically the decrease in the British Pound.
For North America, the actuarial loss recorded in fiscal year 2015 is due to a lower than expected return on assets and a change in assumptions based on the new mortality tables. In October 2014, the Society of Actuaries released final reports on a study of mortality and mortality improvement in U.S. pension plans, which suggest that recent mortality experience across U.S. pension plans is stronger than that which has been assumed in the determination of our pension and postretirement obligations and cost. We estimate that these changes will increase annual U.S. benefit plan costs for the Company starting in fiscal year 2016. For North America, the return on assets more than offset actuarial losses due to a decrease in the discount rates for fiscal year 2014 and the actuarial gain recorded in fiscal year 2013 was due to an increase in the discount rates used for our plans. For Europe, the actuarial loss recorded in fiscal years 2015, 2014 and 2013 was primarily related to a decrease in the discount rates used for our plans. Towers Watson’s discount rate assumptions were determined by matching expected future pension benefit payments with current AA corporate bond yields from the respective countries for the same periods. In the United States, specific bonds were selected to match plan cash flows. In Canada, yields were taken from a corporate bond yield curve. In Europe, the discount rate was set based on yields on European AA corporate bonds at the measurement date. The U.K. is based on the U.K. AA corporate bonds, while Germany and the Netherlands are based on European AA corporate bonds.

26



The estimated amounts that will be amortized from other comprehensive income into net periodic benefit cost during fiscal 2016 for the Company’s defined benefit pension plans are shown below:
 
 
Fiscal 2016
 
North
America
 
Europe
Actuarial loss
$
40,051

 
$
10,860

Prior service (credit)/cost
(7,976
)
 
41

Total
$
32,075

 
$
10,901

The following table provides a reconciliation of the changes in the projected benefit obligations and fair value of assets for the years ended June 30, 2015 and 2014, and the funded status as of June 30, 2015 and 2014.
 
2015
 
 
 
2014
 
North
America - Qualified
 
North
America - Unqualified
 
Europe
 
North
America- Qualified
 
North America- Unqualified
 
Europe
Change in Benefit Obligation
 
 
 
 
 
 
 
 
 
 
 
Benefit obligation at beginning of year
$
2,547,781

 
$
395,778

 
$
1,087,298

 
$
2,324,353

 
$
416,461

 
$
887,047

Service cost
59,948

 
11,241

 
9,856

 
58,777

 
11,569

 
12,321

Interest cost
121,176

 
16,343

 
39,471

 
121,548

 
19,187

 
41,148

Actuarial losses/(gains)
135,221

 
(13,218
)
 
141,358

 
149,163

 
21,416

 
61,836

Benefit payments
(101,960
)
 
(42,212
)
 
(30,522
)
 
(102,495
)
 
(71,576
)
 
(20,566
)
Participant contributions

 

 
1,405

 

 

 
2,338

Curtailments

 

 
3,859

 

 

 

Other
1,217

 

 
196

 
516

 

 
1,462

Foreign currency adjustment
(46,776
)
 
(13,481
)
 
(112,017
)
 
(4,081
)
 
(1,279
)
 
101,712

Benefit obligation at end of year
$
2,716,607

 
$
354,451

 
$
1,140,904

 
$
2,547,781

 
$
395,778

 
$
1,087,298

Change in Plan Assets
 
 
 
 
 
 
 
 
 
 
 
Fair value of plan assets at beginning of year
$
2,813,591

 
$

 
$
919,160

 
$
2,461,764

 
$

 
$
750,856

Actual return on plan assets
79,338

 

 
135,036

 
385,528

 

 
48,166

Company contributions
31,526

 
42,212

 
53,481

 
71,663

 
71,576

 
41,941

Participant contributions

 

 
1,405

 

 

 
2,338

Benefit payments
(101,960
)
 
(42,212
)
 
(30,522
)
 
(102,495
)
 
(71,576
)
 
(20,566
)
Other
1,216

 

 

 
516

 

 
1,208

Foreign currency adjustment
(45,553
)
 

 
(80,123
)
 
(3,385
)
 

 
95,217

Fair value of plan assets at end of year
$
2,778,158

 
$

 
$
998,437

 
$
2,813,591

 
$

 
$
919,160

Funded status at end of year
$
61,551

 
$
(354,451
)
 
$
(142,467
)
 
$
265,810

 
$
(395,778
)
 
$
(168,138
)
Accumulated Benefit Obligation
$
2,694,611

 
$
357,006

 
$
1,132,200

 
$
2,517,911

 
$
390,246

 
$
1,077,939


27



 
2015
 
2014
 
North America - Qualified
 
North America- Unqualified
 
Europe
 
North America- Qualified
 
North America- Unqualified
 
Europe
Amounts recognized in Consolidated Balance Sheets consist of:
 
 
 
 
 
 
 
 
 
 
 
Noncurrent assets
$
73,494

 
$

 
$
1,156

 
$
273,940

 
$

 
$
9,593

Current liabilities

 
(44,316
)
 

 

 
(51,113
)
 

Noncurrent liabilities
(11,943
)
 
(310,135
)
 
(143,622
)
 
(8,131
)
 
(344,665
)
 
(177,730
)
Net amount recognized
$
61,551

 
$
(354,451
)
 
$
(142,466
)
 
$
265,809

 
$
(395,778
)
 
$
(168,137
)
Amounts recognized in Accumulated Other Comprehensive Income consist of:
 
 
 
 
 
 
 
 
 
 
 
Net actuarial loss
$
354,029

 
$
46,067

 
$
202,814

 
$
100,608

 
$
68,224

 
$
178,395

Net prior service (credit)/cost
(35,273
)
 
(9,071
)
 
398

 
(41,757
)
 
(10,965
)
 
477

Accumulated Other Comprehensive Loss
$
318,756

 
$
36,996

 
$
203,212

 
$
58,851

 
$
57,259

 
$
178,872

The following table presents the projected benefit obligation and fair value of plan assets for our qualified plans that have a projected benefit obligation in excess of plan assets as of June 30, 2015 and 2014:
 
2015
 
2014
 
North
America
 
Europe
 
North
America
 
Europe
Projected benefit obligation at end of year
$
101,760

 
$
824,677

 
$
105,278

 
$
210,898

Fair value of plan assets at end of year
$
89,817

 
$
681,055

 
$
97,147

 
$
33,168

The following table presents the projected benefit obligation, accumulated benefit obligation and fair value of plan assets for our qualified plans that have an accumulated benefit obligation in excess of plan assets as of June 30, 2015 and 2014:
 
2015
 
2014
 
North
America
 
Europe
 
North
America
 
Europe
Projected benefit obligation at end of year
$
101,760

 
$
824,677

 
$

 
$
210,898

Accumulated benefit obligation at end of year
$
94,006

 
$
815,974

 
$

 
$
201,540

Fair value of plan assets at end of year
$
89,817

 
$
681,055

 
$

 
$
33,168

Our investment strategy is designed to generate returns that will reduce the interest rate risk inherent in each of the plans’ benefit obligations and enable the plans to meet their future obligations. The precise amount for which these obligations will be settled depends on future events, including the life expectancy of the plan participants and salary inflation. The obligations are estimated using actuarial assumptions, based on the current economic environment.
Each pension plan seeks to achieve total returns sufficient to meet expected future obligations when considered in conjunction with expected future company contributions and prudent levels of investment risk and diversification. Each plan’s targeted asset allocation is determined through a plan-specific Asset-Liability Modeling study. These comprehensive studies provide an evaluation of the projected status of asset and benefit obligation measures for each plan under a range of both positive and negative environments. The studies include a number of different asset mixes, spanning a range of diversification and potential equity exposures.
In evaluating the strategic asset allocation choices, an emphasis is placed on the long-term characteristics of each individual asset class, such as expected return, volatility of returns and correlations with other asset classes within the portfolios. Consideration is also given to the proper long-term level of risk for each plan, the impact on the volatility and magnitude of plan contributions and cost, and the impact certain actuarial techniques may have on the plan’s recognition of investment experience.
For the Towers Watson funded plans in the U.S., Canada and the U.K., the targeted equity allocation as of June 30, 2015 is 23%, 60% and 32%, respectively. In the U.S. and U.K. funded plans, besides the target equity allocation, an additional 44% and 23%, respectively, of the target allocation is directed to other investment vehicles including alternative credit, alternative beta and private equities. The remaining allocation for each of the funded plans is directed to fixed income securities. The duration of the fixed income assets is plan specific and each has been targeted to minimize fluctuations in plan funded status as a result of

28



changes in interest rates. The Netherlands plan is invested in an insurance contract. Consequently, the asset allocation of the plan is managed by the insurer.
We monitor investment performance and portfolio characteristics on a quarterly basis to ensure that managers are meeting expectations with respect to their investment approach. There are also various restrictions and controls placed on managers, including prohibition from investing in our stock.
The expected rate of return on assets assumption is developed in conjunction with advisors and using our asset model that reflects a combination of rigorous historical analysis and the forward-looking views of the financial markets as revealed through the yield on long-term bonds, the price-earnings ratios of the major stock market indices and long-term inflation.
We evaluate the need to transfer between levels based upon the nature of the financial instrument and size of the transfer relative to the total net assets of the plans.
There were no significant transfers between Levels 1, 2 or 3 in the fiscal years ended June 30, 2015 and 2014.
In accordance with Subtopic 820-10, Fair Value Measurement and Disclosures, certain investments that are measured at fair value using the net asset value per share practical expedient have not been classified in the fair value hierarchy. The fair value amounts presented in these tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets.
The fair value of our plan assets by asset category at June 30, 2015 and 2014 are as follows (see Note 2 for a description of the fair value levels and Note 7 for a summary of management’s procedures around prices received from third-parties):
 
Fair Value Measurements at June 30, 2015
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
North
America
 
Europe
 
North
America
 
Europe
 
North
America
 
Europe
 
 
 
Asset category:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash
$
15,581

 
$
37,789

 
$

  
$

  
$

 
$

 
$
53,370

 
Short-term securities
633

 

 

  

  

 

 
96,568

 
Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. large cap companies
48,898

 
11,695

 

  

  

 

 
60,593

 
U.S. mid cap companies
4,441

 

 

  

  

 

 
4,441

 
U.S. small cap companies
1,823

 

 

  

  

 

 
1,823

 
International equities
46,084

 
24,123

 

  

  

 

 
70,207

 
Fixed income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Government issued securities
211,186

 

 

  

  

 

 
211,186

 
Corporate bonds (S&P rating of A or higher)

 

 
316,398

  

  

 

 
316,398

 
Corporate bonds (S&P rating of lower than A)

 

 
218,132

  

  
445

 

 
218,577

 
Other fixed income

 

 
54,374

(a) 
205,202

(a) 

 

 
259,576

 
Pooled / commingled funds

 

 

 

 

 

 
2,175,786

(b)
Mutual funds

 

 

  

  

 

 
159,194

 
Private equity

 

 

  

  
7,108

 

 
135,782

 
Derivatives

 

 
1,476

(c) 
18,827

(c) 

 

 
20,303

 
Insurance contracts

 

 

  

  

 
14,805

 
14,805

 
Total assets
$
328,646

 
$
73,607

 
$
590,380

  
$
224,029

  
$
7,553

 
$
14,805

 
$
3,798,609

 
Liability category:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives
$

 
$

 
$
491

(c) 
$

  
$

 
$

 
$
491

 
Net assets
$
328,646

 
$
73,607

 
$
589,889

  
$
224,029

  
$
7,553

 
$
14,805

 
$
3,798,118

 

29



 
Fair Value Measurements at June 30, 2014
 
 
Level 1
 
Level 2
 
Level 3
 
Total
 
 
North
America
 
Europe
 
North
America
 
Europe
 
North
America
 
Europe
 
 
 
Asset category:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash
$
1,845

 
$
69,433

 
$

  
$

  
$

 
$

 
$
71,278

 
Short-term securities
499

 

 

  

  

 

 
64,363

 
Equity securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. large cap companies
127,996

 
15,440

 

  

  

 

 
143,436

 
U.S. mid cap companies
49,494

 
563

 

  

  

 

 
50,057

 
U.S. small cap companies
40,691

 

 

  

  

 

 
40,691

 
International equities
114,441

 
471

 

  

  

 

 
114,912

 
Fixed income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Government issued securities
206,517

 

 

  

  

 

 
206,517

 
Corporate bonds (S&P rating of A or higher)

 

 
320,005

  

  

 

 
320,005

 
Corporate bonds (S&P rating of lower than A)

 

 
216,983

  

  
450

 

 
217,433

 
Other fixed income

 

 
56,519

(a) 
155,160

(a) 

 

 
211,679

 
Pooled / commingled funds

 

 

 

 

 

 
1,922,479

(b)
Mutual funds

 

 

  

  

 

 
189,014

 
Private equity

 

 

  

  
2,256

 

 
155,456

 
Derivatives

 

 
1,654

(c) 
4,758

(c) 

 

 
6,412

 
Insurance contracts

 

 

  

  

 
18,091

 
18,091

 
Total assets
$
541,483

 
$
85,907

 
$
595,161

  
$
159,918

  
$
2,706

 
$
18,091

 
$
3,731,823

 
Liability category:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivatives
$

 
$

 
$
350

(c) 
$

  
$

 
$

 
$
350

 
Net assets
$
541,483

 
$
85,907

 
$
594,811

  
$
159,918

  
$
2,706

 
$
18,091

 
$
3,731,473

 
(a)
This category includes municipal and foreign bonds.
(b)
This category includes pooled funds of both equity and fixed income securities. Fair value is based on the calculated net asset value of shares held by the plan as reported by the sponsor of the funds and, in accordance with subtopic 820-10, Fair Value Measurements and Disclosures, are not included in the fair value hierarchy.
(c)
We use various derivatives such as interest rate swaps, futures and options to match the duration of the corporate bond portfolio with the duration of the plan liability.
Following is a description of the valuation methodologies used for investments at fair value:
Short-term securities: Valued at the net value of shares held by the Company at year end as reported by the sponsor of the funds.
Common stocks and exchange-traded mutual funds: Valued at the closing price reported on the active market on which the individual securities are traded.
Government issued securities: Valued at the closing price reported in the active market in which the individual security is traded. Government bonds are valued at the closing price reported in the active market in which the bond is traded.
Corporate bonds: Valued using pricing models maximizing the use of observable inputs for similar securities. This includes basing value on yields currently available on comparable securities of issuers with similar credit ratings.
Fixed Income: Foreign and municipal bonds are valued at the closing price reported in the active market in which the bond is traded. Corporate bonds are valued based on yields currently available on comparable securities of issuers with similar credit ratings.
Pooled / Commingled Funds and Mutual Funds: Valued at the net value of shares held by the Company at year end as reported by the manager of the funds.

30



Derivative investments: Valued at the closing level of the relevant index or security and interest accrual through the valuation date.
Private equity funds: The fair value for these investments is estimated based on the net asset value derived from the latest audited financial statements or most recent capital account statements provided by the private equity fund’s investment manager or third-party administrator.
Insurance contracts: The fair values are determined using model-based techniques that include option-pricing models, discounted cash flow models, and similar techniques.
The following table reconciles the net plan investments to the total fair value of the plan assets:
 
June 30,
 
2015
 
2014
Net assets held in investments
$
3,798,118

 
$
3,731,473

Net payable for investments purchased
(24,251
)
 
(5,541
)
Dividend and interest receivable
9,057

 
8,856

Other, net
(6,329
)
 
(2,037
)
Fair value of plan assets
$
3,776,595

 
$
3,732,751

The following table sets forth a summary of changes in the fair value of the plan’s Level 3 assets for the fiscal years ended June 30, 2015 and 2014:
 
Private
Equity
 
Insurance
Contracts
 
Corporate
Bonds
 
Total
Beginning balance at June 30, 2013
$
109,768

 
$
15,040

 
$
411

 
$
125,219

Assets no longer leveled in accordance with ASU 2015-07
(109,768
)
 

 

 
$
(109,768
)
Net actual return on plan assets relating to assets still held at the end of the year

 
676

 
39

 
715

Net purchases, sales and settlements
2,256

 
1,586

 

 
3,842

Change in foreign currency exchange rates

 
789

 

 
789

Ending balance at June 30, 2014
$
2,256

 
$
18,091

 
$
450

 
$
20,797

Assets no longer leveled in accordance with ASU 2015-07
(1,280
)
 

 

 
(1,280
)
Net actual return on plan assets relating to assets still held at the end of the year
(681
)
 
557

 
(5
)
 
(129
)
Net purchases, sales and settlements
6,813

 
(480
)
 

 
6,333

Change in foreign currency exchange rates

 
(3,363
)
 

 
(3,363
)
Ending balance at June 30, 2015
$
7,108

 
$
14,805

 
$
445

 
$
22,358

The following table sets forth our projected pension contributions to our qualified plans for fiscal year 2016, as well as the pension contributions to our qualified plans in fiscal years 2015 and 2014:
 
2016
(Projected)
 
2015
(Actual)
 
2014
(Actual)
U.S
$
30,000

 
$
30,000

 
$
50,000

Canada
$
4,599

 
$
1,526

 
$
21,663

UK
$
21,211

 
$
25,314

 
$
28,706

Germany
$
20,065

 
$
19,785

 
$
10,178


31



Expected benefit payments from our defined benefit pension plans to current plan participants, including the effect of their expected future service, as appropriate, are as follows:
 
Benefit Payments
Fiscal Year
North America
 
Europe
 
Total
2016
$
172,374

 
$
28,850

 
$
201,224

2017
179,968

 
29,675

 
209,643

2018
182,700

 
27,326

 
210,026

2019
186,087

 
29,397

 
215,484

2020
194,534

 
31,718

 
226,252

Years 2021 - 2025
1,080,658

 
216,982

 
1,297,640

 
$
1,996,321

 
$
363,948

 
$
2,360,269

Defined Contribution Plan
Eligible Towers Watson U.S. associates participate in a savings plan design which provides for 100% match on the first 2% of pay and 50% match on the next 4% of pay; associates vest in the employer match upon two years of service. The cost of the Company’s contributions to the plans for the fiscal years ended June 30, 2015, 2014 and 2013 amounted to $30.4 million, $30.0 million and $30.2 million, respectively.
The Towers Watson U.K. pension plan has a money purchase feature to which we make core contributions plus additional contributions matching those of the participating associates up to a maximum rate. Contribution rates depend on the age of the participant and whether or not they arise from salary sacrifice arrangements through which the associate has elected to receive a pension contribution in lieu of additional salary. The cost of the Company’s contributions to the plan for the fiscal years ended June 30, 2015, 2014 and 2013 amounted to $20.5 million, $20.2 million, and $22.2 million, respectively.
Health Care Benefits
We sponsor a contributory health care plan that provides hospitalization, medical and dental benefits to substantially all U.S. associates. We accrue a liability for estimated incurred but unreported claims. The liability totaled $5.5 million and $6.0 million at June 30, 2015 and 2014, respectively. This liability is included in accounts payable, accrued liabilities, and deferred income in the consolidated balance sheets.
Postretirement Benefits
We provide certain health care and life insurance benefits for retired associates. The principal plans cover associates in the U.S. and Canada who have met certain eligibility requirements. Our principal post-retirement benefit plans are primarily unfunded. Retiree medical benefits provided under our U.S. postretirement benefit plans were closed to new hires effective January 1, 2011. Life insurance benefits under the plans were frozen with respect to service, eligibility and amounts as of January 1, 2012 for active associates.
The assumptions used in the valuation of the postretirement benefit cost and obligation were as follows:
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Discount rate
4.68
%
 
5.30
%
 
4.80
%
Expected long-term rate of return on assets
2.00
%
 
2.00
%
 
2.00
%
Rate of increase in compensation levels
%
 
%
 
4.50
%
Health care cost trend
 
 
 
 
 
Initial rate
7.00
%
 
7.08
%
 
7.16
%
Ultimate rate
5.00
%
 
5.00
%
 
5.00
%
Year reaching ultimate rate
2019

 
2019

 
2019


32



 
June 30,
 
2015
 
2014
Discount rate, accumulated postretirement benefit obligation
4.57
%
 
4.68
%
Rate of compensation increase
%
 
%
Health care cost trend
 
 
 
Initial rate
6.91
%
 
7.00
%
Ultimate rate
5.00
%
 
5.00
%
Year reaching ultimate rate
2019

 
2019

Actuarial gains and losses associated with changing any of the assumptions are accumulated as part of the unrecognized net gain or loss and amortized into the net periodic postretirement costs over the average remaining service period of participating associates, which is approximately 9.3 years.
A one percentage point change in the assumed health care cost trend rates would have the following effect:
 
1% Increase
 
1% Decrease
Effect on net periodic postretirement benefit cost in fiscal year 2015
$
82

 
$
(23
)
Effect on accumulated postretirement benefit obligation as of June 30, 2015
$
1,870

 
$
(746
)
Net periodic postretirement benefit cost consists of the following:
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Service cost
$
1,278

 
$
1,460

 
$
1,770

Interest cost
8,137

 
8,856

 
8,807

Expected return on assets
(96
)
 
(112
)
 
(130
)
Amortization of net unrecognized (gains)/losses
(1,761
)
 
(1,752
)
 
369

Amortization of prior service credit
(6,905
)
 
(7,004
)
 
(8,228
)
Net periodic postretirement benefit cost
$
653

 
$
1,448

 
$
2,588

Changes in other comprehensive income for the Company’s postretirement benefit plans as follows:
 
2015
 
2014
Current year actuarial gain/(loss)
$
(48,421
)
 
$
7,131

Amortization of actuarial gain
1,761

 
1,752

Amortization of prior service credit
6,905

 
7,004

Other
(51
)
 
(29
)
Total recognized in other comprehensive income
$
(39,806
)
 
$
15,858

The estimated amounts that will be amortized from other comprehensive income into net periodic benefit cost during fiscal 2016 for the Company’s other postretirement benefit plans are shown below:
 
2016
Actuarial gain
$
(5,992
)
Prior service credit
(6,905
)
Total
$
(12,897
)

33



The following table provides a reconciliation of the changes in the accumulated postretirement benefit obligation and fair value of assets for the fiscal years ended June 30, 2015 and 2014 and a statement of funded status as of June 30, 2015 and 2014:
 
June 30,
 
2015
 
2014
Change in Benefit Obligation
 
 
 
Benefit obligation at beginning of year
$
181,306

 
$
172,729

Service cost
1,278

 
1,460

Interest cost
8,137

 
8,856

Actuarial losses/(gains)
(48,464
)
 
6,972

Benefit payments
(14,504
)
 
(14,443
)
Medicare Part D
639

 
68

Participant contributions
6,545

 
6,035

Foreign currency adjustment
(3,860
)
 
(371
)
Benefit obligation at end of year
$
131,077

 
$
181,306

Change in Plan Assets
 
 
 
Fair value of plan assets at beginning of year
$
5,168

 
$
5,958

Actual return on plan assets
52

 
(47
)
Company contributions
7,220

 
7,665

Participant contributions
6,545

 
6,035

Benefit payments
(14,504
)
 
(14,443
)
Fair value of plan assets at end of year
$
4,481

 
$
5,168

Funded status at end of year
$
(126,596
)
 
$
(176,138
)
Amounts recognized in Consolidated Balance Sheets consist of:
 
 
 
Noncurrent assets
$

 
$

Current liabilities
(3,971
)
 
(4,678
)
Noncurrent liabilities
(122,625
)
 
(171,459
)
Net amount recognized
$
(126,596
)
 
$
(176,137
)
Amounts recognized in Accumulated Other Comprehensive Income consist of:
 
 
 
Net actuarial gain
$
(64,480
)
 
$
(17,769
)
Net prior service credit
(26,929
)
 
(33,835
)
Accumulated Other Comprehensive Income
$
(91,409
)
 
$
(51,604
)
Expected benefit payments to current plan participants, including the effect of their future service, as appropriate, and the related retiree drug subsidy expected to be received, are as follows:
Fiscal Year
Expected
benefit
payments
 
Retiree drug
subsidy
2016
$
16,254

 
$
55

2017
16,676

 

2018
17,557

 

2019
18,532

 

2020
19,531

 

Years 2021-2025
113,737

 

 
$
202,287

 
$
55

Note 12 — Debt, Commitments and Contingent Liabilities
The debt, commitments and contingencies described below are currently in effect and would require Towers Watson, or domestic subsidiaries, to make payments to third parties under certain circumstances. In addition to commitments and contingencies specifically described below, Towers Watson has historically provided guarantees on an infrequent basis to third parties in the ordinary course of business.

34



Towers Watson Senior Credit Facility
On November 7, 2011, Towers Watson and certain subsidiaries entered into a five-year, $500 million revolving credit facility, which amount may be increased by an aggregate amount of $250 million, subject to the satisfaction of customary terms and conditions, with a syndicate of banks (the “Senior Credit Facility”). Borrowings under the Senior Credit Facility bear interest at a spread to either LIBOR or the Prime Rate. During fiscal 2015 and 2014, the weighted-average interest rate on the Senior Credit Facility was 1.43% and 1.93%, respectively. We are charged a quarterly commitment fee, currently 0.175% of the Senior Credit Facility, which varies with our financial leverage and is paid on the unused portion of the Senior Credit Facility. Obligations under the Senior Credit Facility are guaranteed by Towers Watson and all of its domestic subsidiaries (other than our captive insurance companies).
The Senior Credit Facility contains customary representations and warranties and affirmative and negative covenants. The Senior Credit Facility requires Towers Watson to maintain certain financial covenants that include a minimum Consolidated Interest Coverage Ratio and a maximum Consolidated Leverage Ratio (which terms in each case are defined in the Senior Credit Facility). In addition, the Senior Credit Facility contains restrictions on the ability of Towers Watson to, among other things, incur additional indebtedness; pay dividends; make distributions; create liens on assets; make acquisitions; dispose of property; engage in sale-leaseback transactions; engage in mergers or consolidations, liquidations and dissolutions; engage in certain transactions with affiliates; and make changes in lines of businesses. As of June 30, 2015, we were in compliance with our covenants.
As of June 30, 2015, Towers Watson had $40.0 million in borrowings outstanding under the Senior Credit Facility.
Letters of Credit under the Senior Credit Facility
As of June 30, 2015, Towers Watson had standby letters of credit totaling $21.4 million associated with our captive insurance companies in the event that we fail to meet our financial obligations. Additionally, Towers Watson had $0.9 million of standby letters of credit covering various other existing or potential business obligations. The aforementioned letters of credit are issued under the Senior Credit Facility, and therefore reduce the amount that can be borrowed under the Senior Credit Facility by the outstanding amount of these standby letters of credit.
Additional Borrowings, Letters of Credit and Guarantees not part of the Senior Credit Facility
Towers Watson Consultoria Ltda. (Brazil) has a bilateral credit facility with a major bank totaling Brazilian Real BRL 5.5 million (U.S. $1.8 million). BRL 2.0 million (U.S. $0.6 million) of the credit facility is committed to an overdraft facility and as of June 30, 2015, there were no borrowings outstanding under this facility. BRL 3.8 million (U.S. $1.2 million) of the credit facility is committed to lease guarantees. As of June 30, 2015, standby guarantees totaling BRL 1.7 million (U.S. $0.5 million) were outstanding under this facility.
Towers Watson has also provided a $5 million Australian dollar-denominated letter of credit (U.S. $3.8 million) to an Australian governmental agency as required by local regulations. The estimated fair market value of this letter of credit is immaterial because it has never been used, and we believe that the likelihood of future usage is remote.
Towers Watson also has $8.4 million committed to lease guarantees from major banks in support of office leases and performance under existing or prospective contracts.
Towers Watson had an additional $30.0 million outstanding on an uncommitted line of credit as of June 30, 2015. The weighted-average interest rate on this line of credit during the fiscal year ended June 30, 2015 was 1.09%. The line of credit was paid in full on July 1, 2015.

35



Term Loan Agreement Due June 2017
On June 1, 2012, the Company entered into a five-year $250 million amortizing term loan facility (“the Term Loan”) with a consortium of banks. The interest rate on the term loan is based on the Company’s choice of one, three or six month LIBOR plus a spread of 1.25% to 1.75%, or alternatively the bank base rate plus 0.25% to 0.75%. The spread to each index is dependent on the Company’s consolidated leverage ratio. The weighted-average interest rate elected on the Term Loan during fiscal 2015 and 2014 was 1.42%. The Term Loan amortizes at a rate of $6.25 million per quarter, beginning in September 2013, with a final maturity of June 1, 2017. The Company has the right to prepay a portion or all of the outstanding Term Loan balance on any interest payment date without penalty. The following table summarizes the maturity of the loan during the next two fiscal years:
2016
$
25,000

2017
175,000

Total
$
200,000

This agreement contains substantially the same terms and conditions as our existing Senior Credit Facility dated November 7, 2011, including guarantees from all of the domestic subsidiaries of Towers Watson (other than PCIC and SMIC).
The Company entered into the Term Loan as part of the financing of our acquisition of Extend Health in fiscal year 2012.
Indemnification Agreements
Towers Watson has various agreements which provide that it may be obligated to indemnify the other party to the agreement with respect to certain matters. Generally, these indemnification provisions are included in contracts arising in the normal course of business and in connection with the purchase and sale of certain businesses. Although it is not possible to predict the maximum potential amount of future payments that may become due under these indemnification agreements because of the conditional nature of Towers Watson’s obligations and the unique facts of each particular agreement, Towers Watson does not believe any potential liability that might arise from such indemnity provisions is probable or material. There are no provisions for recourse to third parties, nor are any assets held by any third parties that any guarantor can liquidate to recover amounts paid under such indemnities.
Legal Proceedings
From time to time, Towers Watson and its subsidiaries are parties to various lawsuits, arbitrations or mediations that arise in the ordinary course of business. The matters reported on below relate to certain pending claims or demands against Towers Watson and its subsidiaries. We do not expect the impact of claims or demands not described below to be material to Towers Watson’s financial statements. We also receive subpoenas in the ordinary course of business and, from time-to-time, receive requests for information in connection with governmental investigations.
Towers Watson carries substantial professional liability insurance which, effective July 1, 2010, has been provided by SMIC. For the policy period beginning July 1, 2011, certain changes were made to our professional liability insurance program. Our professional liability insurance for each annualized policy period commencing July 1, 2011, up to and including the policy period commencing July 1, 2015, includes a $10 million aggregate self-insured retention above the $1 million self-insured retention per claim, including the cost of defending such claims. SMIC provides us with $40 million of coverage per claim and in the aggregate, above the retentions, including the cost of defending such claims. SMIC secured $25 million of reinsurance from unaffiliated reinsurance companies in excess of the $15 million SMIC retained layer. Excess insurance attaching above the SMIC coverage is provided by various unaffiliated commercial insurance companies.
This structure effectively results in Towers Watson and SMIC bearing the first $25 million of loss per occurrence or in the aggregate above the $1 million per claim self-insured retention. As a wholly-owned captive insurance company, SMIC is consolidated into our financial statements.
Before the Towers Perrin | Watson Wyatt Merger, Watson Wyatt and Towers Perrin each obtained substantial professional liability insurance from PCIC. A limit of $50 million per claim and in the aggregate was provided by PCIC subject to a $1 million per claim self-insured retention. PCIC secured reinsurance of $25 million attaching above the $25 million PCIC retained layer from unaffiliated reinsurance companies. Our ownership interest in PCIC is 72.86%. As a consequence, PCIC’s results are consolidated in Towers Watson’s operating results. PCIC ceased issuing insurance policies effective July 1, 2010 and at that time entered into a run-off mode of operation. Our shareholder agreements with PCIC could require additional payments to PCIC if development of claims significantly exceeds prior expectations.

36



We provide for the self-insured retention where specific estimated losses and loss expenses for known claims are considered probable and reasonably estimable. Although we maintain professional liability insurance coverage, this insurance does not cover claims made after expiration of our current policies of insurance. Generally accepted accounting principles require that we record a liability for incurred but not reported (“IBNR”) professional liability claims if they are probable and reasonably estimable. We use actuarial assumptions to estimate and record our IBNR liability. As of June 30, 2015, we had a $181.5 million IBNR liability balance, net of estimated IBNR recoverable receivables of our captive insurance companies. This net liability was $173.8 million as of June 30, 2014. To the extent our captive insurance companies, PCIC and SMIC, expect losses to be covered by a third party, they record a receivable for the amount expected to be recovered. This receivable is classified in other current or other noncurrent assets in our condensed consolidated balance sheet.
We reserve for contingent liabilities based on ASC 450, Contingencies, when it is determined that a liability, inclusive of defense costs, is probable and reasonably estimable. The contingent liabilities recorded are primarily developed actuarially. Litigation is subject to many factors which are difficult to predict so there can be no assurance that in the event of a material unfavorable result in one or more claims, we will not incur material costs.
Current and Former Employees of Teck Metals, Ltd.
On July 14, 2009, James Weldon, an employee of Teck Metals, Ltd. (“Teck”) commenced an action against Teck and Towers Perrin Inc. (now known as Towers Watson Canada Inc.). On October 17, 2011, Leonard Bleier, a former employee of Teck, sued Teck and Towers Perrin. Aside from their employment status, the allegations in the action commenced by Bleier (retired from Teck in 2006) were substantively similar in all material respects to those in the action commenced by Weldon (employed by Teck at the time the action commenced). Both actions were brought in the Supreme Court of British Columbia, and that court consolidated the actions on June 21, 2012.
On October 1, 2012, the Company filed a response to the plaintiffs' consolidated and amended claim denying the legal and factual basis for the plaintiffs' claim. On December 21, 2012, the court certified the consolidated case as a class action.
At all times relevant to the plaintiffs’ claim, Towers Perrin acted as the actuarial advisor for Teck’s defined benefit pension plan. According to the plaintiffs' allegations, in 1992 and on Towers Perrin's advice, Teck offered its non-union, salaried employees a one-time option to continue participation in Teck’s defined benefit pension plan or to transfer to a newly established defined contribution plan. The plaintiffs also allege that Towers Perrin assisted Teck in preparing—and that Towers Perrin approved—informational materials and a computer-based modeling tool that Teck distributed to eligible employees prior to the employees electing whether to transfer. Several hundred employees elected to transfer from the defined benefit pension plan to the defined contribution plan on January 1, 1993.
The plaintiff class comprises 429 current and former Teck employees who elected to transfer from the defined benefit pension plan to the defined contribution plan.
The plaintiffs, on behalf of the class, alleged that Towers Perrin was professionally negligent and that Teck and Towers Perrin breached statutory and fiduciary duties and acted deceitfully by providing incomplete, inaccurate, and misleading information to participants in Teck’s defined benefit plan regarding the option to transfer to the defined contribution plan. Principally, the plaintiffs alleged that the risks of the defined contribution plan—including investment risk and annuity risk—were downplayed, either negligently or with the specific intent of causing eligible employees to transfer to the defined contribution plan.
The plaintiffs also sought assorted declaratory relief; an injunction reinstating them and all class members into the defined benefit plan with full rights and benefits as if they had not transferred; disgorgement against Teck; damages in the amount necessary to provide the plaintiffs and all class members with the pension and other benefits they would have accrued if they had not transferred; interest as allowed by law; and such further and other relief as to the court may seem just.
In a settlement agreement dated October 31, 2014, the Company, plaintiffs, and Teck agreed to resolve all claims in this litigation, without any admission of wrongdoing. The Supreme Court of British Columbia approved the settlement agreement at an approval hearing on July 24, 2015. Payment of the settlement funds has been made, and the Company's role in the litigation has been concluded.
City of Houston
On August 1, 2014, the City of Houston ("plaintiff") filed suit against the Company in the United States District Court for the Southern District of Texas, Houston Division.
In the complaint, plaintiff alleges various deficiencies in pension actuarial work-product and advice stated to have been provided by the Company's predecessor firm, Towers Perrin, in its capacity as principal actuary to the Houston Firefighters'

37



Relief and Retirement Fund (the "Fund"). ‎Towers Perrin is stated to have acted in this capacity between "the early 1980s until 2002". ‎
In particular, the complaint is critical of two reports allegedly issued by Towers Perrin — one in February 2000 and the other in April 2000 — containing actuarial valuations upon which plaintiff claims to have relied. Plaintiff claims that the reports indicated that the City’s minimum contribution percentages to the Fund would remain in place through at least 2018; and ‎that existing benefits under the Fund could be increased, and new benefits could be added, without increasing plaintiff's financial burden, and without increasing plaintiff's rate of annual contributions to the Fund. The complaint alleges that plaintiff relied on these reports when supporting a new benefit package for the Fund.  These reports, and other advice, are alleged, among other things, to have been negligent, to have misrepresented the present and future financial condition of the Fund and the contributions required to be made by plaintiff to support those benefits, and to have constituted professional malpractice. Plaintiff asserts that, but for Towers Perrin's alleged negligence and misrepresentations, plaintiff would not have supported the benefit increase, and that such increased benefits would not and could not have been approved or enacted.  It is further asserted that Towers Perrin's alleged "negligence and misrepresentations damaged the City to the tune of tens of millions of dollars in annual contributions."
Plaintiff seeks the award of actual damages, exemplary damages, special damages, attorney's fees and expenses, costs of suit, pre- and post- judgment interest at the maximum legal rate, and other unspecified legal and equitable relief.  Plaintiff has not yet quantified fully its asserted damages. 
On October 10, 2014, the Company filed a motion to dismiss plaintiff's entire complaint on the basis that the complaint fails to state a claim upon which relief can be granted. On November 21, 2014, the City filed its response in opposition to the Company's motion to dismiss. To date, no hearing on that motion has been scheduled.
Given the stage of the proceedings, the Company is currently unable to provide an estimate of the reasonably possible loss or range of loss. The Company disputes the allegations, and intends to defend the lawsuit vigorously.
British Coal Staff Superannuation Scheme
On September 4, 2014, Towers Watson Limited ("TWL"), a wholly-owned subsidiary of the Company, received a Letter of Claim (the "Demand Letter") on behalf of Coal Staff Superannuation Scheme Trustees Limited (the "Trustee"), trustee of the British Coal Staff Superannuation Scheme (the "Scheme").  The Demand Letter was sent under the Professional Negligence Pre-Action Protocol, a pre-action dispute resolution procedure which applies in England and Wales.
In the Demand Letter, it is asserted that the Trustee has a claim against TWL in respect of allegedly negligent investment consulting advice provided to it by Watson Wyatt Limited, in the United Kingdom, in particular with regard to a currency hedge that was implemented in connection with the Scheme’s investment of £250,000,000 in a Bluebay local currency emerging market debt fund in August 2008.  It is alleged that the currency hedge has caused a substantial loss to the Scheme, compensatory damages for which loss are quantified at £47,500,000, for the period August 2008 to October 2012.  
TWL sent a Letter of Response on December 23, 2014.
Based on all of the information to date, and given the stage of the matter, TWL is currently unable to provide an estimate of the reasonably possible loss or range of loss.  TWL disputes the allegations, and intends to defend the matter vigorously. 
Meriter Health Services
On January 12, 2015, Towers Watson Delaware Inc. ("TWDE"), a wholly-owned subsidiary of the Company, was served with a Summons and Complaint (the "Complaint") on behalf of Meriter Health Services, Inc. ("Meriter"), plan sponsor of the Meriter Health Services Employee Retirement Plan (the “Plan”).  The Complaint was filed in Wisconsin State Court in Dane County; on February 12, 2015, the Complaint was removed to the United States District Court for the Western District of Wisconsin. On March 10, 2015, Meriter filed a Motion to Remand, seeking to transfer the Complaint back to Wisconsin State Court in Dane County and on July 24, 2015, an amended complaint was filed in the United States District Court for the Western District of Wisconsin.
In the Amended Complaint (the "Amended Complaint"), among other allegations, it is asserted that Meriter has a claim against TWDE, and other entities, in respect of alleged negligence and intentional disregard of Meriter's rights in benefits consulting advice provided to it by Towers, Perrin, Forster & Crosby, Inc. (“TPFC”) and Davis, Conder, Enderle & Sloan, Inc. (“DCES”), including TPFC’s involvement in the Plan design and drafting of the Plan document in 1987, DCES’ Plan review in 2001, and Plan redesign, Plan amendment and drafting of ERISA section 204(h) notices. Additionally, Meriter asserts that TPFC and DCES breached an alleged duty to advise Meriter regarding the competency of Meriter’s then ERISA counsel.

38



In 2010, a putative class action lawsuit related to the Plan was filed by Plan participants against Meriter alleging a number of claims involving ERISA. The lawsuit was settled in 2015 for $82 million. While the Amended Complaint does not include a specific, quantified demand, it does refer to the $82 million paid out by Meriter in settlement of the class action, and other damages (including punitive damages) which are not further particularized in the Amended Complaint. On August 10, 2015, TWDE and other defendants filed with the court their respective answers to the Amended Complaint.
Based on all of the information to date, and given the stage of the matter, TWDE is currently unable to provide an estimate of the reasonably possible loss or range of loss.  TWDE disputes the allegations, and intends to defend the matter vigorously.

Litigation relating to the Towers Watson | Willis Merger

The New Jersey Building Laborers’ Complaint
 
On July 9, 2015, a lawsuit challenging the Towers Watson | Willis Merger was filed in the Court of Chancery, State of Delaware, by alleged Company stockholders, the New Jersey Building Laborers' Statewide Annuity Fund and the New Jersey Building Laborers' Statewide Pension Fund (the "New Jersey Building Laborers’ Complaint") on behalf of a putative class comprised of all public stockholders of the Company other than any named Defendants or affiliates who are Company stockholders.  The New Jersey Building Laborers’ Complaint names as defendants the Company, the members of its board of directors, Willis and Merger Sub. The New Jersey Building Laborers' Complaint generally alleges that the Company's directors breached their fiduciary duties to Company stockholders by agreeing to merge the Company with Willis through an inadequate and unfair process which led to inadequate and unfair consideration and by agreeing to unfair deal protection devices. The New Jersey Building Laborers' Complaint further alleges that Willis and Merger Sub aided and abetted the alleged breaches of fiduciary duties by the Company's directors. The Towers Watson Defendants have not yet responded to the New Jersey Building Laborers' Complaint and intend to defend themselves vigorously against the claims asserted therein.  The asserted loss is not quantified.
 
The City of Atlanta Complaint
 
On July 10, 2015, a lawsuit challenging the Towers Watson | Willis Merger was filed in the Court of Chancery, State of Delaware, by an alleged Company stockholder, the City of Atlanta Firefighters Pension Fund (the "City of Atlanta Firefighters Complaint") on behalf of a putative class comprised of all public stockholders of the Company other than any named Defendants or affiliates who are Company stockholders. The City of Atlanta Firefighters Complaint names as defendants the Company, the members of its board of directors, Willis and Merger Sub.  The substantive assertions and allegations against defendants to the City of Atlanta Firefighters Complaint are the same, or substantially the same, as in the New Jersey Building Laborers' Complaint; and the relief sought by plaintiffs in the City of Atlanta Firefighters Complaint is the same, or substantially the same, as is sought in the New Jersey Building Laborers' Complaint. The Towers Watson Defendants have not yet responded to the City of Atlanta Firefighters Complaint and intend to defend themselves vigorously against the claims asserted therein. The asserted loss is not quantified.
The Cordell Complaint
On July 31, 2015, a lawsuit challenging the Towers Watson | Willis Merger was filed in the Court of Chancery, State of Delaware, by an alleged Company stockholder, Cyndy Cordell (the "Cordell Complaint") on behalf of a putative class comprised of all public stockholders of the Company other than any named Defendants or affiliates who are Company stockholders. The Cordell Complaint names as defendants the Company, the members of its board of directors, Willis and Merger Sub.  The substantive assertions and allegations against defendants to the Cordell Complaint are the same, or substantially the same, as in the New Jersey Building Laborers’ Complaint, and in the City of Atlanta Firefighters’ Complaint; and the relief sought by plaintiffs in the Cordell Complaint is the same, or substantially the same, as is sought in the New Jersey Building Laborers’ Complaint and the City of Atlanta Firefighters’ Complaint.  The Towers Watson Defendants have not yet responded to the Cordell Complaint and intend to defend themselves vigorously against the claims asserted therein. The asserted loss is not quantified.
Note 13 — Variable Interest Entities
The Company adopted ASU 2015-02 under the modified retrospective approach in our fourth quarter of fiscal year 2015 and concluded that it no longer held a variable interest in most of the variable interest entities to which it provides certain service offerings. As a result, those entities are no longer reflected in our disclosure for fiscal year 2015.

39



We offer integrated solutions that include different combinations of investment management or consulting, pension administration, and actuarial services, through entities holding approximately $11.2 million of assets that are considered variable interest entities ("VIEs") and for which our management fee is considered a variable interest.
We determine whether we consolidate based on whether we have both the power to direct the activities that most significantly impact the VIE's performance and have the obligation to absorb losses of, or the right to receive benefits from the VIE that could potentially be significant to the VIE. We are not the primary beneficiary and therefore do not consolidate any of the funds as of June 30, 2015 and June 30, 2014. Our maximum exposure to loss of these unconsolidated VIEs is limited to collection of any unpaid management fees or invested capital (which are not material). The Company has no obligation to provide financial or other support to these VIEs, other than guarantees to provide the minimum statutorily-mandated capital. The Company reassesses its initial evaluation of whether an entity is a VIE when certain reconsideration events occur. The Company reassesses its determination of whether it is the primary beneficiary on an ongoing basis based on current facts and circumstances.
During our third fiscal quarter of 2014 we deconsolidated two previously consolidated funds. Previously, the contracts governing these two funds contained language that restricted the investors' ability to exercise their economic interests in the funds, thereby causing the investors to become related parties of the Company. As these funds were evaluated prior to the adoption of ASU 2015-02, the Company was required to combine its own interests with the interests of these investors for purposes of performing the primary beneficiary test despite not having an indirect economic interest held through those related parties. In aggregate with these related party interests, the Company was deemed to be the primary beneficiary. This restrictive language was modified during our third fiscal quarter, which resulted in the investors, other than the Company's defined benefit retirement plans, to no longer be considered related parties, and the Company to no longer be considered the primary beneficiary of the funds. The mark-to-market gains on the investments prior to deconsolidation were $6.3 million for the year ended June 30, 2014, and are reflected on the accompanying consolidated statements of operations in other non-operating income. The fair value of these investments on the date of deconsolidation, inclusive of the cumulative gains, was $339.0 million, and was removed from the consolidated balance sheets by eliminating the investments of consolidated variable interest entity and by reducing non-controlling interest. The non-controlling interest balance was considered temporary equity as the units held by the investors were redeemable. The changes of the redeemable non-controlling interests balance for the year ended June 30, 2014 are as follows:
Balance as of June 30, 2013
$

Subscriptions of non-controlling interest holders in consolidated VIEs
332,722

Mark-to-market gains on investments held by consolidated VIEs
6,297

Deconsolidation of VIEs
(339,019
)
Balance as of June 30, 2014
$

Note 14 — Accumulated Other Comprehensive Income / (Loss)
Accumulated other comprehensive income /(loss) as presented in the accompanying consolidated statements of comprehensive income includes foreign currency translation, defined pension and post-retirement benefit costs, hedge effectiveness and unrealized gain/loss on available-for-sale securities. Additional information for the other comprehensive income/(loss) and accumulated other comprehensive income/(loss) attributable to controlling interests by component are provided in the following table for the fiscal years ended June 30, 2015, 2014 and 2013. The difference between the amounts presented in this table and the amounts presented in the consolidated statements of comprehensive income are the corresponding components attributable to non-controlling interests, which are not material for further disclosure. Amounts in fiscal year 2014 and 2015 show reclassifications out of accumulated other comprehensive income/(loss) separate from other adjustments due to the prospective adoption of ASU 2013-02, "Comprehensive Income (Topic 220): Reporting of Amounts Reclassified Out of Accumulated Other Comprehensive Income," at the beginning of the fiscal year which requires entities to disclose additional information about items reclassified out of accumulated other comprehensive income.

40



 
 
 
Hedge effectiveness (1)
 
Available-for-sale securities (2)
 
Defined pension and post-retirement benefit costs (3)
 
Foreign currency
translation (1)
 
Before
Tax
 
Tax
 
After
Tax
 
Before
Tax
 
Tax
 
After
Tax
 
Before
Tax
 
Tax
 
After
Tax
As of June 30, 2012
$
(75,332
)
 
$
406

 
$
(152
)
 
$
254

 
$
651

 
$
(182
)
 
$
469

 
$
(416,037
)
 
$
139,901

 
$
(276,136
)
Other comprehensive income/(loss):
(55,764
)
 
(169
)
 
47

 
(122
)
 
(104
)
 
48

 
(56
)
 
182,220

 
(74,997
)
 
107,223

As of June 30, 2013
$
(131,096
)
 
$
237

 
$
(105
)
 
$
132

 
$
547

 
$
(134
)
 
$
413

 
$
(233,817
)
 
$
64,904

 
$
(168,913
)
Other comprehensive income/(loss):
133,367

 
(1,540
)
 
434

 
(1,106
)
 
558

 
(153
)
 
405

 
(45,677
)
 
8,999

 
(36,678
)
Amounts reclassified from accumulated other comprehensive income/(loss)

 
1,447

 
(408
)
 
1,039

 
(761
)
 
173

 
(588
)
 
16,592

 
(3,269
)
 
13,323

Net current-period other comprehensive income/(loss)
133,367

 
(93
)
 
26

 
(67
)
 
(203
)
 
20

 
(183
)
 
(29,085
)
 
5,730

 
(23,355
)
As of June 30, 2014
$
2,271

 
$
144

 
$
(79
)
 
$
65

 
$
344

 
$
(114
)
 
$
230

 
$
(262,902
)
 
$
70,634

 
$
(192,268
)
Other comprehensive income/(loss) before reclassifications:
(228,312
)
 
3,650

 
(1,432
)
 
2,218

 
(168
)
 
54

 
(114
)
 

 

 

Amounts reclassified from accumulated other comprehensive income/(loss)

 
(2,178
)
 
854

 
(1,324
)
 
(35
)
 

 
(35
)
 
(249,865
)
 
90,836

 
(159,029
)
Net current-period other comprehensive income/(loss)
(228,312
)
 
1,472

 
(578
)
 
894

 
(203
)
 
54

 
(149
)
 
(249,865
)
 
90,836

 
(159,029
)
As of June 30, 2015
$
(226,041
)
 
$
1,616

 
$
(657
)
 
$
959

 
$
141

 
$
(60
)
 
$
81

 
$
(512,767
)
 
$
161,470

 
$
(351,297
)
(1)
Reclassification adjustments from accumulated other comprehensive income are included in general and administrative expenses (see Note 8 Derivative Financial Instruments for additional details regarding the reclassification adjustments for the hedge settlements)
(2)
Reclassification adjustments from accumulated other comprehensive income are included in income from discontinued operations
(3)
Reclassification adjustments from accumulated other comprehensive income are included in the computation of net periodic pension cost (see Note 11 – Retirement Benefits for additional details) which is included in salaries and employee benefits in the accompanying consolidated statements of operations
Note 15 — Restricted Stock
In conjunction with the Towers Perrin | Watson Wyatt Merger, shares of Towers Watson common stock issued to Towers Perrin shareholders were divided among four series of non-transferable Towers Watson common stock, Classes B-1, B-2, B-3 and B-4, each with a par value of $0.01 per share. The shares discussed below reflect a reduction of shares through our tender offer and our secondary public offering and by the acceleration of vesting due to involuntary associate terminations detailed below. In addition, on January 31, 2011, we completed the acquisition of EMB and issued 113,858 Class B-3 and 113,858 Class B-4 common stock to the sellers as consideration.
On January 1, 2011, 2012, 2013 and 2014, 5,642,302 shares of Class B-1, 5,547,733 shares of Class B-2, 5,661,591 shares of Class B-3 common stock and 5,374,070 shares of Class B-4 common stock, respectively, converted to freely tradable Class A common stock.
The Towers Perrin restricted stock unit (“RSU”) holders received 10% of the total consideration issued to Towers Perrin shareholders in conjunction with the Towers Perrin | Watson Wyatt Merger. The RSUs were converted into 4,248,984 Towers Watson Restricted Class A shares, of which an estimated 10% were expected to be forfeited by associate Restricted Class A shareholders who were subject to a service condition. The service condition was fulfilled from the grant date through each of the three annual periods from January 1, 2010 until December 31, 2012 and the actual forfeitures were recorded compared to estimated. The restriction lapsed annually on January 1 and the Restricted Class A shares became freely tradable shares of Class A common stock on such dates.
In January 2013, 482,463 forfeited shares were cancelled and a corresponding amount (plus associated dividends) was distributed in the form of Class A shares to Towers Perrin shareholders as of December 31, 2009 in proportion to their ownership in Towers Perrin on the date of the Towers Perrin | Watson Wyatt Merger. Shareholders of Restricted Class A shares

41



had voting rights and received dividends upon annual vesting of the shares. The final 1,109,212 outstanding Restricted Class A shares became freely tradable on January 1, 2013 and were further reduced by shares withheld for tax purposes.
For the fiscal year ended June 30, 2013, we recorded $3.6 million of non-cash share-based compensation expense in connection with the issuance of Towers Watson Restricted Class A common stock to Towers Perrin RSU holders in the Towers Perrin | Watson Wyatt Merger. The graded method of expense methodology assumed that the restricted shares were issued to Towers Perrin RSU holders in equal amounts of shares which vested as separate awards over one, two and three years.
Note 16 – Share-Based Compensation
Registration of Equity Plans
Acquired Plans. In connection with the acquisition of Extend Health in May 2012, Towers Watson filed a Form S-8 Registration Statement and assumed the Extend Health, Inc. 2007 Equity Incentive Plan. The assumed options are exercisable for 377,614 shares of Towers Watson Class A common stock. The registration also covers 55,514 shares of Towers Watson Class A common stock available for issuance under the plan. In connection with the acquisition of Liazon Corporation in November 2013, Towers Watson filed a Form S-8 Registration Statement and assumed the Liazon Corporation 2008 Stock Option Plan and the Liazon Corporation 2011 Equity Incentive Plan, as amended. The assumed options are exercisable for 37,162 shares of Towers Watson Class A common stock. Upon vesting, the assumed restricted stock units will convert into 70,533 shares of Towers Watson Class A common stock. The registration also covers 18,531 shares of Towers Watson Class A common stock available for issuance under the plans.
Towers Watson & Co. Employee Stock Purchase Plan. Towers Watson assumed the amended and restated Watson Wyatt 2001 Employee Stock Purchase Plan (the “Stock Purchase Plan”) which enables associates to purchase shares of Towers Watson Class A common stock at a 5% discount. The Stock Purchase Plan is a non-compensatory plan under generally accepted accounting principles of stock-based compensation. As a result, no compensation expense is recognized in conjunction with this plan. In fiscal year 2010, Towers Watson filed an S-8 Registration Statement registering 4,696,424 shares available for issuance under the Stock Purchase Plan. There were no shares issued during fiscal years 2015, 2014 or 2013.
Towers Watson & Co. 2009 Long-Term Incentive Plan. In January 2010, Towers Watson filed a Form S-8 Registration Statement to register 12,500,000 shares of Towers Watson Class A common stock that may be issued pursuant to the Towers Watson & Co. 2009 Long-Term Incentive Plan (the “2009 Plan”) and 125,648 shares of Class A common stock that may be issued upon exercise of the unvested stock options previously granted under the Watson Wyatt 2000 Long-Term Incentive Plan. The Watson Wyatt 2000 Long-term Incentive Plan was assumed by Towers Watson and the registered shares for the Watson Wyatt 2000 Long-term Incentive Plan are limited to exercise of awards that were outstanding at the time of the Towers Perrin | Watson Wyatt Merger. The assumed options were exercisable for shares of Towers Watson Class A common stock based on the exchange ratio of one share of Watson Wyatt Class A common stock underlying the options for one share of Towers Watson Class A common stock. The 2009 Plan was approved by Watson Wyatt shareholders on December 18, 2009.
Restricted Stock Units
Executives and Employees
The Compensation Committee of our Board of Directors approves performance-vested restricted stock unit awards pursuant to the Towers Watson & Co. 2009 Long Term Incentive Plan. RSUs are designed to provide us an opportunity to offer our long-term incentive program ("LTIP") and to provide key executives with a long-term stake in our success. RSUs are notional, non-voting units of measurement based on our common stock. Under the RSU agreement, participants become vested in a number of RSUs based on the achievement of specified levels of financial performance during the performance period set forth in the agreement, provided that the participant remains in continuous service with us through the end of the performance period. Any RSUs that become vested are payable in shares of our Class A Common Stock. Dividend equivalents will accrue on certain RSUs and vest to the same extent as the underlying shares. The form of performance-vested restricted stock unit award agreement includes a provision whereby the Committee could provide for continuation of vesting of restricted stock units upon an employee’s termination under certain circumstances such as a qualified retirement. This definition of qualified retirement is age 55 and with 15 years of experience at the company and a minimum of one year of service in the performance period.
These awards are typically approved by the Compensation Committee of the Board of Directors in the first quarter of the fiscal year. The LTIP awards are generally based on the value of the executive officer’s annual base salary and a multiplier, which is then converted into a target number of RSUs based on our closing stock price as of the date of grant. Between 0% and 204%, or between 0% and 240% for the 2014 Exchange Solutions ("ES") LTIP, of the target number of RSUs will vest based on the extent to which specified performance metrics are achieved over the applicable performance period, subject to the employee or executive officers’ continued employment with us through the end of the performance period, except in the case of a qualified retirement. For participants that meet the requirement for qualified retirement, we record the expense of their awards over the

42



one-year service period as performed. The Compensation Committee approved the grants and established adjusted three-year average EPS and revenue growth during the performance period as the performance metrics for the awards, with the exception of the 2014 ES LTIP awards, which metrics are based on EBITDA margin and revenue growth. We record stock-based compensation expense over the performance period beginning with the date of grant and will adjust the expense for their awards based upon the level of performance achieved.
The Compensation Committee of the Board of Directors also approves RSUs to certain employees under our Select Equity Plan (“SEP”) during the first quarter of the fiscal year. The RSUs vest annually over a three-year period and include an assumed forfeiture rate.
The following table presents key information with regard to each of the awards that had been granted for the year ended June 30, 2015:
Plan
 
Performance Period
 
RSUs Awarded
 
Grant Date Stock Price
 
Assumed Forfeiture Rate
2015 LTIP
 
July 1, 2014 to June 30, 2017
 
82,350
 
$100.02 and $131.35
 
None
2014 LTIP
 
July 1, 2013 to June 30, 2016
 
65,355
 
$105.90 and $110.70
 
None
2013 LTIP
 
July 1, 2012 to June 30, 2015
 
121,075
 
54.59
 
None
2014 ES LTIP
 
July 1, 2013 to June 30, 2015
 
30,192
 
91.43
 
None
2014 SEP
 
July 1, 2014 to June 30, 2017
 
112,464
 
106.89
 
0.05
2013 SEP
 
July 1, 2013 to June 30, 2016
 
131,286
 
91.43
 
0.05
2012 SEP
 
July 1, 2012 to June 30, 2015
 
147,503
 
53.93
 
0.05
Total expense related to our LTIP and SEP awards, and other miscellaneous RSU awards for the fiscal year ended June 30, 2015, 2014 and 2013 was $33.0 million, $19.0 million and $18.1 million, respectively.
Acquired RSU Plan
Liazon RSUs. In November 2013, in connection with the acquisition, we assumed the Liazon Corporation 2011 Equity Incentive Plan and converted the outstanding unvested restricted stock units into 70,533 Towers Watson restricted stock units using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of these restricted stock units was calculated using the fair value share price of Towers Watson’s closing share price on the date of acquisition. We determined the fair value of the portion of the 70,533 outstanding RSUs related to pre-acquisition employee service using Towers Watson graded vesting methodology from the date of grant to the acquisition date to be $5.7 million which was added to the transaction consideration. The fair value of the remaining portion of RSUs related to the post-acquisition employee services was $2.1 million, and will be recorded over the future vesting periods. For the fiscal years ended June 30, 2015 and 2014, we recorded $0.9 million and $1.1 million, respectively, of non-cash stock based compensation. No expense was recorded in fiscal year 2013.
Outside Directors
The Towers Watson & Co. Compensation Plan for Non-Employee Directors provides for cash and stock compensation for outside directors for the service on the board of directors. During the fiscal year ended June 30, 2015, 2014 and 2013, 8,059, 10,251 and 16,027 RSUs, respectively, were granted for the annual award for outside directors for service on the board of directors in equal quarterly installments over the fiscal year of grant. We recorded $0.8 million, $0.9 million and $0.9 million, respectively, of non-cash stock based compensation for the fiscal years ended June 30, 2015, 2014 and 2013 related to awards for outside directors.

43



The table below presents restricted stock units activity and weighted average fair values for executives, employees and outside directors for fiscal year 2015:
 
Number of
Shares
 
Weighted Average
Fair Value
 
(In thousands,
except per-share amounts)
Nonvested as of June 30, 2014
627

 
$
59.80

Granted
218

 
104.43

Vested
(405
)
 
68.85

Forfeited
(16
)
 
87.71

Nonvested and expected to vest as of June 30, 2015
424

 
$
89.15

As of June 30, 2015, $11.8 million of total stock-based compensation related to the nonvested awards above has not yet been recognized. We expect that this expense will be recognized in our consolidated statement of operations over the next 0.9 weighted-average years.
Stock Options
There were no grants of stock options during the fiscal year ended June 30, 2015, 2014 and 2013 under the 2009 Plan. As of June 30, 2015, there were 29,181 stock options outstanding under the 2009 Plan which were fully expensed and vested prior to fiscal year 2011.
Acquired Option Plans
Liazon Options. In November 2013, in connection with the Liazon acquisition, we assumed the Liazon Corporation 2011 Equity Incentive Plan and converted the outstanding unvested employee stock options into 37,162 Towers Watson stock options using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of the vested stock options was calculated using the Black-Scholes model with a volatility and risk-free interest rate over the expected term of each group of options using the fair value share price of Towers Watson’s closing share price on the date of acquisition. The fair value of the new awards was less than the acquisition date fair value of the replaced Liazon options; accordingly, no compensation expense was recorded. We determined the fair value of the portion of the 37,162 outstanding options relating to the pre-acquisition employee service using Towers Watson graded vesting methodology from the date of grant to the acquisition date to be $2.2 million, which was added to the transaction consideration. The fair value of the remaining portion of unvested options related to the post-acquisition employee service was $1.7 million, which will be recorded over the future vesting periods.
Extend Health Options. In May 2012, we assumed the Extend Health, Inc. 2007 Equity Incentive Plan and converted the outstanding unvested employee stock options into 377,614 Towers Watson’s stock option awards using a conversion ratio stated in the agreement for the exercise price and number of options. The fair value of the vested stock options were calculated using the Black-Scholes model with a volatility and risk-free interest rate over the expected term of each group of options with the fair value share price of Towers Watson’s closing share price on the date of acquisition. The fair value of the new awards were less than the acquisition date fair value of the replaced Extend Health options, accordingly, no compensation expense was recorded. The fair value of 199,620 of the 377,614 outstanding options using Towers Watson graded vesting methodology from the date of grant to the acquisition date, representing the employee service provided to date, was $11.2 million and was added to the consideration price. The fair value of 177,994 unvested options, less 10% estimated forfeitures, was $7.9 million and will be recorded over the future vesting periods.
Total expense related to our acquired option plans for the fiscal years ended June 30, 2015 and 2014 was $1.4 million, and $2.0 million, respectively. In accordance with the Extend Health acquisition agreement, we accelerated the vesting of 23,620 stock options for participants who were involuntarily terminated as a result of the acquisition and recorded $0.4 million of stock-based compensation expense in fiscal 2013. Inclusive of this acceleration, we recorded $6.2 million of stock-based compensation expense for these awards in fiscal 2013.

44



The weighted-average fair value of the stock option grants under the Liazon plan was calculated using the Black-Scholes formula, and is included in the valuation assumptions table below. Compensation expense is recorded over a three-year graded vesting term as if one-third of the options granted to a participant are vested over one year, one-third are vested over two years and the remaining one-third are vested over three years.
 
Liazon Options
 
Fiscal Year Ended June 30, 2014
Stock option grants:
 
Risk-free interest rate
0.57
%
Expected lives in years
2.7

Expected volatility
24.6
%
Weighted-average grant date fair value of options granted
$
104.67

Number of shares granted
37,162

The table below presents stock option activity and weighted average exercise prices for fiscal year 2015:
 
Number of
Shares
 
Weighted
Average
Exercise
Price
 
Aggregate
Intrinsic
Value
 
Average
Remaining
Contractual
Life
 
(thousands)
 
 
 
(thousands)
 
(years)
Outstanding at June 30, 2014
301

 
$
27.01

 
$
17,149

 
3.4
Granted

 
$

 
 
 
 
Exercised
(203
)
 
$
33.22

 
$
28,715

 
 
Forfeited
(1
)
 
$
10.47

 
 
 
 
Expired

 
$

 
 
 
 
Outstanding at June 30, 2015
97

 
$
20.76

 
$
10,172

 
5.9
Exercisable at June 30, 2015
80

 
$
23.04

 
$
8,230

 
5.5
Information regarding stock options outstanding as of June 30, 2015 is as follows:
Exercise Price
 
Number of
Shares
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average Exercise
Price
 
Number of
Shares
 
Weighted
Average
Remaining
Contractual
Life
 
Weighted
Average
Exercise Price
$0.75 - $1.55
 
4,925

 
4.5
 
$
1.45

 
4,925

 
4.5
 
$
1.45

$3.31 - $3.97
 
17,388

 
5.2
 
$
3.49

 
17,388

 
5.2
 
$
3.49

$6.49
 
20,574

 
8.4
 
$
6.49

 
7,756

 
8.4
 
$
6.49

$19.21 - $25.18
 
24,774

 
6.3
 
$
19.74

 
20,848

 
6.2
 
$
19.55

$42.47
 
5,464

 
4.2
 
$
42.47

 
5,464

 
4.2
 
$
42.47

$45.88
 
23,717

 
4.7
 
$
45.88

 
23,717

 
4.7
 
$
45.88

 
 
96,842

 
 
 
$
20.76

 
80,098

 
 
 
$
23.04

The aggregate intrinsic value is the sum of the amounts by which the market price of our common stock exceeded the exercise price of the options at June 30, 2015, for those options for which the market price was in excess of the exercise price.
Note 17 — Income Taxes
Income before income taxes shown below is allocated between operations in the United States (including international branches) and foreign countries. The components of income from continuing operations before income taxes are as follows:
 
2015
 
2014
 
2013
Domestic
$
340,380

 
$
262,462

 
$
239,990

Foreign
245,313

 
236,044

 
189,011

 
$
585,693

 
$
498,506

 
$
429,001


45



The components of the income tax provision for continuing operations include:
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Current tax (benefit)/expense:
 
 
 
 
 
U.S.
$
55,133

 
$
31,880

 
$
25,684

State and local
11,652

 
10,231

 
7,025

Foreign
62,825

 
30,536

 
40,557

 
129,610

 
72,647

 
73,266

Deferred tax expense/(benefit):
 
 
 
 
 
U.S.
52,413

 
49,109

 
49,674

State and local
5,093

 
4,232

 
8,761

Foreign
12,946

 
12,261

 
5,290

 
70,452

 
65,602

 
63,725

Total provision for income taxes
$
200,062

 
$
138,249

 
$
136,991

Included in the U.S. and state and local current tax expense for fiscal year 2015 is a $4.6 million and a $0.7 million tax benefit, respectively, including interest and penalties, due to the release of uncertain tax positions related to U.S. Federal lapses in statute of limitations and effective settlement of certain tax years. Included in the U.S. current tax expense for fiscal year 2014 is a $13.2 million and a $1.7 million tax benefit, respectively, including interest and penalties, due to the release of uncertain tax positions related to U.S. Federal lapses in statute of limitations and effective settlement of certain tax years. Included in the U.S. current tax expense for fiscal year 2013 is a $6.0 million tax benefit, including interest and penalties, due to the release of uncertain tax positions related to U.S. Federal lapses in statute of limitations and effective settlement of certain tax years.
The reported income tax provision for continuing operations differs from the amounts that would have resulted had the reported income before income taxes been taxed at the U.S. federal statutory rate. The principal reasons for the differences between the amounts provided and those that would have resulted from the application of the U.S. federal statutory tax rate are as follows:
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Tax provision at U.S. federal statutory tax rate of 35 percent
$
204,998

 
$
174,477

 
$
150,149

Increase (reduction) resulting from:
 
 
 
 
 
Foreign income tax rate differential, net
(23,352
)
 
(21,902
)
 
(22,540
)
State income taxes, net of federal tax effect
10,740

 
11,344

 
13,288

Non-deductible expenses and foreign dividend
6,302

 
237

 
6,563

Tax credits
(6,010
)
 
(1,807
)
 
(2,104
)
Valuation allowance
(557
)
 
(5,108
)
 
(5,821
)
Legal entity restructuring
(832
)
 
7,077

 
5,159

Release of U.S. uncertain tax positions
(5,252
)
 
(14,910
)
 
(5,977
)
Other
14,025

 
(11,159
)
 
(1,726
)
Income tax provision
$
200,062

 
$
138,249

 
$
136,991

The provision for income taxes for fiscal year 2015 is 34.2% compared with 27.7% in fiscal year 2014. Our effective tax rate increased by 6.5% for fiscal year 2015 as compared to fiscal year 2014 primarily due to prior year income tax benefits on the release of uncertain tax positions related to lapses in statute of limitations and effective settlement of tax positions in the U.S of 2.1% and an increase in current year uncertain tax positions of 2.4%.
The provision for income taxes for fiscal year 2014 is 27.7% compared with 31.9% in fiscal year 2013. Our effective tax rate decreased by 4.2% for fiscal year 2014 as compared to fiscal year 2013 primarily due to current year income tax benefits on the release of uncertain tax positions related to lapses in statute of limitations and effective settlement of tax positions in various taxing jurisdictions, primarily the U.S.
Deferred income tax assets and liabilities reflect the effect of temporary differences between the assets and liabilities recognized for financial reporting purposes and the amounts recognized for income tax purposes. We recognize deferred tax assets if it is more likely than not that a benefit will be realized.

46



Deferred income tax assets (liabilities) included in the consolidated balance sheets at June 30, 2015 and 2014, are comprised of the following:
 
June 30,
 
2015
 
2014
Depreciation and amortization
$
(136,324
)
 
$
(123,684
)
Trademarks and tradename
(115,678
)
 
(117,308
)
Goodwill
(45,191
)
 
(42,477
)
Unbilled receivables
(52,147
)
 
(64,275
)
Other
(3,398
)
 
(8,583
)
Gross deferred tax liabilities
$
(352,738
)
 
$
(356,327
)
Accrued retirement benefits
$
178,402

 
$
139,633

Deferred rent
9,256

 
9,947

Net operating loss carryforwards
29,934

 
37,562

Share-based compensation
5,710

 
6,533

Accrued liabilities
59,830

 
62,516

Accrued compensation
49,079

 
41,660

Deferred revenue
9,632

 
25,692

Foreign tax credit
26,188

 
37,716

Other
9,854

 
16,228

Gross deferred tax assets
$
377,885

 
$
377,487

Deferred tax assets valuation allowance
$
(25,725
)
 
$
(30,019
)
Net deferred tax (liability)/asset
$
(578
)
 
$
(8,859
)
The net deferred income tax assets at June 30, 2015 are classified between current deferred tax assets of $39.4 million and current deferred tax liabilities of $4.3 million and noncurrent deferred tax assets of $62.8 million and noncurrent deferred tax liabilities of $98.5 million.
We maintain a valuation allowance of $25.7 million and $30.0 million at June 30, 2015 and 2014, respectively, against certain of our deferred tax assets, as it is more likely than not that they will not be fully realized. The net decrease in the valuation allowance of $4.3 million in fiscal year 2015 primarily relates to changes in foreign currency translation.
At June 30, 2015, we had tax loss carryforwards in federal and various foreign jurisdictions amounting to $93.2 million of which $55.1 million can be indefinitely carried forward under local statutes. The remaining $38.1 million of loss carryforwards will expire, if unused, in varying amounts from fiscal year 2016 through 2035. At June 30, 2015, we had state tax loss carryforwards of $65.4 million, which will expire in varying amounts from fiscal year 2016 to 2036. In addition, at June 30, 2015 we had foreign tax credit carryforwards of $26.2 million, which will expire in varying amounts from fiscal year 2018 to 2023.
The historical cumulative earnings of our foreign subsidiaries are reinvested indefinitely and we do not provide U.S. deferred tax liabilities on these amounts. We believe the Company’s current cash position, and access to capital markets (via a supplemental offering, if needed) will allow it to meet its U.S. cash obligations without repatriating historical cumulative foreign earnings. Further, non-U.S. cash is used for working capital needs of our non-U.S. operations and may be used for foreign restructuring expenses or acquisitions. The cumulative foreign earnings related to ongoing operations as of June 30, 2015 were approximately $1.0 billion. It is not practicable to estimate the U.S. federal income tax liability that might be payable if such earnings are not reinvested indefinitely. If future events, including material changes in estimates of cash, working capital, long-term investment requirements or U.S. tax reform necessitate that these earnings be distributed, an additional provision for U.S. income and foreign withholding taxes, net of foreign tax credits, may be necessary.
At June 30, 2015, the amount of unrecognized tax benefits associated with uncertain tax positions, determined in accordance with ASC 740-10, excluding interest and penalties, was $36.0 million. This liability can be reduced by $5.5 million of offsetting deferred tax benefits associated with timing differences, foreign tax credits and the federal tax benefit of state income taxes. If recognized, $29.5 million of this difference would impact our effective tax rate.

47



A reconciliation of the beginning and ending balances of the liability for unrecognized tax benefits is as follows:
 
2015
 
2014
 
2013
Balance at July 1
$
32,362

 
$
40,650

 
$
39,309

Increases related to tax positions in prior years
8,461

 
996

 
1,169

Decreases related to tax positions in prior years
(5,314
)
 
(927
)
 
(4,732
)
Decreases related to settlements
(2,468
)
 

 
(189
)
Decreases related to lapse in statute of limitations
(3,611
)
 
(19,135
)
 
(2,387
)
Increases related to current year tax positions
7,803

 
11,223

 
7,426

Cumulative translation adjustment
(1,264
)
 
(445
)
 
54

Balances at June 30
$
35,969

 
$
32,362

 
$
40,650

The liability for the periods ended June 30, 2014 and 2013, respectively, may be reduced by $9.3 million and $14.6 million of deferred tax benefits that, if recognized, would have a favorable impact on our effective tax rate. There are no material balances that would result in adjustments to other tax accounts.
Interest and penalties related to unrecognized tax benefits are included in income tax expense. At June 30, 2015, we had cumulative accrued interest of $1.9 million and penalties of $0.6 million, totaling $2.5 million. At June 30, 2014, we had accrued interest of $2.5 million and penalties of $0.1 million, totaling $2.6 million.
Tax expense for the fiscal year ended June 30, 2015 includes an interest benefit of $0.6 million. Tax expense for the fiscal year ended June 30, 2014 includes interest benefit of $2.7 million and a tax benefit for penalties of $0.1 million.
The Company believes the outcomes which are reasonably possible within the next 12 months may result in a reduction in the liability for uncertain tax positions in the range of $1.3 million to $5.2 million, excluding interest and penalties.
The Company and its subsidiaries file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. During fiscal year 2015 the Company recognized approximately $5.3 million of income tax benefits, including interest and penalties, due to U.S. Federal lapses in statute of limitations and effective settlement related to tax fiscal years 2011, 2012 and 2013. Beginning in fiscal 2014, we are audited by the U.S. Internal Revenue Service under the Compliance Assurance Process ("CAP"). Under CAP, the U.S. Internal Revenue Service works with large business taxpayers to identify and resolve issues prior to the filing of a tax return. As of June 30, 2015, the Company has not been advised of any significant adjustments. We also have ongoing income tax examinations in certain states for tax years ranging from 2008 to 2013. The statute of limitations in certain states extends back to tax year 2002 as a result of changes to taxable income resulting from prior year federal tax examinations. A summary of the tax years that remain open to tax examination in our major tax jurisdictions are as follows:
 
Open Tax Years
(fiscal year ending in)
United States — federal
2014 and forward
United States — various states
2002 and forward
Canada — federal
2007 and forward
Germany
2010 and forward
The Netherlands
2010 and forward
United Kingdom
2010 and forward
Note 18 — Segment Information
Towers Watson has four reportable operating segments or business areas:
Benefits
Exchange Solutions
Risk and Financial Services
Talent and Rewards
Towers Watson’s chief operating decision maker is the chief executive officer. It was determined that Towers Watson operational data used by the chief operating decision maker is that of the segments. Management bases strategic goals and decisions on these segments and the data presented below is used to assess the adequacy of strategic decisions, the method of achieving these strategies and related financial results.

48



Management evaluates the performance of its segments and allocates resources to them based on net operating income on a pre-bonus, pre-tax basis. Revenue includes amounts that were directly incurred on behalf of our clients and reimbursed by them (reimbursable expenses).
On January 23, 2014, Towers Watson announced plans to expand the Exchange Solutions segment by combining operations and associates from the Health & Welfare practice of the Technology and Administration Solutions North America line of business, and certain associates from the Health and Group Benefits line of business, both previously in the Benefits segment, with the Retiree & Access Exchanges line of business and the Liazon acquisition to better align their respective strategic goals. The restructuring took effect on July 1, 2014. We have reclassified certain portions of the revenue (net of reimbursable expenses) and net operating income previously reflected in the Benefits segment in the quarterly filing for years ended June 30, 2014 and 2013 to conform to the current segment alignment within Exchange Solutions. The reorganization had no impact on the Risk and Financial Services and Talent and Rewards segments.
All statement of operations related items presented have been recast to exclude the operating results of our Brokerage business, which has been classified as discontinued operations. Balance sheet related items presented for prior periods include our Brokerage business.
The table below presents revenue (net of reimbursable expenses) for the continuing operations of the reported segments for the fiscal years ended June 30, 2015, 2014 and 2013:
 
For the Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Benefits
$
1,922,380

 
$
1,873,289

 
$
1,902,511

Exchange Solutions
375,020

 
276,360

 
186,805

Risk and Financial Services
603,621

 
638,437

 
645,345

Talent and Rewards
622,820

 
582,703

 
573,336

Total revenue (net of reimbursable expenses)
$
3,523,841

 
$
3,370,789

 
$
3,307,997

The table below presents net operating income for the continuing operations of the reported segments for the fiscal years ended June 30, 2015, 2014 and 2013:
 
For the Year Fiscal Ended June 30,
 
2015
 
2014
 
2013
Benefits
$
692,161

 
$
599,907

 
$
644,144

Exchange Solutions
61,813

 
51,941

 
46,741

Risk and Financial Services
160,442

 
148,448

 
132,285

Talent and Rewards
159,233

 
119,287

 
114,227

Total net operating income (loss)
$
1,073,649

 
$
919,583

 
$
937,397

The table below presents depreciation and amortization for the continuing operations of the reported segments for the fiscal years ended June 30, 2015, 2014 and 2013:
 
For the Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Benefits
$
21,215

 
$
19,956

 
$
23,435

Exchange Solutions
9,029
 
6,139
 
2,431
Risk and Financial Services
4,115
 
4,988
 
6,799
Talent and Rewards
11,334
 
5,811
 
7,842
Total depreciation and amortization
$
45,693

 
$
36,894

 
$
40,507


49



The table below presents receivables for the continuing operations of the reported segments as of June 30, 2015, 2014 and 2013:
 
As of June 30,
 
2015
 
2014
 
2013
Benefits
$
436,245

 
$
478,617

 
$
466,616

Exchange Solutions
64,728

 
45,696

 
41,170

Risk and Financial Services
128,074

 
152,930

 
164,926

Talent and Rewards
158,667

 
148,800

 
147,656

Total receivables
$
787,714

 
$
826,043

 
$
820,368


A reconciliation of the information reported by segment to the consolidated amounts follows as of and for the fiscal years ended June 30 (in thousands):
 
Fiscal Year Ended June 30,
 
2015
 
2014
 
2013
Revenue:
 
 
 
 
 
Total segment revenue
$
3,523,841

 
$
3,370,789

 
$
3,307,997

Reimbursable expenses and other
121,112

 
111,123

 
124,518

Revenue
$
3,644,953

 
$
3,481,912

 
$
3,432,515

Net Operating Income:
 
 
 
 
 
Total segment net operating income
1,073,649

 
919,583

 
937,397

Differences in allocation methods (1)
25,513

 
19,298

 
(12,832
)
Amortization of intangibles
(65,741
)
 
(75,212
)
 
(76,963
)
Transaction and integration expenses
(6,984
)
 
(1,049
)
 
(30,753
)
Stock-based compensation (2)
(22,040
)
 
(11,285
)
 
(18,978
)
Discretionary compensation
(373,672
)
 
(301,428
)
 
(324,370
)
Payroll tax on discretionary compensation
(20,451
)
 
(17,484
)
 
(19,377
)
Other, net
(21,673
)
 
(37,915
)
 
(21,719
)
Income from operations
$
588,601

 
$
494,508

 
$
432,405

Depreciation and Amortization Expense:
 
 
 
 
 
Total segment expense
$
45,693

 
$
36,894

 
$
40,507

Intangible asset amortization, not allocated to segments
65,741

 
75,212

 
76,963

Information technology and other
60,853

 
62,712

 
55,570

Total depreciation and amortization expense
$
172,287

 
$
174,818

 
$
173,040

Receivables:
 
 
 
 
 
Total segment receivables — billed and unbilled (3)
$
787,714

 
$
826,043

 
$
820,368

Valuation differences and other
12,649

 
(4,810
)
 
5,470

Total billed and unbilled receivables
800,363

 
821,233

 
825,838

Assets not reported by segment
4,593,811

 
4,806,553

 
4,506,239

Total assets
$
5,394,174

 
$
5,627,786

 
$
5,332,077

(1)
Depreciation, general and administrative, pension, and medical costs are allocated to our segments based on budgeted expenses determined at the beginning of the fiscal year as management believes that these costs are largely uncontrollable to the segment. To the extent that the actual expense base upon which allocations are made differs from the forecast/budget amount, a reconciling item will be created between internally allocated expenses and the actual expense that we report for GAAP purposes.
(2)
Stock-based compensation excludes RSUs granted in conjunction with our performance bonus, which are included in discretionary compensation.
(3)
Total segment receivables, which reflect the receivable balances used by management to make business decisions, are included for management reporting purposes.

50



The following represents total revenue and long-lived assets information by geographic area as and for the fiscal years ended June 30:
 
Revenue
 
Long-Lived Assets
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
North America
$
2,232,600

 
$
2,046,488

 
$
1,972,981

 
$
2,335,107

 
$
2,484,019

 
$
2,293,045

Europe
1,132,085

 
1,162,888

 
1,161,973

 
1,115,257

 
1,211,700

 
1,193,188

Rest of World
280,268

 
272,536

 
297,561

 
44,806

 
44,466

 
47,308

 
$
3,644,953

 
$
3,481,912

 
$
3,432,515

 
$
3,495,170

 
$
3,740,185

 
$
3,533,541

Revenue is based on the country of domicile for the legal entity that originated the revenue. Exclusive of the United States and the United Kingdom, revenue from no single country constituted more than 10% of consolidated revenue. Revenue from no single client constituted more than one percent of consolidated revenue.
The following represents total revenue and long-lived assets information for the United States, the United Kingdom, and all foreign countries for the fiscal years ended June 30, 2015, 2014 and 2013:
in thousands
Revenue
 
Long-Lived Assets
 
2015
 
2014
 
2013
 
2015
 
2014
 
2013
United States
$
2,044,366

 
$
1,829,309

 
$
1,760,827

 
$
1,995,346

 
$
2,086,754

 
$
1,885,791

 
 
 
 
 
 
 
 
 
 
 
 
United Kingdom
710,499

 
717,856

 
721,543

 
903,411

 
947,227

 
940,146

Rest of World
890,088

 
934,747

 
950,145

 
596,413

 
706,204

 
707,604

Total Foreign Countries
1,600,587

 
1,652,603

 
1,671,688

 
1,499,824

 
1,653,431

 
1,647,750

 
$
3,644,953

 
$
3,481,912

 
$
3,432,515

 
$
3,495,170

 
$
3,740,185

 
$
3,533,541

Note 19 — Earnings Per Share
We present earnings per share (“EPS”) using the two-class method when we have participating securities outstanding. This method addresses whether awards granted in share-based transactions are participating securities prior to vesting and therefore need to be included in the earning allocation in computing earnings per share using the two-class method. This method requires non-vested share-based payment awards that have non-forfeitable rights to dividends or dividend equivalents to be treated as a separate class of securities in calculating earnings per share. Our participating securities include non-vested restricted stock. On January 1, 2013, all remaining outstanding shares of this restricted stock vested and were converted to freely tradable shares of Towers Watson Class A common stock. See Note 15 for further information. The components of basic and diluted earnings per share for the fiscal year ended June 30, 2013 are as follows:
 
Income
 
Shares
 
Per Share
Amount
Basic EPS
 
 
 
 
 
Income from continuing operations
292,010

 
 
 
 
Less: Income attributable to non-controlling interests
(3,160
)
 
 
 
 
Income from continuing operations attributable to common stockholders
$
295,170

 
 
 
 
Less: Income allocated to participating securities
3,289

 
 
 
 
Income from continuing operations attributable to common stockholders
$
291,881

 
70,312

 
$
4.15

Diluted EPS
 
 
 
 
 
Share-based compensation awards
 
 
405

 
 
Income available to common stockholders
$
291,881

 
70,717

 
$
4.13


51



Note 20 — Unaudited Quarterly Financial Data
Summarized quarterly financial data for results from continuing operations for the fiscal years ended June 30, 2015 and 2014 are as follows (in thousands, except per share amounts):
 
2015 Quarter Ended
 
September 30
 
December 31
 
March 31
 
June 30
Revenue
$
878,107

 
$
957,922

 
$
920,714

 
$
888,210

Income from operations
$
125,998

 
$
167,010

 
$
164,477

 
$
131,116

Income from continuing operations before income taxes
$
125,564

 
$
165,752

 
$
163,385

 
$
130,992

Net income attributable to common stockholders
$
81,558

 
$
110,176

 
$
104,142

 
$
89,102

Earnings per share (attributable to common stockholders):
 
 
 
 
 
 
 
Net income, basic
$
1.16

 
$
1.58

 
$
1.50

 
$
1.29

Net income, diluted
$
1.16

 
$
1.57

 
$
1.49

 
$
1.28

 
 
2014 Quarter Ended
 
September 30
 
December 31
 
March 31
 
June 30
Revenue
$
809,939

 
$
888,155

 
$
904,833

 
$
878,985

Income from operations
$
102,421

 
$
128,426

 
$
138,423

 
$
125,238

Income from continuing operations before income taxes
$
100,552

 
$
132,611

 
$
141,144

 
$
124,199

Net income attributable to common stockholders
$
88,214

 
$
86,188

 
$
102,506

 
$
82,392

Earnings per share (attributable to common stockholders):
 
 
 
 
 
 
 
Net income, basic
$
1.21

 
$
1.22

 
$
1.40

 
$
1.17

Net income, diluted
$
1.21

 
$
1.21

 
$
1.39

 
$
1.17

The accompanying unaudited quarterly financial data has been prepared in accordance with generally accepted accounting principles in the United States for interim financial information and with Item 302 of Regulation S-K. In our opinion, all adjustments considered necessary for a fair statement have been made and were of a normal recurring nature.
Note 21 — Subsequent Events
On July 9, 2015, we entered into an agreement with KPMG to sell our Human Resources Service Delivery practice within our Talent and Rewards segment. We expect the transaction to close in the first quarter of fiscal year 2016.

52